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Nuclear export of messenger ribonucleic acid (mRNA) is a 
complex and essential process for a correct gene expression in all 
eukaryotic cells. The export of mRNA through the nuclear pore 
complex depends mostly on the crosstalk and coordination of several 
proteins forming what is known as mRNPs (messenger 
ribonucleoproteins) that play dynamic, interconnecting roles in the 
different mRNA biogenesis steps such as pre-mRNA processing, 
stability, and export. 
One key protein in this process is Mex67, conserved from yeast 
to humans, is the major messenger RNA exporter also involved in 
ribosomal RNA export. Mex67 interacts with Mtr2 to form an 
evolutionary conserved heterodimer essential for proper mRNA export 
and subsequently the survival of the cell. Mex67 have been studied for 
many years, however due to the complexity and interconnectivity of 
the different processes in mRNA biogenesis, there is yet to uncover 
many details on the dynamics of the process and the crosstalk 
between Mex67 and its many partners.  
In this study, using a combination of biochemical, biophysical, 
and structural analysis, we characterize the interaction between 
Mex67 and a novel partner protein called Mip6 (Mex67 interacting 
protein 6). We were able to reconstitute a stable complex in vitro, and 
extensively study the mechanism in which the two proteins interact. 
We also solved the crystal structure of the C-terminal region of Mex67 
that interacts with Mip6 and identified the UBA domain of Mex67, 
known to bind FG nucleoporins and Hpr1 protein as also the site 
where Mip6 binds. However, little was known about the structure or 
function of Mip6 and its paralogue Pes4. Here we proved that Mip6 is 
an RNA binding protein with four RNA recognition motifs that binds 
RNA in vitro with high affinity. Additionally, its fourth RNA 
recognition motif was also the site of binding of Mex67. Furthermore, 
we showed that the Mex67 complex formation with Mip6 RRM4 
compromises its ability to bind RNA or vice versa. We also designed a 
point mutation on Mip6 RRM4 that disrupts its interaction with 
Abstract 
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Mex67 but not with RNA. Subsequent in vivo yeast assays led us to 
hypothesize a role of Mip6 as an adaptor protein for Mex67 in nuclear 
export especially upon stress. Additional function of Mip6 was the 
localization of its bound mRNA to cytoplasmic stress granules in 
cellular stress conditions. 
Moreover, the crystal structures of Mip6 RRM3, Pes4 RRM3, 
Pes4 RRM4, and Pes4 RRM3/4 were also solved. All RRMs adopted a 
canonical RRM fold with conserved RNP1 and RNP2 sequences 
normally involved in RNA binding, except Mip6 RRM3 that was 
missing the aromatic ring in RNP2. In the structure of RNA-free Pes4 
RRM3/4, the tandem RRM domains were connected with a flexible 
disordered linker and no inter-domain contact between them. Finally, 
although Pes4 RRM4 was binding RNA in vitro, it did not have the 
ability to interact with Mex67 thus suggesting a separate evolutionary 
function for Mip6 and Pes4.  
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La exportación nuclear de ácido ribonucleico mensajero 
(ARNm) es un proceso complejo y esencial para una expresión 
correcta de los genes en todas las células eucariotas. La 
exportación de ARNm a través del complejo del poro nuclear 
depende principalmente de la interacción y coordinación de 
varias proteínas, que forman lo que se conoce como mRNPs 
(ribonucleoproteínas mensajeras), que tienen un papel dinámico 
e interconectado en las diferentes etapas de la biogénesis de 
ARNm, tales como el procesamiento del pre-ARNm, estabilidad, 
y exportación. 
Una proteína clave en este proceso es Mex67, conservada 
de levaduras a humanos, que es la principal exportadora de ARN 
mensajero y también está implicada en la exportación de ARN 
ribosomal. Mex67 interacciona con Mtr2 para formar un 
heterodímero conservado evolutivamente esencial para una 
exportación adecuada de ARNm y la consiguiente supervivencia 
de la célula. Se ha estudiado Mex67 durante muchos años, sin 
embargo, debido a la complejidad e interconectividad de los 
diferentes procesos de biogénesis de ARNm, todavía quedan por 
descubrir muchos detalles de la dinámica del proceso y las 
interacciones entre Mex67 y sus muchas proteínas asociadas. 
En este estudio, combinando un análisis bioquímico, 
biofísico y estructural, hemos caracterizado la interacción entre 
Mex67 y una nueva proteína asociada denominada Mip6 
(proteína 6 que interacciona con Mex67). Hemos podido 
reconstituir un complejo estable in vitro y estudiar 
extensivamente el mecanismo por el cual interaccionan estas dos 
proteínas. También hemos resuelto la estructura cristalográfica 
de la región C-terminal de Mex67 que interacciona con Mip6 e 
identificado el dominio UBA de Mex67, conocido por unirse a 
nucleoporinas FG y a la proteína Hpr1, así como el sitio por el 
que se une Mip6. No obstante, se sabía muy poco sobre la 
estructura o la función de Mip6 y su parálogo Pes4. Hemos 
Resumen 
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probado que Mip6 es una proteína de unión a ARN con cuatro 
motivos de reconocimiento de ARN que se unen a ARN in vitro 
con una afinidad alta. Además, su cuarto motivo de 
reconocimiento de ARN es también el sitio de unión a Mex67. 
Posteriormente, demostramos que la formación del complejo de 
Mex67 con el dominio RRM4 de Mip6 compromete su capacidad 
para unir ARN o viceversa. También diseñamos una mutación 
puntual en el RRM4 de Mip6 que rompe la interacción con 
Mex67 pero no con el ARN. Los ensayos posteriores in vivo en 
levaduras nos permitieron establecer una hipótesis sobre el papel 
de Mip6 como proteína adaptadora  para Mex67  en la 
exportación nuclear, especialmente en condiciones de estrés. 
Una función adicional de Mip6 era la localización del ARNm que 
se unía a ella en gránulos de estrés en condiciones de estrés 
celular. 
Además, hemos resuelto las estructuras cristalográficas 
del RRM3 de Mip6, RRM3 de Pes4, RRM4 de Pes4 y los RRM3 y 4 
de Pes4. Todos los RRMs adoptaron una conformación canónica 
RRM con secuencias RNP1 y RNP2 conservadas generalmente 
implicadas en la unión a ARN, excepto el RRM3 de Mip6 que 
carecía del anillo aromático en RNP2. En la estructura sin ARN 
de los RRM3 y 4 de Pes4, los dominios RRM tándem estaban 
conectados por una región flexible desordenada y no había un 
contacto inter-dominio entre ellos. Finalmente, aunque el RRM4 
de Pes4 se unía a ARN in vitro, no presentaba  la capacidad de 
interaccionar con Mex67 lo cual sugiere una divergencia 
evolutiva de la función de Mip6 y Pes4. 
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L´exportació nuclear d´àcid ribonucleic missatger 
(mRNA) es un procés complex i essencial per a una correcta 
expresió gènica en totes cèl·lules eucariotes. L´exportació del 
mRNA a través del complex del porus nuclear depén 
principalment de la interacció i coordinació de diverses 
proteïnes, que formen el que es coneix com mRNPs 
(ribonucleoproteïnes missatgeres), que tenen un paper dinàmic i 
interconnectat en les diferents etapes de la biogènesi d´ARNm, 
com el processament del pre-ARNm, estabilitat, localització i 
exportació. 
Una proteïna clau en aquest procés és MEX67, 
conservada de llevats fins a humans, que és la principal 
exportadora de ARN missatger i també està implicada en 
l´exportació de ARN ribosomal. Mex67 interacciona amb Mtr2 
per a formar un heterodímer conservat evolutivament essencial 
per a una exportació adequada d´ARNm i la consegüent 
supervivència de la cèl·lula. S´ha estudiat Mex67 durant molts 
anys, però degut a la complexitat i interconectivitat dels diferents 
processos de biogènesi d´ARNm, encara queden per descobrir 
molts detalls de la dinàmica del procés i les interaccions entre 
Mex67 i les seues moltes proteïnes associades. 
En aquest estudi, combinant l´anàlisi bioquímic, biofísic i 
estructural, hem caracteritzat la interacció entre Mex67 i una 
nova proteïna associada anomenada Mip6 (proteïna 6 que 
interacciona amb Mex67). Hem pogut reconstituir un complex 
estable in vitro i estudiar extensivament el mecanisme pel qual 
interaccionen estes dos proteïnes. També hem resolt l´estructura 
cristal·logràfica de la regió C-terminal de Mex67 que interacciona 
amb Mip6 i identificat el domini UBA de Mex67, conegut per 
unir-se a nucleoporines FG i a la proteïna Hpr1, així com ser el 
lloc pel que s´uneix Mip6. No obstant, se sabia molt poc sobre 
l´estructura o la funció de Mip6 i el seu paràleg Pes4. Hem 
comprobat que Mip6 es una proteïna d´unió a ARN amb quatre 
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motius de reconeixement d´ARN que s´uneixen a ARN in vitro 
amb una afinitat alta. A més, el seu quart motiu de 
reconeixement d´ARN és també el lloc d´unió a Mex67. 
Posteriorment, demostràrem que la formació del complex de 
Mex67 amb el domini RRM4 de Mip6 compromet la seua 
capacitat per a unir ARN o viceversa. També vam dissenyar una 
mutació puntual en el RRM4 de Mip6 que trenca la interacció 
amb Mex67 però no amb l´ARN. Els assajos posteriors in vivo en 
llevats ens van permetre establir una hipòtesi sobre el paper de 
Mip6 com a proteïna adaptadora per a Mex67 en l´exportació 
nuclear, especialment en condicions d´estrès. Una funció 
adicional de Mip6 era la localització de l´ARNm que s´unia a ella 
en grànuls d´estrès en condicions d´estrès cel·lular. 
A més, hem resolt les estructures cristal·logràfiques del 
RRM3 de Mip6, RRM3 de Pes4, RRM4 de Pes4 i els RRM3 i 4 de 
Pes4. Tots els RRMs adoptaren una conformació canònica RRM 
amb seqüències RNP1 i RNP2 conservades generalment 
implicades en la unió a ARN, excepte el RRM3 de Mip6 que 
mancava del anell aromàtic en RNP2. En la estructura sense ARN 
dels RRM3 i 4 de Pes4, els dominis RRM tàndem estàven 
conectats per una regió flexible desordenada i no hi havia un 
contacte interdomini entre ells. Finalment, encara que el RRM4 
de Pes4 es unia a ARN in vitro, no presentava la capacitat 
d´interaccionar amb Mex67, la cual cosa sugerix una divergencia 
evolutiva de la funció de Mip6 y Pes4. 
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[In the beginning, there was no life, and then nature said, 
“Let there be RNA”, and the world came alive.                       
All forms of life came to be.] 
Nucleic acids, DNA (Deoxyribonucleic acid) and RNA 
(Ribonucleic acid), are the fundamental codes and building blocks of 
life, all forms of life on earth. In order to grow, function, and replicate, 
cells in all living beings require DNA, RNA, and proteins, in which the 
function of each one depends on the other. 
 For decades, scientists searched for the origin of life. 
Nowadays, the widely accepted hypothesis among scientists is an 
“RNA-first world”, as RNA being a putative first precursor of life. For 
RNA, like DNA, is a genetic information storehouse and like proteins 
it has the ability to self-fold into secondary structures or even tertiary 
structures, thus acting as biocatalyst, self-replicating (Robertson & 
Joyce, 2014), self-cleaving ribozymes (Jimenez, Polanco & Lupták, 
2015), and/or in regulating gene expression.  
 
Figure 1.1. RNA world. The hypothesis that RNA preceded DNA in early cells. 
Whether RNA was central to early biochemistry, or proceeded 
by an earlier primitive form of genetic code, RNA molecules are 
definitely central and fundamental to the function of all modern cells. 
However, in contemporary biology, the genetic material is copied, 
transcribed, and translated by complex protein machineries. 
Nevertheless, messenger RNA (mRNA) is never alone. Through 
the short life of mRNA, starting from its transcription and processing 
in the nucleus to its translation and decay in the cytoplasm, mRNA is 
always coated and protected by an assembly of multiple RNA-binding 
proteins (RBPs) (Müller-McNicoll & Neugebauer, 2013). These RBPs 
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are loaded on the mRNA transcripts during all the different 
interconnecting processes, to ensure the protection, fidelity, 
regulation and proper execution of all the steps during the mRNA 
cycle in the correct order of events, which is crucial for proper and 
efficient gene expression. Although individual RBPs can have several 
functions on their own, usually they form part of large multi-protein 
complexes, where all its components interplay, recruiting additional 
proteins or dissociating others, thus interconnecting the different 
processes in a dynamic, efficient manner.  
In recent years, and due to increasingly evolving advances in 
both molecular and structural biology, we are having a better 
understanding of the mechanism of action of these dynamic processes, 
and a clearer view on the involved molecular players, their 
interactions, crosstalk, and functions.  
However though, as we advance our knowledge on crucial 
events like mRNA export in which the survival of eukaryotic cells 
depend on, we are being faced with a far more complex, dynamic, and 
overlapping processes than previously anticipated that we have yet to 
uncover. Therefore, shedding light and studying this critical cell 
process have been a field of interest not only to improve our 
understanding of how eukaryotic cells function, but also to apply our 
knowledge on developing future therapeutic strategies for disease 
associated with mRNA export defects or even targeting cancer cells.    
Since the yeast species Saccharomyces cerevisiae have been a 
very useful eukaryotic system, and many cellular processes including 
the mRNA biogenesis and export have been better studied and 
understood using yeast, it will be the main focus here bearing in mind 
the general conservation of this mechanism from yeast to humans.  
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1.1. Messenger RNA (mRNA) biogenesis: Interconnecting 
processes  
To ensure a proper gene translation, prior mature mRNA 
transcripts have to be properly synthesized and processed in the 
nucleus in order to be competent for export to the cytoplasm where it 
can get translated into functional proteins. This involves various 
extensive processing steps, and the coupling between these steps is 
thought to be indispensable for precise and efficient gene expression 
(Fujiwara, Shiki, & Masu, 2012). 
1.1.1. Transcription initiation:  
 Transcription is the first step of translating genetic 
information encoded in DNA, and its initiation is a very complex 
process. In prokaryotes, this process is carried out by a single RNA 
polymerase species that transcribes all types of RNA, however in 
eukaryotes, different types of molecular machines called nuclear RNA 
polymerases; RNA polymerase I (Pol I), Pol II, and Pol III are required. 
While Pol I transcribes the ribosomal RNA (rRNA) precursor, Pol III 
transcribes small non-coding RNAs such as transfer RNAs (tRNA). Pol 
II, on the other hand, is the transcribing enzyme responsible for the 
transcription of all protein coding genes to produce mRNAs, some 
other few small nuclear RNAs, and most non-coding RNA genes, thus 
a major controller of gene expression.  
Pol II cannot recognize the promoters of target genes alone 
(Fujiwara et al., 2012; Woychik & Hampsey, 2002); hence the 
transcription of these protein coding genes requires the assembly of an 
evolutionary conserved transcription-initiation complex. This consists 
of the assembly of Pol II with general transcription factors TFIIB, 
TFIID, TFIIE, TFIIF and TFIIH at a gene promoter to form the pre-
initiation complex (PIC) (Sainsbury, Bernecky, & Cramer, 2015; 
Woychik & Hampsey, 2002). This complex, especially Pol II activity, is 
regulated and orchestrated by the not-so conserved Mediator multi-
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protein complex associated with 
unphosphorylated carboxy-terminal 
domain (CTD) region of Pol II (Allen & 
Taatjes, 2015).  
This process is initiated by the 
binding of TFIID transcription factor 
that harbours the TATA box-binding 
protein (TBP) and several other TBP-
associated factors (TAFs). TBP, the 
initiation factor, is conserved and 
essential for transcription for all 
promoters by any of the three 
eukaryotic RNA polymerases. TBP 
binds directly to the minor groove in 
DNA with nano-molar affinity, bending 
the helix by ~90 degrees. TFIIA, the 
auxiliary factor, works to stabilize this 
TBP-DNA complex at this stage.  
Another transcription factor, 
TFIIB, interact with both TBP and DNA 
facilitating the DNA bending but 
importantly recruits Pol II to the 
promoter. This classical model, of 
preformed TFIIB-TBP-DNA complex 
binding to Pol II-TFIIF complex is 
called the core initiation complex, and 
is conserved for the transcription 
systems. TFIIE and TFIIH binding to 
the later core initiation complex are 
required for DNA opening. TFIIH, 
harbouring DNA helicases, melts the 
DNA in an ATP dependent manner, 
thus exposing the template strand and 
Figure 1.2.  A schematic 
representation of Pol II 
transcription initiation. A 
model of the stepwise assembly 
of the general transcription 
factors and Pol II on promoter 
DNA (Sainsbury et al., 2015). 
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Figure 1.3. mRNA processing 
steps coupled to transcription. 
The phosphorylated CTD of Pol 
II critical for the elongation 
progression and mRNA 
processing is shown on the right 
(Hocine, Singer, & Grünwald, 
2010). 
thereby allowing the RNA synthesis to begin (Sainsbury et al., 2015). 
The later stimulates the phosphorylation of Pol II CTD, 
releasing its contact with the Mediator and PIC thus leaving the 
promoter and transitioning from initiation to productive elongation 
(Allen & Taatjes, 2015).  
1.2. Elongation:  
Once RNA synthesis starts, 
biogenesis of eukaryotic mRNA requires 
that the transcripts produced by RNA 
polymerase II mature through several 
post transcriptional dynamic processing 
steps that must be completed 
accurately before it can be exported.  
These processes include 5´capping, 
splicing, and 3´ end processing/ 
polyadenylation. The transcribed pre-
mRNA undergoes these three major 
processing steps co-transcriptionally 
(figure 1.3).  
The accurate execution of each 
of these processes is a large 
determinant of the fate of a transcript, 
in which a tight coordination and 
mechanistic coupling of the 
consecutive events is required to 
produce and export functional mRNAs.    
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1.2.1. Co-transcriptional 5´Capping: 
During the first processing event, the eukaryotic RNA 
polymerase transcripts are modified by the addition of a 7-methyl 
guanosine cap (m⁷GpppN) on its 5´ -end. This process is carried out 
co-transcriptionally by the enzymatic action of RNA triphosphatase 
(Tpase), RNA guanylyltransferase (GTase), and guanine-N7 
methyltransferase (guanine-N7 MTase) which associates with Pol II 
phosphorylated CTD (Figure 1.3). 
Once the nascent pre-mRNA is capped, the nuclear cap-
binding protein complex (CBC) binds with high affinity to the 5´cap. 
CBC, a heterodimer composed of two subunits, cap binding proteins 
CBP20 and CBP80, seems to be the first protein complex to assemble 
with the pre-mRNAs (Andrés Aguilera, 2005).  
This assembly is essential for the subsequent steps of mRNA 
processing. mRNA capping is critical, not only because it protects the 
pre-mRNA from 5´-3´exonuclease cleavage, but also for the 
recruitment of the splicing machinery through the nuclear CBC, 
polyadenylation, and ultimately nuclear export (Ramanathan, Robb, & 
Chan, 2016).  
1.2.2. Coupling to splicing: 
The precise removal of non-coding intervening sequences, or 
introns, from the pre-mRNA transcripts is crucial for proper gene 
expression (Hocine, Singer, & Grünwald, 2010). In high eukaryotes the 
vast majority of nascent RNA transcripts undergo this crucial editing 
process to remove introns. The CBC enhances the recruitment and 
assembly of the spliceosome, an evolutionary conserved MDa complex 
composed of 5 small nuclear RNAs and their associated proteins 
(snRNP) to the 5´splice site. Subsequent transesterification reactions 
carried out by the snRNP leads to the excision of the introns and the 
ligation of the exon sequences in order to generate a mature mRNA 
transcript. 
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An important splice-dependent mark is the deposition of the 
multiprotein exon-exon junction complex (EJC) to the spliced 
junctions by the spliceosome, 20-24 nucleotides upstream of exon-
exon junctions (Le Hir et al., 2000). This dynamic post splicing 
complex serves as a binding platform for the proteins involved in the 
later mRNA processing as it accompanies mRNAs to the cytoplasm. 
EJC plays a role in the recruitment of the export machinery to the 
spliced transcripts, thus enhancing the efficiency of nucleo-
cytoplasmic export of spliced mRNA. It does so through proteins 
associated with the EJC, such as ALYREF (Yra1 in S. cerevisiae) a 
component of the TRancription-EXport (TREX) complex, that serves 
as an adaptor protein and a binding site for the co-transcriptional 
recruitment of the export factor Mex67 to the maturing transcripts(Le 
Hir, Gatfield, Izaurralde, & Moore, 2001; Strässer et al., 2000).  
In humans, Few shuttling members of the serine-arginine (SR) 
proteins family involved in splicing also play a role in mRNA export, 
coupling splicing to export, by serving as adaptor proteins for the 
export factor, TAP (Mex67 human homolog), in mRNA export (Huang, 
Gattoni, Stévenin, & Steitz, 2003). 
1.2.3. 3´ Polyadenylation and transcription termination: 
Next, 3´end processing of the spliced, protein coding, 
transcripts, consists of an endonucleolytic cleavage at the 3´end 
followed by polyadenylation where a poly-adenosine tail (Poly-A tail) 
of approximately 70-90 nucleotides (250-300 in humans) is added. 
This process is required to ensure the maturity and stability of the 
transcribed gene and for efficient export and translation later on.  
The newly synthesized mRNA contains several sequenced 
elements (cis elements) recognized by cleavage factor complexes to 
define the cleavage site (figure 1.4.). 
Once the transcript have been cleaved, It is released from Pol 
II transcription machinery, and the poly(A) polymerase (PAP) starts 
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adding the adenosines that comprise the poly (A) tail aided by poly A 
binding proteins (PABPs). This process paves the way to the release 
the mature mRNA from the transcription site. And like all co-
transcriptional processes, it is tightly coupled with mRNA export. 
In yeast, poly (A) binding proteins such as Nab2 are also an 
export adaptor that exports the nucleus with the mature messenger 
ribonucleoproteins (RNPs). Its function is required for efficient 
polyadenylation and nuclear export as it links the two processes and 
any loss in its expression would lead to hyperadynylation and nuclear 
accumulation of poly(A)⁺ RNA (Hector et al., 2002; Kuhlmann, Valkov, 
& Stewart, 2014).  
 
1.3. Nucleo-cytoplasmic RNA export 
Eukaryotic cells are defined by their compartmentalization 
into different organelles that serve as the sites for different cellular 
activities (Jun Katahira, 2012). One of the most important features of 
this definition is the physical separation of the nucleus and the 
cytoplasm by a nuclear envelope, which ensures and controls 
Figure 1.4. 3´ Polyadenylation and 
transcription termination. Cleavage 
and polyadenylation specificity factor 
(CPSF), the core component of the 3´end 
processing complex, specifically 
recognizes the core sequence element 
AAUAAA in the polyadenylation site and 
catalyses cleavage. Whereas the cleavage 
stimulating factor (CSTF) recognizes the 
U/GU-rich elements downstream the 
AAUAAA sequence. Other cleavage 
factors are involved in this process. 
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molecular exchanges between the nucleus and the cytoplasm through 
a specialized and evolutionary conserved structure, the nuclear pore 
complex (NPC). This nuclear pore complex acts as a two-way gate, 
allowing macromolecules such as RNA, proteins, or ribonucleoprotein 
(RNP) particles to be transported in and out from the nucleus to 
cytoplasm and vice versa (Kabachinski & Schwartz, 2015; 
Knockenhauer & Schwartz, 2016).  
While proteins are synthesized in the cytoplasm, the nucleus is 
the storage site of the DNA and the site of transcription and 
processing of the different types of RNA. Therefore, the export of RNA 
molecules from the nucleus to the cytoplasm is fundamental for gene 
expression. The RNA molecules exported through the NPC include not 
only messenger mRNA, but also ribosomal rRNA, transfer tRNA, 
microRNA (miRNA), small nuclear RNA (snRNA). While the 
biogenesis of some types of RNA (snRNA) requires the transport in 
and out of the nucleus, others like mRNA and tRNA move exclusively 
in one way direction out of the nucleus. Their journeys are aided by 
mobile transport factors, and is mediated almost solely through the 
NPC (Fujiwara et al., 2012; Knockenhauer & Schwartz, 2016; Köhler & 
Hurt, 2007). 
This dynamic transport of cargoes through the NPC requires 
the two major transport systems in eukaryotes: The nuclear 
transporters of the importin/exportin-β super family, commonly 
known as karyopherins, which are further categorized into importins 
and exportins, and the nuclear exporter Mex67-Mtr2 (Nxf1-Nxt1/Tap-
p15 in humans) heterodimer (figure 1.5.). 
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Figure 1.5. Major RNA nuclear export routes. Major export factors for each type of RNA with 
their adaptor proteins are shown in the figure (Köhler & Hurt, 2007). 
1.3.1 RNA export factors 
Exportins: 
Most nucleo-cytoplasmic transport is signal-mediated. 
Karyopherins, or importin β family members, responsible for the 
major part of that transport, are a conserved super-family of transport 
nuclear factors. They function by the recognition/binding of short 
peptide signals on cargo proteins, in a guanosine triphosphate GTP-
bound form of the guanine nucleotide binding protein Ran (Ran-GTP) 
gradient dependent manner. They can recognize nuclear localization 
signals (NLS) and nuclear export signals (NES) in proteins to direct 
them, through the NPC, in or out of the nucleus respectively (Chook & 
Süel, 2011; Köhler & Hurt, 2007). 
That is to say, karyopherins include nuclear import factors 
(importins) that recognize the NLS in the cargo protein, and nuclear 
export factors (exportins) that recognize the NES sequence.  
Exportins recognize and bind, chiefly, the NES sequences 
which are usually a hydrophobic, classically leucine rich, short peptide 
sequences in cargo proteins. The export of some classes of RNA similar 
to that of proteins follows the general paradigm of exportins-mediated 
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protein export, though each might require different exportins. 
Processed and mature tRNA is mainly exported by exportin-t (Xpot, 
Los1 in yeast) by binding directly to the tRNA in a RAN-GTP 
dependent manner, while the non-coding, gene regulating, miRNA is 
mostly exported by exportin-5 (Xpo5 or Exp5) in a similar simple 
conserved export route (Köhler & Hurt, 2007; Okamura, Inose, & 
Masuda, 2015). On the other hand, exportin-1 (Xpo1), or better known 
as Crm1 (Chromosome maintenance region 1) plays a major role in 
snRNAs and rRNA export (figure 1.5). 
Crm1/ Xpo1 
Crm1 or Xpo1, first characterized as an exporter binding NES 
sequence of the viral HIV-1 Rev protein (Fornerod, Ohno, Yoshida, & 
Mattaj, 1997), is one of the most conserved RanGTPase-driven nuclear 
export factors that is structurally well characterized (X. Dong et al., 
2009; Güttler et al., 2010; Monecke et al., 2009). Like other exportins, 
the directionality of Crm1 exported cargoes is driven and regulated by 
the asymmetric distribution of Ran-GTP (nucleus) and Ran-GDP 
(cytoplasm). The cargo-exportin-RanGTP complexes in the nucleus 
drive the export through the nuclear pore to the cytoplasm, where the 
cargo is released upon the hydrolysis of Ran-GTP by Ran-GTPase 
activating protein (Ran-GAP).  
The Importance of Crm1 comes from the fact that it exports a 
wide range of substrates from the nucleus, including ribosome, 
mRNPs, snRNA, and many regulatory proteins. It was also suggested 
that Crm1 also plays a role in the nucleo-cytoplasmic shuttling of 
mature microRNAs (Castanotto, Lingeman, Riggs, & Rossi, 2009), and 
is essential for replication of viruses such as HIV. But unlike other 
exportins such as Xpot and Xpo5, Crm1 cannot bind directly to its 
targeted RNA; instead it requires adaptor proteins bound to RNA. It is 
an export factor for leucine rich NESs (Fornerod et al., 1997), where it 
binds physically to the NES sequences in the associated adaptor RNPs. 
however, it is also known for Crm1 to recognize not only short 
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peptides but also large portion of the export cargo (Monecke et al., 
2009). The mechanism of recognition in which Crm1 is able to 
recognize its wide range of substrates and its ability to carry multiple 
cargoes is yet to be better understood. 
1.4. mRNA export: From transcription site to the nuclear pore  
Like others RNAs, mRNA is transcribed in the nucleus, but 
unlike the export of many RNAs, mRNA export is exclusively 
unidirectional, mechanistically different process. Although the 
classical Crm1/Xpo1 exportin was demonstrated to be involved in the 
export of only small groups unspliced or partially spliced of mRNAs 
(Cullen, 2003; S. Dong et al., 2007; Gallouzi & Steitz, 2001), it doesn´t 
have a major role in mRNA export (Neville & Rosbash, 1999; Reed, 
Clouse, Luo, & Zhou, 2001). Instead, Mex67/Mtr2 heterodimer in yeast 
(TAP/P15 or NFX1/NFT1 in metazoan) is the general nuclear exporter 
of mRNA in the form of mature ribonucleoproteins (mRNP) particle. 
This heterodimer is evolutionary conserved from yeast to humans (J. 
Katahira et al., 1999). It is structurally unrelated to the classical 
karyopherins/exportin transport system, and does not obey the 
classical RanGTP-RanGDP gradient directionality paradigm (Reed et 
al., 2001). Instead, mRNA export is known as a facilitated and energy-
dependent process (Dargemont & Kühn, 1992). Although, like 
karyopherins, Mex67/Mtr2 interacts directly with the FG repeats of the 
NPC nucleoporins (Askjaer et al., 1999; Bayliss, Littlewood, & Stewart, 
2000; Sträßer, Baßler, & Hurt, 2000).  
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Mature ribonucleoprotein (RNP) complex formation is a 
hallmark of the mRNA export, not required for the export of other 
types of RNA. Like rRNA, mRNA is never alone and definitely doesn´t 
travel alone. Prior to export, nascent transcripts must be 5´capped, 
spliced, and polyadenylated correctly as mentioned previously. RBPs 
associate with the nascent pre-mRNA transcripts early on during 
transcription and elongation/maturation processes ensuring the tight 
coupling between mRNA biogenesis and export. RBPs are usually 
components of multi-protein complexes recruited to the mRNA 
transcripts in a carefully orchestrated series of processing steps, which 
are all kept under tight 
surveillance before being 
exported to the cytoplasm. 
These RBPs usually contain 
RNA recognition/binding 
domains to interact with the 
mRNA along the way to 
produce a mature, exportable 
mRNP particle (Kurshakova, 
Georgieva, & Kopytova, 2016; 
Tutucci & Stutz, 2011). 
Although the exact 
mechanism of packaging of 
mRNP is not yet fully 
understood, and many more 
RNA-binding proteins that 
play a role in its formation 
are yet to be discovered, we 
know that the composition 
and formation of an export-
competent mRNP complex, is 
highly dynamic where its 
proper packaging is critical 
for the regulation and export 
Figure 1.6. Steps of mRNP Export from 
transcription to the cytoplasm. All processes are 
coupled and overlapped (Wickramasinghe & 
Laskey, 2015) 
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of the mRNA from the nucleus. RBPs recruit the Mex67/Mtr2 
heterodimer to the mRNP.  
Although Mex67, unlike Crm1, can itself bind with mRNA (S. 
Aibara, Valkov, Lamers, & Stewart, 2015), it operates with many of the 
adaptor RNA-binding proteins that act as bridges, mediating and 
further stabilizing the interaction between the mRNA and its 
Mex67/Mtr2 heterodimer export factor. But before an mRNP can enter 
the NPC, a tight quality control is performed during the whole, pre-
export, process to ensure that aberrant RNAs are degraded, and only 
mature mRNPs are exported. This nuclear quality control is, mostly, 
carried out co-transcriptionally by members of the TRAMP (trf4-Air2-
Mtr4p polyadenylation) and exosome protein complexes, which survey 
mRNA, and identify and degrade any defective mRNPs (Chlebowski, 
Lubas, Jensen, & Dziembowski, 2013; Kilchert & Vasiljeva, 2013). 
Mature mRNPs are then escorted to the nucleoplasmic side of the 
NPC, or more specifically, the nuclear basket by the TREX and TREX2 
(transcription –export complexes) (Fischer et al., 2002; Sträßer et al., 
2002). Once mature mRNP is assembled and targeted to the NPC, 
Mex67 promotes the docking of mRNP to the nuclear basket of the 
NPC and the translocation through the central channel of the NPC via 
its physical interaction with the phenylalanine-glycine (FG repeats) of 
the nucleoporins. mRNA transcripts are always exported in a 5´-
3´direction.  
1.4.1. mRNA export adaptors 
Although mRNP biogenesis and export steps are often 
described separately for simplicity, they are tightly coupled and 
interdependent, with some factors participating in multiple stages. 
Importantly, the early requirement of proteins not only allows efficient 
pre-mRNA processing and mRNP assembly but also protects the 
mRNA from degradation through continuous competition with the 
nuclear surveillance machineries (Tutucci & Stutz, 2011). 
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Among the big number of adaptor proteins/complexes that 
play a role in mRNA export, many have been identified, but it is likely 
that more will be uncovered among the huge number of the predicted 
RBPs in eukaryotes. Due to the limited space we have, here we are 
going to discuss, in brief, the key adaptor proteins/complexes in the 
mRNA export machinery. 
1.4.1.1 THO/TREX Complex 
The THO complex, a nuclear protein complex with a key role 
in the co-transcriptional formation of the export-competent mRNPs, is 
conserved from yeast to humans. The yeast THO has a stable core of 
tetrameric sub-complex formed by Tho2, Hpr1, Mft1, and Thp2 
associated with a fifth protein named Tex1 (figure 1.7). In metazoan, 
THO contains 3 more subunits THOC5, THO6, and THOC7 that does 
not appear to have yeast homologs (Rehwinkel et al., 2004).  
       
Figure 1.7. Components of the THO/TREX complex involved in coupling co-transcriptional 
elongation to mRNA export (Jun Katahira, 2012). 
THO has a key role in the mRNA co-transcriptional elongation 
during mRNPs biogenesis by Pol II. However, recently it was also 
shown to enhance transcription initiation and elongation by RNA Pol I 
(Yinfeng Zhang, French, Beyer, & Schneider, 2016). Loss of any of the 
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THO subunits impairs transcription elongation, genome stability, and 
mRNA export. 
 Expected to be one of the first players to act co-
transcriptionally, helping recruiting other adaptor proteins to ensure a 
correct packaging of mRNPs and further recruiting the export 
machinery required for its export, THO was also shown crucial to 
prevent the formation of DNA-RNA hybrids (R-loops) by binding to 
chromatin and to the nascent mRNA (Huertas & Aguilera, 2003). Hpr1, 
being the first known key component in the THO complex, was first 
identified in genetic screen for hyper-recombinant mutants in S. 
cerevisiae (A Aguilera & Klein, 1988). Further studies found a role for 
Hpr1 in transcription elongation and mRNA export as it recruits the 
export factor Mex67 to the mRNP through the ubiquitin-dependent 
interaction with Mex67 C-terminal ubiquitin associated (UBA) domain 
(Gwizdek et al., 2006; Hobeika et al., 2009).  
 
Figure 1.8. THO/TREX complex co-transcriptional arrangement and its role in the recruitment 
of the mRNA export machinery (Tutucci & Stutz, 2011). 
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Two additional adaptor proteins named Yra1 (ALY in humans) 
and Sub2 (Uap56 in humans) are then associated with the THO to 
form the conserved TRanscription-EXport (TREX) complex (Sträßer et 
al., 2002) which, as the name indicates, couples transcription to 
export. Sub2, a dead-box ATPase required for spliceosome assembly 
process (Libri, Graziani, Saguez, & Boulay, 2001), is recruited to the 
transcription machinery via the THO complex. Once bound, Sub2 
assumes a semi-open conformation stimulating its ATPase activity, 
allowing the recruitment of the adaptor protein Yra1 where they 
interact and cooperatively bind to RNA (figure 1.9.) (Ren et al., 2017; 
Sträßer & Hurt, 2001). Previous studies have reported that Sub2 is 
dispensable for Yra1 recruitment; instead yra1 is recruited by 
interacting with Pcf11 (the Pol II CTD binding subunit of cleavage-
polyadenylation factor CF1A) (Johnson, Cubberley, & Bentley, 2009; 
Saguez & Jensen, 2009). Yra1 is also associated with cap-binding and 
the EJC during splicing as mentioned earlier.  
 
Figure 1.9. A model of TREX-mediated mRNP remodelling prior to nuclear export (Ren et al., 
2017). 
The THO complex assembly with Yra1 and Sub2, is ATP-
dependent which is also conserved with the human homologs (Dufu et 
al., 2010; Ren et al., 2017). This TREX complex packing, important for a 
stable mRNP formation and export (Zenklusen, Vinciguerra, Wyss, & 
Stutz, 2002), subsequently recruits and assists in loading the export 
factor Mex67/Mtr2 to the mRNPs, through the direct interaction 
between Yra1 and Mex67 (Strässer et al., 2000). However, Sub2 and 
Mex67 compete for the same binding site on Yra1 (figure 1.9.). That is 
to say, after Yra1 is recruited to TREX by sub2, it dissociates from Sub2 
as Mex67 binds (Sträßer & Hurt, 2001).  
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While yeast THO/TREX is associated transcriptionally with all 
actively transcribed genes since most genes are intronless, human 
TREX requires 5´capping and Its assembly is coupled to transcription, 
indirectly, through splicing (Masuda et al., 2005), suggesting a 
regulation mechanism where Mex67 is exclusively recruited to spliced 
transcripts, thus making sure only correctly spliced/processed mRNPs 
can export the nucleus.  However, some studies indicated that 
splicing-independent mechanisms also seem to operate in higher 
eukaryotes (Chung et al., 2016). 
In humans, Mex67 
in its free form exhibits a 
closed conformation. It´s 
recruitment to the mRNP 
by the TREX complex, and 
its contact with TREX 
subunits remodels Mex67 
to an open conformation, 
exposing its RNA binding 
domain (Viphakone et al., 
2012). The TREX adaptor 
proteins thus handover the 
mRNA to Mex67 and 
enhances its RNA-binding 
ability essential for its export function (Hautbergue, Hung, Golovanov, 
Lian, & Wilson, 2008) (figure 1.10.). Whether the yeast counterpart 
utilizes a similar mechanism to bind mRNA is not so clear. 
  This recruitment of Mex67/Mtr2 to the mRNP via TREX brings 
Mtr2/Mex67/mRNP closer to the nuclear pore that will then facilitate 
the mRNP transverse through the NPC. 
Other major known adaptors of Mex67 involved in mRNA 
export is the poly (A) RNA binding protein Nab2 mentioned earlier, 
that is capable of interacting spontaneously with Mex67 and Yra1, 
Figure 1.10. The conformational changes in TAP 
(NXF1) induced by TREX binding prior to mRNA 
export (Viphakone et al., 2012). 
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where Yra1 enhances the Mex67/Nab2 interaction (Iglesias et al., 2010). 
However, unlike Yra1 that dissociates from Mex67 prior to nuclear 
export, Nab2 travels with the mRNP and Mex67 through the NPC 
where it is released in the cytoplasm (Tran, Zhou, Corbett, & Wente, 
2007). Another  multifunctional protein that participates in a variety 
of RNA-related processes, including transcription, splicing, mRNA 
export, and translation is Npl3 (Santos-Pereira, Herrero, Moreno, & 
Aguilera, 2014). Npl3 is a conserved mRNA binding export adaptor that 
packs co-transcriptionally and shuttles with mRNPs (Lei, Krebber, & 
Silver, 2001).  
Bearing that in mind, the precise mechanism of the dynamic 
and complex crosstalk between mRNA and all the different proteins in 
the TREX-mediated mRNP assembly awaits further understanding.  
1.4.1.2 TREX2 complex 
Close to the nuclear pore, another complex named TREX2 has 
been recently described to further couple Transcription and mRNA 
export. TREX2 is an evolutionary conserved complex composed of five 
subunits Sac3, Sus1, Thp1, Cdc31, and Sem1 in yeast, and their 
homologs in human.  
First identified as a sac3/Thp1 complex, it was proposed that 
this sac3/Thp1 complex functions in docking the export machinery to 
the nuclear basket of the NPC (Fischer et al., 2002). That was 
demonstrated through the binding ability of sac3 to Mex67 on one 
hand, and its ability to interact with Nup1 and Nup60 nucleoporins at 
the nuclear face of the NPC on the other hand. In yeast, like THO 
mutants, deletion of any of TREX-2 subunits results in mRNA export 
defects. Moreover, recently a study showed that defects in THO and 
TREX-2 assembly causes accumulation of mRNP granules (Eshleman, 
Liu, McGrath, Parker, & Buchan, 2016). Further studies have confirmed 
the positioning of the TREX-2 at the nuclear pore (Rodrı́guez-Navarro 
et al., 2004). However, a recent study suggested that TREX2 is a stably 
associated NPC complex, possibly with other functions independent of 
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transcription (Umlauf et al., 2013). Sac3 was also shown to interact 
with Sub2 thus additionally proposing an involvement in coordinating 
co-transcriptional processing with export.  
The TREX-2 complex is based on a Sac3 scaffold to which Thp1, 
Sem1 associate with the middle part whereas Cdc31 and two copies of 
Sus1 bind to its C-terminal domain (CID) (Shintaro Aibara, Bai, & 
Stewart, 2016) (figure. 1.11). The Sac3/Sem1/Thp1 association results in a 
structural conformation necessary for mRNA binding (Marius Boulos 
Faza et al., 2009). Additionally, the FG like repeats in the N-terminus 
of Sac3 binds the Mex67/Mtr2 exporter (Dimitrova et al., 2015), 
Therefore escorting the export machinery Mtr2/Mex67/mRNP to the 
NPC. 
             
Figure 1.11. Sac3 serves as a scaffold for which the components of TREX-2 bind and Mex67 binds. 
(Shintaro Aibara et al., 2016). 
Interestingly, Sus1 is also a component of the SAGA complex 
involved in histone modifications (acetylation and de-ubiquitination) 
and transcription activation (Rodrı́guez-Navarro et al., 2004), thus 
linking transcription initiation to export. A recent study emphasised 
this relation by showing that TREX-2 furthermore directly interacts, 
with the mediator complex associated with Pol II during transcription 
initiation (Schneider et al., 2015). Thus connecting the transcription 
site to the export machinery and bringing transcribed genes closer to 
the NPC facilitating mRNP export to the cytoplasm, especially for 
actively transcribed genes. However, how TREX-2 regulates this gene 
expression machinery and its exact mechanism of action is yet to be 
uncovered.  
Mex67 binding site 
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Figure 1.12. Mex67-dependent mRNA nuclear export. The recruitment of Mex67/Mtr2 by 
THO/TREX complex, and later the interaction of the mRNP particle with the TREX-2 complex 
positioned at the nuclear face of the NPC (Kurshakova et al., 2016). 
1.5. rRNA export 
The large pre-60S and the small pre-40S ribosomal subunits 
are assembled in the nucleus before being transported to the 
cytoplasm to contribute to the polysomic formation. Like mRNA, the 
ribosomal subunits export the nucleus in the form of RNPs. Due to the 
fact that the ribosomal subunits are one of the largest RNA-containing 
particles to pass through the NPC channel, studies have shown that its 
export involves several export factors that can work cooperatively, but 
independently to ensure efficient export of the ribosomal subunits and 
prevent any disassembled ribosomal RNP or backsliding to the 
nucleus. Notably, unlike the case of mRNA, the export machinery is 
recruited to the pre-ribosomal particles at a late stage after it had 
already undergone complicated steps of processing and maturation.   
Subsequently, the mature pre-60S and pre-40S subunits follow 
separate export routes. Currently, we better understand the pre-60S 
subunit export but many aspects about the pre-40S subunit export are 
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not yet well understood. What’s known so far is a role for three export 
receptors: exportin Crm1/Xpo1, Mex67/Mtr2, and Arx1 (figure 1.13.).  
Crm1 requirement for the export of both pre-60S and pre-40S 
rRNA in a RanGTP dependent manner is conserved from yeast to 
humans, however as mentioned earlier it requires different adaptor 
proteins in each case since it cannot bind the rRNA on its own. Nmd3 
is well known to be the NES-containing adaptor protein required by 
Crm1 in the case of pre-60S export (Sengupta et al., 2010).  On the 
other hand, Arx1, can bind and accompany the pre-60S through the 
NPC but whether it has a role to play in the pre-40S export is not yet 
known (Bradatsch et al., 2007).  
Like Crm1, Mex67/Mtr2 heterodimer have been also recently 
described to be involved in the export of both pre-60S and pre-40S 
rRNA (Marius B. Faza et al., 2012; Yao et al., 2007). Both Mex67 and 
Arx1, unlike Crm1, accompany the rRNA through a direct contact with 
the ribosomal subunits. Mex67 has been demonstrated to bind the 
pre-60S and 5S ribosomal RNA in vitro (Yao et al., 2007). All three 
exporters translocate the rRNA through direct interaction with the FG 
nucleoporins lining the NPC channel, although none of them is 
structurally related. Whether TAP, the human homolog of Mex67 also 
functions in rRNA is unclear. Additionally, whether unknown Mex67 
adaptor proteins contribute in this process is not yet well understood. 
Moreover, Npl3 known as an export adaptor for Mex67 in the mRNP 
export machinery have also been characterized to mediate the export 
of pre-60S ribosomal subunit independently of Mex67 (Hackmann, 
Gross, Baierlein, & Krebber, 2011).  
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Figure 1.13. The Pre-60S Export in yeast (Köhler & Hurt, 2007). 
1.6. Nuclear Pore Complex (NPC) 
After the mature mRNP is properly packaged and docked to 
the NPC nuclear face, the clear next step is for the mRNP to pass 
through the NPC irreversibly to the cytoplasm.  
Despite the dynamic protein composition of the NPC in 
different species, the structure and function of the NPS in eukaryotes 
is remarkably evolutionary conserved (Knockenhauer & Schwartz, 
2016; Lin et al., 2016). It is, almost, the sole mean of communication 
between the nucleus and cytoplasm. The NPS are vast protein 
assemblies, embedded in the nuclear envelope, acting like a channel or 
a gate that regulates the selective and massive transport of 
macromolecules between these cellular compartments (Knockenhauer 
& Schwartz, 2016; Niño, Hérissant, Babour, & Dargemont, 2013). These 
compartments need to communicate extensively between each other, 
and therefore molecules need to be exchanged frequently, reliably, 
and efficiently across membranes. Thus, NPC serves not only as a 
nucleoplasmic mediator, but also as a regulator of gene expression 
(Lin et al., 2016).  
The NPC is one of the largest protein assemblies in the cell, 
with an estimated size of ~50 MDa in yeast NPC to ~120 MDa for that 
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of vertebrates. Due to its massive size and flexibility, scientists had 
hard time determining its structure. Our most accurate current view 
of the NPC today comes from biochemical and structural studies using 
x-ray crystallography for separate sub complexes in addition to cryo-
EM (Hoelz, Glavy, & Beck, 2016). The work from Lin D. et al. recently 
published in the journal Science have combined previous structural 
studies with additional work  to reconstitute a high resolution, fairly 
accurate, biochemical interaction map of the symmetric core of the 
nuclear pore (Lin et al., 2016, Figure 1.14).  
            
Figure 1.14. Composite structure of the NPC symmetric core (Lin et al., 2016). 
It is a cylindrical channel composed of multiple copies of more 
than 30 different nuclear pore proteins (nucleoporins) divided into 
three main categories. Most nucleoporins arrange in an eight fold 
symmetrical core structure perpendicular to the nuclear envelope, 
while others extend asymmetrically on the nuclear and cytoplasmic 
faces (forming the nuclear basket and the cytoplasmic filaments 
respectively). Many nucleoporins contain disordered repetitive 
sequences called FG repeats, due to their high content in 
phenylalanine and glycine residues. These FG repeats wrap the central 
channel to form a selective barrier. While ions, metabolites, and 
macromolecules below 40 KDa can pass freely through the NPC by 
FG repeats 
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passive diffusion; larger macromolecules, and RNA molecules in the 
form of RNP complexes requires ,tightly regulated active, transport 
mediated by transport factors.  
After the escorting/docking of mature mRNPs to the nuclear 
basket of the NPC, Mex67 then interacts physically with the FG 
repeats of the central channel nucleoporins through its C-terminal 
UBA domain and NTF2 central domain, pulling the mature mRNPs 
further into the NPC and out to the cytoplasm. 
1.6.1. Role in mRNA quality control 
Practically every step of mRNA biogenesis involves rigorous 
quality control to detect possible errors in transcription, mRNA 
processing or export. In addition to the role of the nuclear 
exosome/TRAMP in the quality control of mRNA mentioned earlier, 
anchored to the NPC on the nuclear basket of the NPC, are the 
filamentous myosin-like proteins (Mlp1/Mlp2 in yeast/ Tpr in 
vertebrates). Mlps act as “gate keepers” or the final mRNA quality 
control check points, making sure that only mature, correctly spliced 
mRNPs are exported from the nucleus. Thus, preventing the escape of 
any aberrant, non-spliced, or misfolded mRNP missed by the nuclear 
surveillance machinery and therefore, blocking the translation of 
improperly synthesized mRNAs. This is achieved by their ability to 
associate with RNP complexes on their journey exporting the nucleus 
through their C-terminal globular domain (Green, Johnson, Hagan, & 
Corbett, 2003). It is still unclear how exactly Mlps recognize 
malformed mRNPs, but it was shown that Mlp1 interact with several 
proteins of the export machinery such the Poly (A) binding protein 
Nab2, Npl3 (Fasken, Stewart, & Corbett, 2008), and Sac3 of TREX-2 
(Oeffinger et al., 2007) (Figure 1.15.). 
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1.6.2. mRNA export termination and cytoplasmic mRNPs 
remodelling 
Once the mRNP make it through the NPC and to the 
cytoplasmic side of the NPC, it requires a termination step to release 
the mRNA from its export factors in order to be further translated by 
the ribosome. Dead-box family enzymes have been known to play role 
in many aspects of RNA metabolism, but importantly for their 
function as ATP-dependent helicases in RNA-duplexes unwinding 
and/or the removal of RNA associated proteins (Fairman et al., 2004; 
Jankowsky & Bowers, 2006). Dbp5, a highly conserved DEAD-box 
protein helicase (DDX19 in humans) that shuttles between the nucleus 
and cytoplasm plays a major role in this compositional re-arrangement 
step. Dbp5 associates with nascent transcripts in the nucleus and plays 
an essential role in mRNA export (Snay-Hodge et al., 1998), but it´s 
ATPase activity in mRNP remodelling was suggested to be only 
activated in the cytoplasm, where the conformational changes leads to 
the dissociation of the mRNP bound export receptor Mex67 and other 
export factors such as Nab2 (Lund & Guthrie, 2005; Tran et al., 2007). 
This is due to the fact that Dbp5 requires the function of another NPC-
associated cytoplasmic protein called Gle1 and its co-factor InsP6 
(inositol hexaisophosphate) to activate it (Weirich et al., 2006).   
The current model (figure 1.15) proposes that, at a steady-state 
Dbp5 localizes to the NPC through a direct interaction with Nup159 
(Nup214 in humans) a conserved nucleoporin attached to the 
cytoplasmic face of the NPC. However, another cytoplasmic 
nucleoporin Nup42, adjacent to Nup159, interacts with Gle1-InsP6, 
which stimulates ATP binding and thus activation of Dbp5. The 
resulting Dbp5-ATP/Gle1-InsP6 complex is crucial as it changes Dbp5 
conformation that allows its binding to mRNA (Montpetit et al., 2011). 
The consequent ATP-hydrolysis then triggers a conformational change 
that results in the release of the mRNA and bound export factors, and 
hence mRNP remodelling (Montpetit et al., 2011). However, other 
studies suggested that the ADP bound form Dbp5 and not the ATP-
Introduction 
41 
 
bound Dbp5 is crucial to remove export factors such as Nab2 from 
mRNA (Tran et al., 2007). Furthermore, the resulting Dbp5-ADP binds 
Nup159 promoting the release of its bound ADP and thus aiding Dbp5 
recycle, whereas export factors are re-imported into the nucleus 
(Noble et al., 2011).  
It is now known that this ATP-dependent remodelling 
mechanism of Dbp5 is responsible for providing directionality to the 
exported mRNPs by capturing the Mex67 bound mRNPs at the 
cytoplasmic face of nuclear pore, where its instant mRNP remodelling 
function generates an irreversible release in the cytoplasm, thus 
preventing its regression to the NPC central channel (Lund & Guthrie, 
2005).  
 
Figure 1.15. Exported mRNP  capturing and remodeling by Dbp5 at the cytoplasmic face of 
the NPC. 
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A recent study, showed a novel role of Dbp5 in rRNA export, 
proposing a distinct export/cytoplasmic remodelling mechanism for 
the pre-ribosomal subunit. Besides demonstrating that Dbp5 is also 
required for the nuclear export of pre-ribosomal subunits (pre-40S; 
pre-60S), it suggested that unlike its function in mRNP remodelling, 
Dbp5 ATPase cycle stimulated by Gle1 is dispensable in this case. 
Additionally, ATPase deficient dbp5 mutants that selectively inhibit 
mRNA export do not affect ribosomal transport. That is to say, 
whereas ATPase dependent activity of Dbp5 is required to dissociate 
bound export receptor Mex67 from the emerging mRNA, it does not 
displace Mex67 from the pre-ribosomal RNA. Instead, Mex67 remains 
bound to ribosomal subunits upon transit to the cytoplasm where it is 
detectable on translating ribosomes (Neumann, Wu, Hackmann, & 
Krebber, 2016). 
This suggest that different RNPs may engage in different 
transport mechanisms both involving Dbp5, where its direct contact 
with Mex67 might aid in capturing the ribosomal subunits upon their 
cytoplasmic appearance at the NPC preventing any backsliding 
(Neumann et al., 2016). When and how the Mex67 is released from the 
ribosomal subunits, and whether additional adaptor proteins are 
involved in this process is currently unknown. And why Dbp5 acts 
differently with different RNP cargoes is yet to be investigated.  
MEX67 
Mex67, a 67.35 KDa protein, was first identified in yeast (S. 
cerevisiae)  through its genetic interaction with nucleoporin Nup85, 
where a synthetic lethal screen with a mutant allele nup85∆, that 
exhibits a poly (A) ⁺ RNA export defect, led to the identification of 
Mex67 as a novel and essential mRNA export factor (Segref et al., 
1997). Regardless of the poor sequence homology to  the yeast Mex67, 
TAP/NFX1 was characterized as the human homolog of Mex67, as an 
evolutionary conserved nuclear export factor, both in structure and 
function, that shuttles between the nucleus and the cytoplasm, 
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capable of interacting with nucleoporins, and binding to poly (A) ⁺ 
RNA both in vivo and in vitro (J. Katahira et al., 1999; Segref et al., 
1997).  
 
Figure 1.16. Mex67 domain distribution and the binding sites organization. Mex67 contains 
four major ordered domains.  The N terminal region containing the RNA-recognition motif 
(RRM) and the leucine rich repeat (LRR) domain is the expected site of binding of adaptor 
proteins Yra1 and Sub2. Whereas the nuclear transport factor 2-like (NTF2) domain is the site of 
interaction with Mtr2 forming the Mex67/Mtr2 heterodimer and also the binding site of Sac3 
from the TREX-2 complex. Additionally, the N-terminal region is involved in RNA binding, while 
the C-terminal ubiquitin associated (UBA) domain and the NTF2 domain are directly involved in 
binding FG nucleoporins of the nuclear pore complex. The C-terminal UBA domain is also the 
binding site of Hpr1 protein of the THO complex. 
Mex67 belongs to the nuclear export factors (NFX) family, and 
is the major export receptor for mRNAs in the form of mRNPs, and 
also have a role in rRNA export. It also plays an essential role in mRNP 
release and directionality of transport (Smith et al., 2015). It contains 
four modular domains: an N terminal RNA-recognition motif (RRM), a 
leucine rich repeat (LRR), a nuclear transport factor 2-like (NTF2) 
domain, and a C-terminal ubiquitin associated (UBA) domain (figure 
1.16.).   
Through its NTF2 domain, Mex67 forms the functional 
heterodimer with Mtr2 (p15 in humans) that is crucial for the nuclear 
mRNA export (Santos-Rosa et al., 1998) (figure 1.17). Mutants where 
Mex67 and Mtr2 can no longer interact show inhibition of nuclear 
mRNA export and cell growth (Santos-Rosa et al., 1998). Additionally, 
over expression of the human TAP/p15 can partially rescue the lethal 
Mex67/Mtr2 knockout strain in S. cerevisiae (J. Katahira et al., 1999).  
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Figure 1.17. Crystal structure of the Mex67 NTF2 domain (Green)/Mtr2 (pink) heterodimer at 2.8 
A° resolution. PDB ID: 1OF5. 
Both the NTF2 domain, as well as the UBA domain of Mex67 
contain binding sites for the FG repeats of the NPC nucleoporins in 
the context of strengthening the interaction (Fribourg, Braun, 
Izaurralde, & Conti, 2001; Sträßer et al., 2000) thus both contributing 
to the NPC association/translocation process. Moreover, Mex67/Mtr2 
also interacts with Sac3 of the TREX-2 complex through the NTF2 
domain of Mex67 (Dimitrova et al., 2015). The flexible RRM domain 
and LRR domain of Mex67 are known to have the ability to bind RNA 
on their own, but in yeast the structural orientation of the LRR 
domain relative to the NTF2/Mtr2 regions creates a large positively 
charged surface that have been seen to extend the surface of RNA 
binding and to augment the contribution made to RNA binding by the 
RRM and LRR domains (S. Aibara et al., 2015; Teplova, Wohlbold, 
Khin, Izaurralde, & Patel, 2011). The N-terminal domain of Mex67 is 
also involved in the binding with Yra1.  
The C-terminal UBA domain of Mex67, however, have been 
proven necessary and sufficient for cargoes export through the nuclear 
pore  since it is a direct site of  interaction with the all types of FG 
repeats (FG, GLFG or FXFG core sequences where X is any residue) 
(Bachi et al., 2000; Grant, Neuhaus, & Stewart, 2003; Hobeika et al., 
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2009; Sträßer et al., 2000). Interestingly, it is also the binding site of 
Hpr1 of the THO.TREX complex, where it synchronizes the 
recruitment of the export machinery with transcription, and plays a 
role in Hpr1 ubiquitination dependent turnover (Gwizdek et al., 2006). 
Structural studies have showed that both Hpr1 and the FG repeats 
compete for the same binding site in the UBA domain (Hobeika et al., 
2007, 2009) which suggests they don’t bind simultaneously especially 
that both Hpr1 and the FG repeat show similar binding affinity for the 
UBA domain. However, the binding of Hpr1 and not the FG repeats 
appears to promote UBA interaction to tetra-ubiquitin (Hobeika et al., 
2007, 2009).  
Mex67 is usually recruited primarily to mature, spliced mRNPs, 
but it was also shown to be implicated in the export of un-spliced or 
partially spliced forms of viral RNA (Teplova et al., 2011). Recently, 
Mex67/Mtr2 heterodimer have been also shown in S. Cerevisiae to 
bind and export the pre-60S ribosomal subunit in vivo as well as 
binding 5S rRNA in vitro, where loop insertions in the NTF2 domain of 
Mex67 and Mtr2 are crucial structural requirements for this function. 
It was suggested that an electrostatic interaction could occur between 
the positively charged Mex67 loop and an exposed negatively charged 
rRNA surface on the pre-60S subunit (Yao et al., 2007). Importantly, 
the predicted site on NTF2 for FG repeats interaction is located on the 
opposite face of the loop-confined surface. Remarkably, the same 
loops were later shown to recruit and bind Mex67/Mtr2 to the pre-40S 
subunits (Marius B. Faza et al., 2012). But surprisingly, these loop 
insertions are missing from the NTF2 region of the TAP/p15 human 
homolog. Therefore, whether the human Mex67 is also involved in the 
export of pre ribosomal subunits is still to be investigated. However, in 
higher eukaryotes, several Mex67 isoforms of the NXF family members 
might have other specialized transport functions and perhaps 
compensate this pre ribosomal subunits export function (Herold et al., 
2000).  
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Another important role has been very recently uncovered for 
Mex67 in yeast. The new study suggested that under cellular heat 
stress, and unlike their role in mRNA export under normal conditions, 
Mex67 adaptor proteins dissociate from regular mRNAs thus 
dissociating Mex67 from its regular cargo. Instead, it was suggested 
that the now freely available Mex67 selectively binds and rapidly 
exports heat shock transcripts, without the need of adaptor proteins, 
bypassing the quality control system. It was also proposed that in this 
case, Mex67 interacts directly with the RNA Pol II largest subunit 
(Rbp1) thus enabling rapid export of heat shock mRNAs, speeding up 
translation and guarantying cell survival under extreme cases (Zander 
et al., 2016).  
MIP6 
The first mention of the yeast protein Mip6 was in the same 
paper where Mex67 was first characterized. It was identified through a 
two-hybrid interaction screen against a yeast genome library using 
Mex67 as bait in an attempt to find any possible Mex67 partners 
(Segref et al., 1997). It was described as an uncharacterized open 
reading frame (ORF) in yeast, and was named Mex67 interacting 
protein 6 (Mip6). Additionally, it was suggested that an intact Mex67 
carboxy-terminal domain which includes part of the P/Q/G domain, as 
stated, is required for the two-hybrid interaction with Mip6 (Segref et 
al., 1997).  
Although Mex67 have been extensively studied afterwards, 
Mip6 structure, function, and mechanism of action remain unknown. 
Software predictions predicted Mip6 as a putative RNA-binding 
protein with predicted three putative RNA recognition motifs (RRMs), 
but whether Mip6 is really capable of binding RNA or if together with 
Mex67 is involved in the mRNA export mechanism was never 
investigated.  
On the other hand, it was suggested that Mip6 have high homology 
for Pes4, another yeast putative RNA binding protein which was found 
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as a suppressor of DNA-polymerase ε subunit. Little else is known 
about Pes4 structure or function (Segref et al., 1997).   
However though, a recent study on protein concentration dependent 
cellular toxicity, suggested that over expression of the yeast dosage 
sensitive Mip6 protein causes the protein to localize, reversibly, to 
cytoplasmic RNP granules causing a reduction in the global translation 
rates and thus triggering cellular toxicity and growth impairment 
when strongly over expressed (Bolognesi et al., 2016). 
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While Mex67 have been well studied before, more is yet to be 
learned regarding its structure and the dynamics of its interactions 
and function. Additionally, considering the insufficient literature 
concerning Mip6 or its Pes4 paralog structurally and functionally and 
the very few evidence in which the interaction between Mip6 and 
Mex67 and the subsequent function and implications of this complex 
formation is based on, our main objectives initially set were as follows: 
1. In vitro expression and purification of Mip6, Mex67, and 
Pes4 constructs. 
2. Crystallizing and solving the structure of Mip6 and Pes4. 
3. Elucidating and confirming the RNA binding properties of 
Mip6. 
4. Studying and characterizing the interaction between Mip6 
and Mex67. 
5. Defining the minimum interaction boundaries required by 
the Mip6/Mex67 interaction and studying its properties. 
6. Checking whether Pes4 retained the ability to bind Mex67. 
7. Reconstituting the Mip6/Mex67 complex in vitro and using 
it for crystallization trials in an attempt to solve the 
complex structure. 
8. Studying the role of nucleic acid binding in the complex 
formation between Mip6 and Mex67. 
9. Speculating on possible in vivo functions for Mip6 and the 
Mip6/Mex67 complex regarding mRNA export. 
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3.1. Cloning 
Plasmids used in this study were either commercially available 
or were obtained from lab members. Mip6 FL pMAL-c2X construct 
was received from Dr. Susana Rodriguez Navarro lab (Centro de 
Investigación Príncipe Felipe (CIPF); Valencia, Spain), Pes4 initial 
constructs were a gift from Dr. Jose Manuel Pérez Cañadillas lab 
(Institute of physical chemistry Rocasolano, CSIC, Madrid, Spain), and 
pMBPKI and pGKI vector were a gift from Dr. Marcin Węgrecki 
engineered by him in our laboratory from pET28-NKI/LIC 6His/3C 
vector originally obtained from Dr. Anastassis Perrakis group (NKI, 
Amesterdam). 
The constructs used for this project were modified from 
previously obtained constructs and cloned into different available 
plasmids in the lab. The gene sequences coding for all of proteins of 
interest used in this study: Mip6, Mex67, and Pes4 were that of S. 
Cerevisiae yeast species proteins.  The genes coding for proteins of 
interest or for the deletions of the proteins were amplified by PCR 
(Polymerase Chain Reaction) using primers listed in table 3.1. The 
Primers overhangs varied depending on the cloning method and 
plasmids used.  
Primer Sequence 
Mip6 NKI Fwd 5´cagggacccggtatgccaaactctcATGGTAATGTATTGAATAAT 3’ 
Mip6 NKI Rev 5´cgaggagaagcccggTTAAACTGTAAATCCGAGGCTTTCAGCA 3´ 
Mip6 pOPINM Fwd 5´aagttctgtttcagggcccgATGCCAAACTCTCATGGT 3´ 
Mip6 pOPINM Rev 5´atggtctagaaagctTTAAACTGTAAATCCGAGGC 3´ 
Mip6 390 pOPINM Fwd 5´aagttctgtttcagggcccgatg AAGCCTGTTCATAATCAA 3´ 
Mip6 111 BamHI Fwd 5´gacacggatccatgAATAGTTTGTTTATAG 3´ 
Mip6 279 Xho Rev 5´ccggcctcgagtcaAGTTCTTACTTCTTT 3´ 
Mip6 313 BamHI Fwd 5´gacacggatccatgAAAACAATATTAGTCA 3´ 
Mip6 389 Xho Rev 5´ccggcctcgagtcaATCTTTACCAGGACCA 3´ 
Mip6 480 Xho Rev 5´ccggcctcgagtcaATTCTTTGACCATGATGCCT 3´ 
Mip6 401 BamHI Fwd 5´gtacctggatccatg AAAACAAAGGTTTAT 3´ 
Mip6 390 BamHl Fwd 5´gtacctggatccatgAAGCCTGTTCATAAT3´ 
Mip6 390 NKI Fwd 5´cagggacccggtAAGCCTGTTCATAATCAAATTGGAACG 3´ 
Mip6 495 NKI Rev 5´cgaggagaagcccggttaGTTGTTACCATCGTCATAGT 3´ 
Mip6 480 NKI Rev 5´cgaggagaagcccggttaATTCTTTGACCATGATGCCT 3´ 
Mex67 528 BamHI Fwd 5´gtacctggatccatggtcATGGCTCCCACT 3´ 
Mex67 NotI Rev 5´gacgcttgcggccgcTTAGAACTGCACAAATGC 3´ 
Mex67 545 BamHI Fwd 5´gtacctggatccatgAATCCCGTACAACTCGAG 3´ 
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Mex67 544 NotI Rev 5´gacgcttgcggccgcttaTAGCCGCGACTGGACATC 3´ 
Mex67 481 BamHI Fwd 5´gtacctggatccatgGCAATAGCACAGCCTCCA 3´ 
Pes4 RRM3/4 NKI Fwd 5´cagggacccggtatgAATTCTATATTCATCAAAAACCTTCCA 3´ 
Pes4 RRM3/4 NKI Rev 5´cgaggagaagcccggttaATTATTTTGTCTTTCCCAAGATGT 3´ 
 
Table 3.1. Primers used for cloning the constructs used in this work. The sequences that 
include the overhangs and the extra nucleotides not part of the gene are shown in lower case 
letters. 
The PCR reaction mix had a final volume of 25 µl and was 
prepared as shown in the following table 3.2: 
Component 25 µl reaction Final concentration 
5x Kapa Hifi buffer 5 µl 1x 
10 mM Kapa dNTPs mix 0.75 µl 0.3 mM each 
10 µM forward primer 0.75 µl 0.3 µM 
10 µM reverse primer 0.75 µl 0.3 µM 
Pure DMSO 1.25 µl  
Template DNA 1 µl or as required (10-100 ng) As required 
1 U/μL KAPA HiFi (Hifidelity) 
DNA Polymerase (Kapa 
Biosystems) 
0.5 µl 0.5 U 
MQ (Milli-Q) water 15 µl (up to 25 µl) N/A 
 
Table 3.2. PCR reaction mixture preparation for Kapa Hifi Hot start 
Polymerase. 
The PCR reaction was then performed with the following 
cycling protocol setup: 
setup Temperature Duration Cycles of Amplification 
Initial denaturation 95°C 3 minutes 1 
Denaturation 98°C 20 seconds 
30 Annealing 
60-70°C depending on 
desired Tm (melting 
temperature) 
15-20 seconds 
Extension 72 °C 30 seconds/kb 
Final extension 72 °C 5 minutes (1 minute/kb) 1 
 
Table 3.3. PCR reaction amplification conditions setup. 
 
PCR amplified products were then visualized on 1-2% agarose 
gels (depending on the size of the expected DNA band) stained with 1x 
GelRed (Biotium) and run at 100V for the required duration. The 
molecular weight marker used to assess the visualized band size was 
DNA ladder 1kb (Nippon Genetics). The PCR products of interest were 
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then purified using commercially available kits (SPEEDTOOLS PCR 
CLEAN UP kit from BIOTOOLS; E.Z.N.A Cycle Pure Kit and 
MicroElute Gel Extraction Kit from OMEGA bi0-tek). DNA 
concentration obtained was afterwards quantified with NanoDrop 
(Thermo Scientific). The resulting DNA fragments were then 
incorporated into the corresponding plasmids depending on the 
required method as follows: 
o Cloning using Restriction enzymes: complementary 
compatible ends were generated by digesting both the insert 
and vector with the same desired restriction enzymes 
purchased from New England Biolabs (NEB). The reaction was 
prepared as such: 
 Insert PCR product Plasmid 
Sample 30 µl 15 µl 
Restriction enzyme (NEB) 2 µl 1.5 µl 
10x Buffer (NEB) 4 µl 2 µl 
100x BSA (10mg/ml) 0.5 µl 0.5 µl 
MQ water Up to 40 µl Up to 25 µl 
Incubation temperature 37 °C 37 °C 
Incubation time 2 hours 2 hours 
 
The NEBuffer used depended on the restriction enzymes used 
and the quantity of enzyme was also variable depending of the 
amount of DNA used. Additionally, 1 µl of SAP (Shrimp 
Alkaline Phosphatase) purchased from Fermentas was added 
to the plasmid sample after 1 hour 30’ of incubation at 37 °C 
before being further incubated for an additional half an hour.  
The insert and vector samples were then visualized on 1% 
agarose gel and the digested insert and vector samples were 
purified from directly sample or from gel. The ligation was 
then carried out using the Quick ligation kit (NEB) where 50 
ng of digested vector were mixed with 3-fold molar excess of 
insert and the final volume was adjusted to 10 µl with MQ 
water. 10 µl of Quick ligation reaction buffer was then added to 
the mixture with a final 1 µl of Quick T4 DNA ligase and 
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incubated at room temperature for 5 minutes before being 
chilled on ice and transformed into E. coli (Escherichia coli) 
DH5α bacterial cells. 
 
o Ligase Independent Cloning (LIC): The vectors were 
linearized by KpnI restriction enzyme (NEB) and further 
purified using a commercial PCR clean kit, then both the 
vectors and insert were treated separately with T4 DNA 
polymerase (Thermo scientific) in a reaction mix of a final 
volume of 20 µl as following: 15.3 µl of DNA ( ̴ 0.1 pmol of 
vector or insert) was mixed with 4 µl of 5x T4 DNA polymerase 
buffer (Thermo Scientific), 0.5 µl of 100 mM Deoxyadenosine 
triphosphate (dATP) (for insert) or 0.5 µl of 100 mM 
Deoxythymidine triphosphate (dTTP) (for vector), and 0.2 µl of 
T4 DNA polymerase (5U/µl). The reaction was incubated for 5-
15 minutes at room temperature and then for 10 minutes at 70 
°C to inactivate the enzyme. Vector and insert were then mixed 
in equal volumes (2 µl each) and left to incubate 5 minutes at 
room temperature. Then 1 µl of EDTA (50 mM) was added and 
the mixture was further incubated for additional 5 minutes at 
room before being transformed into E. coli DH5α cells.  
 
o In-Fusion Cloning: was performed using the commercial 
Clontech In-Fusion kit. The vector pOPINM was linearized 
through KpnI and HindIII enzymes  according to instructions 
provided by Oxford Protein Production Facility (OPPF, UK) 
that produced the pOPIN vectors suite. The linearized vector 
was then mixed with purified PCR fragment of insert (50-100 
ng each) and 1 µl of 5x In-Fusion HD Enzyme Premix. MQ 
water was added up to 5 µl of total volume. The reaction was 
incubated for 15 minutes at 50 °C, and then placed on ice to 
stop the reaction. 10 µl of TE (Tris-EDTA) buffer were 
immediately added to dilute the reaction before being 
transformed into E. coli DH5α cells.  
Materials and Methods 
59 
 
The constructs used in this study are summarized in Table 3.4 with the 
corresponding cloning method used.  
Construct Primers vector Cloning method 
Mip6 FL pNKI Mip6 NKI Fwd 
Mip6 NKI Rev 
pET28-NKI/LIC 
6His/3C 
LIC 
Mip6 FL  pMBPKI Mip6 NKI Fwd 
Mip6 NKI Rev 
pMBPKI LIC 
Mip6 FL  pGKI Mip6 NKI Fwd 
Mip6 NKI Rev 
pGKI LIC 
Mip6 FL pOPINM Mip6 pOPINM Fwd 
Mip6 pOPINM Rev 
pOPINM In-Fusion 
Mip6 111-480 pGEX-
6P-2 
Mip6 111 BamHI Fwd 
Mip6 480 Xho Rev 
pGEX-6P-2 Restriction enzymes 
Mip6 RRM1/2 
pGEX-6P-2 
Mip6 111 BamHI Fwd 
Mip6 279 Xho Rev 
pGEX-6P-2 Restriction enzymes 
Mip6 RRM3/4 
pGEX-6P-2 
Mip6 390 BamHl Fwd 
Mip6 480 Xho Rev 
pGEX-6P-2 Restriction enzymes 
Mip6 390 pOPINM Mip6 390 pOPINM Fwd 
Mip6 pOPINM Rev 
pOPINM In-Fusion 
Mip6 RRM3 pGEX-
6P-2 
Mip6 313 BamHI Fwd 
Mip6 389 Xho Rev 
pGEX-6P-2 Restriction enzymes 
Mip6 390-495 pNKI Mip6 390 NKI Fwd 
Mip6 495 NKI Rev 
pET28-NKI/LIC 
6His/3C 
LIC 
Mip6 390-480 pNKI Mip6 390 NKI Fwd 
Mip6 480 NKI Rev 
pET28-NKI/LIC 
6His/3C 
LIC 
Mip6 401-480 
pGEX-6P-2 
Mip6 401 BamHI Fwd 
Mip6 480 Xho Rev 
pGEX-6P-2 Restriction enzymes 
Mex67 528 pGEX-
6P-2 
Mex67 528 BamHI Fwd 
Mex67 NotI Rev 
pGEX-6P-2 Restriction enzymes 
Mex67 UBA pGEX-
6P-2 
Mex67 545 BamHI Fwd 
Mex67 NotI Rev 
pGEX-6P-2 Restriction enzymes 
Mex67 ∆UBA pGEX-
6P-2 
Mex67 481 BamHI Fwd 
Mex67 544 NotI Rev 
pGEX-6P-2 Restriction enzymes 
Pes4 RRM3/4 pNKI Pes4 RRM3/4 NKI Fwd 
Pes4 RRM3/4 NKI Rev 
pET28-NKI/LIC 
6His/3C 
LIC 
 
Table 3.4. Constructs used in this work. Primers are shown in table 3.1. 
After successful incorporation methods, the mix was 
transformed into bacterial DH5α E. coli strain cells using heat shock. 
100 µl of chemically competent cells were thawed on ice for 5 minutes. 
The ligation mix was then introduced and further incubated on ice for 
20-30 minutes. The cells were then heat shocked by placing them at 42 
°C for 1.5 minutes and then placed on ice for 5 minutes. 500 µl of fresh 
LB media was then added to the cells and cells were incubated in a 
shaker at 37°C for about 1 hour. After 1 hour, the cells were plated on 
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LB-agar containing required antibiotics depending on the resistance of 
each plasmid, and then incubated at 37°C for around 18 hours. 
Colonies from subsequent plates were used to perform colony PCR to 
scan for positive colonies according to the following conditions: 
setup Temperature Duration Cycles of Amplification 
Initial denaturation 95°C 3-5 minutes 1 
Denaturation 95°C 30 seconds 
30-35 Annealing 
50-70°C depending on 
desired Tm (melting 
temperature) 
30 seconds 
Extension 72 °C 1 min/kb 
Final extension 72 °C 5-10 minutes 1 
 
Positive colonies of choice were then inoculated in 5ml of LB 
culture media supplemented with the appropriate antibiotic (Final 
concentration of 33 µg/ml for Kanamycin or 100 µg/ml for Ampicillin) 
depending on the plasmid antibiotic resistance and incubated at 37°C 
over night. The cells were then collected by centrifugation (4000 rpm 
for 15-20 minutes) and then the plasmid was extracted using 
QuickGene Plasmid Kit S II (Fujifilm) according to the instruction 
manual. The DNA concentration of the resulting plasmids was 
measured using NanoDrop (Thermo Scientific) and then sent to the 
sequencing service at the Institute of Biomedicine of Valencia for 
sequence analysis to assure all constructs were well done.  
3.2. Site directed mutagenesis  
The mutation of interest in the sequence of the gene was 
generated following the QuickChange site-directed mutagenesis 
protocol (Kapa Biosystems) using forward and reverse primers where 
the mutation is introduced in the central part of the primer. These 
primers are designed to amplify the whole plasmid, generating 
amplified plasmid copies that contain the mutation. Kapa Hifi Hot 
start polymerase was used to set the mutagenesis as the following: 
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setup Temperature Duration Cycles of Amplification 
Initial denaturation 95°C 2 minutes 1 
Denaturation 98°C 20-30 seconds 
16 cycles Annealing 
60 °C depending on 
desired Tm (melting 
temperature) 
15 seconds 
Extension 72 °C 30 sec/kb 
Final extension 72 °C 1-5 minutes 1 
 
The obtained PCR product was then visualized on a 1% agarose 
gel. Further incubation of the PCR product with 1.5 µl of DpnI enzyme 
(NEB; 20,000 U/ml) was carried on for 1-2 hours at 37°C to digest the 
template plasmid not containing the mutation. The mix was then 
chilled on ice to stop the reaction and transformed by heat shock into 
DH5α E. coli bacterial cells as previously described and some colonies 
inoculated in LB with the correct antibiotics and left at 37 °C 
overnight. The subsequent extracted plasmid was sequenced to 
confirm a successful mutagenesis.  
3.3. Protein over-expression in E. coli 
Proteins were transformed into the Bl21 (DE3) or Bl21 codon 
plus (DE3)-RIPL chemically competent bacterial E. coli cells 
(Stratagene) for expression. 1 µl of DNA (5-100 ng/µl) was added to 100 
µl of the chemically competent cells and incubated 20-30 minutes on 
ice. The cells were then heat shocked by placing them at 42 °C for 45 
seconds and then back on ice for 5 minutes. 500 µl of fresh LB media 
was added to the cells and further incubated for 1 hour at 37 °C 
shaking. 100 µl of the cells were plated in LB-agar containing the 
appropriate antibiotics. The plates were placed in a 37 °C incubator 
overnight.  
The expression of newly tested proteins was assessed by using 
a small-scale expression system. If soluble protein is obtained, then 
the protein was further expressed and purified on a large scale.  
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3.3.1. Small-scale expression 
From the LB-agar plate of the E. coli (DE3) BL21 codon plus RIPL 
cells, two colonies were picked to be checked for expression: one in LB 
medium using IPTG expression, and the second in ZY medium using 
the Auto-induction system. 
o IPTG expression test: one colony was inoculated in 10 ml of 
LB media with the appropriate antibiotics depending on the 
plasmid resistance and the type of cells used to express the 
protein (Chloramphenicol at a final concentration of 33 µg/ml 
added in case of Bl21 (DE3) codon plus). The culture was left 
growing at 37 °C for 5-6 hours until OD (optical density) of 0.6-
0.7 and then the expression of protein was induced by adding 
0.5-0.8 mM of IPTG (Isopropyl β-D-1-thiogalactopyranoside). 
The culture was then left at 20 °C overnight.  
o Auto-induction: A culture of 9.3 ml of ZY media, 10 µl MgSO4 
(1M), 200 µl 5052 (50x), and 500 µl NPS (20x) plus required 
antibiotics were inoculated with the other colony and were 
incubated at 37 °C shaking until an OD of 1. The culture was 
then changed to 20 °C and left there overnight. In cases of 
Kanamycin is required as antibiotic, double the normally used 
quantity at 33 µg/ml is required. 
Recipes: NPS 20X (0.5 M (NH4)2SO4, 1M KH2PO4, 1M 
Na2HPO4; 5052 50x (25% glycerol, 2.5% glucose, 10% α-
lactose); ZY (1% Tryptone, 0.5% yeast extract). 
The next day, the cultures from both expression systems were 
centrifuged and the cells were collected at 4000 rpm speed at 4 °C for 
20 minutes. The supernatants were then discarded and the cells re-
suspended with 1 ml PBS 1x (Phosphate-Buffered Saline) buffer and 
transferred to 1.5 ml Eppendorf tubes, then further centrifuged, 
supernatants discarded and pelleted cells preserved for further small 
scale purification to assess the solubility of the protein. Additionally, 
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depending on the solubility, different temperatures were also used for 
expressing the proteins. 
3.3.2. Large-scale over-expression 
The proteins that showed good solubility after the small-scale 
expression followed by small-scale purification were then expressed on 
a large scale for large-scale protein purifications. The expression 
system and media used for the large scale expression depended on 
which small scale expression system showed more protein solubility, 
and accordingly some proteins were expressed using the IPTG 
expression system while others using Auto-induction. 
o IPTG expression: 50 ml of a pre-culture of LB media 
with antibiotics was inoculated with a colony from the 
agar plate following bacterial cells transformation into 
a strain suitable for expression, and left to grow at 37°C 
overnight. The next morning, the overnight pre-
culture, was added into a 950 ml of fresh LB with 
antibiotics and left shaking at 37 °C until an OD of 0.6-
0.8 was reached. The culture was then put at 20°C (or 
lower depending on the protein) and induced with 0.5-
0.8 mM of IPTG and left expressing overnight (Mip6 
RRM4 W442A mutant was expressed at 12 °C for 72 
hours before cells were collected). After expression, the 
cells were collected and centrifuged at 3500 rpm for 45-
55 minutes at 4°C. The supernatants were then 
discarded and pellets washed with PBS and further 
centrifuged at 4000 rpm for 30 minutes at 4 °C, 
supernatants discarded and pelleted cells frozen at -80 
°C for future use.  
o Auto-induction: An isolated colony was inoculated in 
a 10 ml pre-culture of 9.3 ml ZY media, 10 µl MgSO4 (1 
M), 200 µl Glucose (40%), 500 µl NPS (20x) plus 
antibiotics and left growing overnight at 37 °C. The 
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next morning, 1 litre of fresh Auto-induction culture 
was prepared: 930 ml of ZY media, 1 ml MgSO4 (1 M), 
20 ml 5052 (50x), 50 ml NPS (20x) with antibiotics and 
separated into two, 2 Litre, flask containing 500 ml litre 
each. 5 ml of the overnight pre-culture was then 
inoculated in each flask and left at 37°C to grow until 
an OD of 0.8-1. The cultures were then moved to a 
lower temperature (20 °C or less depending on the 
protein) and left there for at least 18 hours depending 
on the temperature used for expression. For proteins 
with no problems in solubility, the expression was 
carried out at 18-20 °C for 18-23 hours. As for Mip6 FL 
for example, the protein was expressed at 16 °C for 48 
hours due to low solubility of the protein. The cells 
were centrifuged at 3500 rpm for 45-55 minutes at 4 °C, 
then supernatants discarded and pellets re-suspended 
in PBS 1x and further centrifuged at 4000 rpm for 30 
minutes, and pellets were frozen at 80 °C for future 
purification.  
3.3.3. Protein expression in insect cells-baculovirus system 
Mip6 FL cloned in pOPINM (N terminal 6xHis tag followed by 
MBP tag), produced by In-fusion cloning following the OPPF (Oxford 
Protein Production Facility, UK) insect expression protocol, was used 
for Sf9 cells transfection. 2 ml of Sf9 (Spodoptera frugiperda) cells were 
disposed on a six-well plate (1x106 of cells/well) and the plate was left 
at 27 °C for 1 h. The transfection mix was then prepared containing 200 
µl of Sf900II media (Life Technologies), 1 µl of Ian Jones bacmid (750 
ng) (Zhao, Chapman, & Jones, 2003), 1 µl of Mip6 FL pOPINM plasmid 
(500-1500 ng) and 4 µl of FugeneHD (promega) for each well and then 
the mix left for 30 minutes at room temperature. After that, the mix 
was added to each well containing Sf9 cells and the plates were left at 
27 °C. After 5-7 days after transfection, the supernatants containing P0 
virus were collected and the cells collected by centrifugation (1000 x g 
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for 15 minutes at 4 °C) were then lysed and lysates centrifuged at 4 °C 
for 15 minutes. The soluble fraction in the supernatants and the 
insoluble fraction were then analyzed on SDS-PAGE and western blot 
to detect soluble protein. 
 We also tried the Bac-to-Bac expression system (Life 
Technologies) with Mip6 FL protein cloned into pFastBacHTb vector 
and transformed into DH10Bac E. coli competent cells where obtained 
positive colonies were used to extract the recombinant bacmid. 5 µl of 
bacmid DNA (1-2 µg) with 4 µl fugeneHD transfection reagent 
(Promega) were transfected into Sf9 insect cells in Sf900II medium to 
a final volume of 2 ml and plates were left at for 1 week at 27 °C with 
daily checking. 500 µl of transfected cells were then inoculated in 30 
ml of 1.5x106 Sf9 cells and further left for one week at 27 °C. A serial 
dilution of the virus was then done in a 96-well plate and the 
fluorescence of GFP (Green Fluorescent Protein) expressing cells was 
checked with confocal microscope after 5 days to assess the success of 
the transfection. High five insect cells at a density of 2x106 in Express 
five medium (Gibco) were then infected with the recombinant virus 
and incubated at 27 °C for 72 hours. The cells were then harvested by 
centrifugation for 15 minutes at 1100 rpm, washed with PBS 1x and 
centrifuged at 600 g for additional 30 minutes. The supernatants were 
discarded and the pelleted cells were stored at -80 °C for further use.  
Table 3.5 bellow summarizes the expression system and purification 
method used for every protein used in this study. 
Protein Residues 
Tag 
(Cleavage 
site) 
Host Expression method 
Affinity 
Chromatograph
y Purification 
Mip6 FL 1-659 
6xHis (3C)-
Nterm 
GST (3C) 
Nterm 
MBP (3C) 
Nterm 
Bl21; BL21 
C+; sf9 
IPTG induction; 
Auto-induction; 
Baculovirus 
5ml HisTrap; 5ml 
GSTrap; 5ml 
MBP trap; 5ml 
amylose resin 
packed gravity 
column 
Mip6(111-
480) 
111-480 GST (3C) Nterm BL21 C
+ Auto-induction 5ml GSTrap 
Mip6 
RRM1/2 111-279 
GST (3C) 
Nterm BL21 C
+ Auto-induction 5ml GSTrap 
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Mip6 
RRM3/4 313-480 
GST (3C) 
Nterm BL21 C
+ Auto-induction 5ml GSTrap 
Mip6 390 
pOPINM 390-659 
MBP (3C) 
Nterm BL21 C
+ Auto-induction 5ml MBP trap 
Mip6 
RRM3 313-389 
GST (3C) 
Nterm BL21 C
+ Auto-induction 5ml GSTrap 
Mip6 
RRM4(390-
495) 
390-495 6xHis (3C)-Nterm BL21 C
+ Auto-induction 5ml HisTrap 
Mip6 
RRM4(390-
480) 
390-480 6xHis (3C)-Nterm BL21 C
+ Auto-induction 5ml HisTrap 
Mip6 
RRM4(401-
480) 
401-480 GST (3C) Nterm BL21 C
+ Auto-induction 5ml GSTrap 
Mip6 
W442A 390-482 
TRX-His 
(TEV) Nterm BL21 IPTG induction 5ml HisTrap 
Mex67(528
-599) 
528-599 GST (3C) Nterm BL21 C
+ Auto-induction 5ml GSTrap 
Mex67 
UBA 545-599 
GST (3C) 
Nterm BL21 C
+ Auto-induction 5ml GSTrap 
Mex67 
∆UBA 481-544 
GST (3C) 
Nterm BL21 C
+ Auto-induction 5ml GSTrap 
Pes4 
RRM3/4 303-473 
6xHis (3C)-
Nterm BL21 C
+ Auto-induction 5ml HisTrap 
 
Table 3.5. The proteins purified on a large scale for this study and the type of affinity 
chromatography used. All purifications were followed by size exclusion chromatography 
purification.  The host column represents the host used to express the protein (Bl21: E. coli (DE3) 
strain; BL21 C+: E. coli (DE3) codon plus RIPL strain; Sf9: Spodoptera frugiperda cells). 
3.4. Protein purifications 
All buffers used for the purification are summarized in table 3.6. 
3.4.1. Small-scale purification 
The cells obtained from the small-scale expressions produced 
in E. coli (section 3.3.1) were purified on a small scale to assess the 
expression and solubility of the protein. Depending on the tag fused to 
each protein, different resins were used for the small-scale 
purification: High Density Nickel beads (Agarose Bead Technologies) 
for His tagged proteins, Glutathione Sepharose 4B beads (GE 
Healthcare) for GST tagged proteins, and Amylose Resin (NEB) for 
MBP tagged proteins. The purification protocol was as follows: 
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o Pelleted cells were re-suspended in 300 µl of lysis 
buffer. 
o The samples were then sonicated in a Bioruptor UCD-
200 (Diagenode) at medium intensity (200 W) with 30 
seconds ON/OFF intervals for 30 minutes at 4 °C. 
o After sonication, samples were centrifuged at 4 °C for 
20 minutes at maximum speed (16000-21000 x g). 
o The soluble fraction in the supernatants was then 
added to 70-100 µl of beads previously washed with 
water and equilibrated by 1 ml of Buffer A. 
o The samples were then left mixing with the beads on a 
rotator for 30-60 minutes at 4°C. 
o The beads were then precipitated by centrifugation for 
5 minutes at 4000 rpm. The non-bound fraction in the 
supernatants was then discarded and beads were 
washed three to four times with 1 ml of fresh buffer A. 
o Finally, 50 µl of elution buffers were added, or simply 
50 µl of SDS-PAGE sample loading buffer (6x), before 
being boiled for 10 minutes. 
Aliquots from all the steps of the purification in addition to the 
elution samples were then analyzed on 10% SDS-PAGE. A molecular 
weight Blue Star Pre-stained Protein Marker (Nippon) was used to 
assess the molecular weight corresponding to the visualized bands. 
The acrylamide gel was run at 200 V for the time needed, and stained 
with a Coomassie Blue solution (1g Coomassie Blue, 40% methanol, 
10% acetic acid, 50% distilled water) for 5-10 minutes and then de-
stained in a de-staining solution (10% Methanol, 10% acetic acid, 80% 
distilled water). 
3.4.2. Large-scale protein purification 
3.4.2.1. Cell lysis and protein extraction 
The cells collected from the large-scale expressions were first 
left to thaw on ice, before being re-suspended in cold lysis buffer 
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(buffer composition depends on the tag of the protein, refer to table 
3.6) on ice, supplemented with one pill of Complete EDTA-free 
Protease Inhibitor Cocktail (Roche). The cells were then lysed by 
sonication 15-30 minutes (1 second ON 1 second OFF pulses) at 25% 
amplitude using Bioblock scientific vibra cell W75042 sonicator. The 
duration of soniction changed depending on the volume of cells and 
type of cells to be lysed. The lysed cells were then centrifuged at 15 000 
rpm for 45 minutes in Sorvall RC6, SS-34 rotor at 4 °C. The resulting 
supernatants were then filtered using a 0.45 µm syringe filter (VWR) 
and loaded into the desired affinity chromatography column for 
purification. Aliquots from both supernatants and pellets were taken 
to be visualized later on acrylamide gel. 
 Affinity Purification Protocol 
Buffer HisTrap FF GSTrap HP 
Lysis Buffer 
50 mM Hepes pH 7.5 
500 mM NaCl 
10 mM Imidazole 
5% Glycerol 
0.1% Triton X-100 
1 mM BME* 
50 mM Hepes pH 7.5 
500 mM NaCl 
5% Glycerol 
0.1% Triton X-100 
1 mM BME 
Buffer A 
50 mM Hepes pH 7.5 
500 mM NaCl 
10 mM Imidazole 
5% Glycerol 
1 mM BME 
50 mM Hepes pH 7.5 
500 mM NaCl 
5% Glycerol 
1 mM BME 
Elution Buffer 
50 mM Hepes pH 7.5 
500 mM NaCl 
500 mM Imidazole 
5% Glycerol 
1 mM BME 
50 mM Hepes pH 7.5 
500 mM NaCl 
20 mM reduced 
gluthatione 
5% Glycerol 
1 mM BME 
 
 Affinity Purification protocol 
Buffer MBP Trap HP HiTrap Heparin 
Lysis Buffer 
50 mM Hepes pH 7.5 
500 mM NaCl 
5% Glycerol 
0.1% Triton X-100 
1 mM DTT 
1 mM EDTA 
N/A 
Buffer A 
50 mM Hepes pH 7.5 
500 mM NaCl 
5% Glycerol 
1 mM DTT 
50 mM Hepes pH 7.5 
100 mM NaCl 
5% Glycerol 
1 mM BME 
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1 mM EDTA 
Elution Buffer 
50 mM Hepes pH 7.5 
500 mM NaCl 
20 mM Maltose 
5% Glycerol 
1 mM DTT 
1 mM EDTA 
50 mM Hepes pH 7.5 
1 M NaCl 
5% Glycerol 
1 mM BME 
SE (size-
exclusion) Buffer 
50 mM Hepes pH 7.5 
150 mM NaCl 
5% Glycerol 
1 mM BME 
50 mM Hepes pH 7.5 
150 mM NaCl 
5% Glycerol 
1 mM BME 
  
Table 3.6. Buffers used in protein purifications depending on the type of purification 
protocol used. *ß-Mercaptoethanol (BME). The affinity columns used are obtained from GE  
Healthcare. HP stands for high performance, while FF stands for fast flow columns. 
3.4.2.2. Affinity chromatography of His-tagged proteins 
A 5 ml HisTrap FF (GE healthcare) was used for the IMAC 
(Immobilized metal ion affinity chromatography). The column was 
washed with 10 column volumes of MQ water, and then equilibrated 
with 10 column volumes of Buffer A before the protein filtered lysate 
was loaded on it with a Gilson peristaltic pump- MINIPULS 3. After 
loading the protein sample, the column was washed with additional 10 
column volumes of Buffer A to remove any proteins non-specifically 
bound to the column. The FPLC ÄKTA purifier system along with 
UNICORN control software from GE healthcare was then used to carry 
out the elution step. A linear gradient of increasing concentrations of 
the elution buffer was used to identify at what elution buffer 
concentration the protein of interest elutes from the column as pure 
as possible. Fractions of 5 ml were collected and the fractions were 
then analyzed and visualized on 10 or 15% SDS-PAGE for checking 
which aliquots contained protein and the state of purity of the protein.  
3.4.2.3. Affinity chromatography of GST-tagged proteins 
Filtered protein lysate was loaded on a 5ml GSTrap HP column 
(GE Healthcare) that was already washed with 10 column volumes of 
MQ water and equilibrated with 10 column volumes of Buffer A all 
using a Gilson peristaltic pump MINIPULS 3. Once the sample was all 
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loaded into the column, the column was washed with 30 ml of Buffer 
A to remove any unbound, and the column bound protein was eluted 
with 100% elution buffer directly. The samples were then visualized on 
10% SDS-PAGE. 
3.4.2.4. Affinity chromatography of MBP-tagged proteins 
The same procedure followed for the GST-tagged proteins was 
used for purifying MBP-tagged proteins but on MBP HP columns (GE 
Healthcare). MBP tagged Protein was eluted with the elution buffer 
containing 20 mM Maltose.  
Additionally, in other cases an amylose resin (NEB) packed 
gravity column was used instead of the commercially packed MBP HP 
columns. However, the same protocol was followed but manually 
without the use of a peristaltic pump.  
3.4.2.5. Affinity chromatography using HiTrap Heparin HP 
column 
In some cases where a protein of interest co-purified with 
nucleic acids, an additional step of purification using a HiTrap 
Heparin column was used. The column was washed with 10 column 
volumes of MQ water, and equilibrated with 10 column volumes of 
Buffer A. The protein sample to be loaded on the Heparin column was 
first dialyzed against a low salt buffer (Buffer A for HiTrap Heparin 
purification, Table 3.6). The elution of the column was done using the 
FPLC ÄKTA purifier system and managed using UNICORN control 
software (GE Healthcare) using a linear gradient of increasing 
concentrations of elution buffer. The absorbance at 260 and 280 nm 
was constantly monitored in order to check which protein fractions 
were nucleic acid-free. All purification samples were then checked on 
10% SDS-PAGE gel.  
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3.4.2.6. Protein tag digestion 
The proteins where the digestion of their fused tag was 
required were dialyzed against Buffer SE overnight using a protein 
Slide-A-Lyzer Dialysis Cassette (Thermo Scientific) with the molecular 
weight cutoff size depending on the molecular weight of the protein to 
be dialyzed. PreScission protease (PP) (human rhinovirus 3C protease 
and GS), consisting of human rhinovirus 3C protease fused to GST, 
was added to the sample depending on the quantity of protein (1 
µg/ml) and left to digest the Tag overnight at 4 °C. For proteins that 
had a TEV ( Tobacco Etch Virus) cleavage site instead, same procedure 
was followed with TEV protease added instead of PP. 
After digestion, the protein samples were then passed again 
through GSTrap (for GST-tagged proteins), GSTrap followed by His 
Trap (for His tagged proteins), or GSTrap followed by MBP column 
(for MBP tagged proteins) in order for the column to capture the 
digested tag and the PP while tag-free protein pass through. The 
samples were also run on acrylamide gel of 10 or 15% to follow the 
success of the digestion process. 
3.4.3. Size exclusion chromatography (gel filtration) 
After affinity purification, the fractions with obtained protein 
of interest were concentrated, using Amicon Ultra (Millipore) with a 
size cutoff depending on the molecular weight of each protein, to a 
final volume of 1-2 ml. This concentrated protein was then injected 
alone or mixed with another concentrated protein into either Hiload 
Superdex 200 16/60 column (GE Healthcare) or Hiload Superdex 75 
16/60 column for smaller proteins using Äkta Prime (GE Healthcare). 
Before injecting, the columns were washed with 180 ml of MQ water 
then equilibrated with 180 ml of SE buffer. The gel filtration columns 
were previously calibrated by well-defined protein standards with 
known molecular weight before use in order to properly estimate the 
results. Elution of the protein was monitored by absorbance at 280 
nm, and samples from the elution peak (s) of the protein were 
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analyzed on SDS-PAGE (10 or 15%). The fractions containing pure 
protein of interest were then concentrated using Amicon Ultracel 
concentrators until a volume containing desired concentration of 
protein was obtained. The protein aliquots were then flash-frozen in 
liquid nitrogen and stored at -80 °C. 
3.5. SDS-PAGE (Sodium Dodecyl Sulfate PolyAcrylamide Gel 
Electrophoresis) 
During all steps of different purifications, aliquots of proteins 
in each step were prepared by mixing with SDS-PAGE loading buffer 
6x (0.3 M Tris pH 6.8, 26.1% glycerol, 2%  SDS, 7 mg Bromophenol 
Blue, 675 µl ß-mercaptoethanol, 30% distilled water) and boiled at 95 
°C for 10 minutes then centrifuged for one minute to spin down. The 
samples were then run on 10% polyacrylamide gels (or 15% for smaller 
protein molecular weight) using a voltage of 200 V and using NuPAGE 
MOPS SDS at 1X (Life Technologies) as a running buffer. 
For visualization, the protein gels were stained with Coomassie 
Blue solution (1g Coomassie Blue, 40% methanol, 10% acetic acid, 50% 
distilled water) for 5-10 minutes followed by de-staining in a solution 
of 10% Methanol, 10% acetic acid, 80% distilled water. 
3.6. Protein quantification 
The final concentration of the protein was assessed by using 
the Bradford method (Bio-Rad) against Bovine Serum Albumin (BSA) 
standard curve by mixing 2 µl of the protein with 998 µl of the 
Bradford solution in a cuvette and measuring the absorbance at 600 
nm using the spectrophotometer Ultrospec 10 Cell density meter 
(Amersham Biosciences). 
Another more accurate approach to measure the concentration 
of the protein was by mixing the protein in equal amounts with 6M 
guanidinium chloride solution, and measuring the absorbance at A280 
by applying Beer-Lambert law using NanoDrop (Thermo Scientific) 
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taking into account the extinction coefficient of each protein 
calculated using ProtParam tool (ExPASy). 
3.7. Native gel electrophoresis  
For the native gel band shift assay, a total amount of 20 µg of 
protein was incubated with increasing concentrations of total cell 
extract RNA done in our laboratory by Dr. Sara Zamora Caballero and 
incubated on ice for around 15-30 minutes. The samples were then 
mixed with 5x sample buffer (0.3M Tris-HCL pH 8.5, 0.05% (w/v) 
bromophenol blue, 40% (v/v) glycerol) and loaded on a 10% native 
polyacrylamide gel using a Tris-Glycine running buffer at pH 8.3. The 
gel was previously pre-run alone with the buffer for 40 minutes at 100 
V before running the samples. The voltage used to run the gel was 100 
V and it was run for 4 hours at 4 °C. The later staining and de-staining 
of the gel were done as described in section 3.5. 
3.8. In vitro binding experiments 
3.8.1. Poly (U) agarose beads binding experiment 
10 mg of lyophilized Polyuridylic acid-Agarose powder (Sigma 
Aldrich; P8563) were weighed and washed with DEPC (diethyl 
pyrocarbonate) treated, RNAse free, water and left to swell for few 
minutes. The beads were then equilibrated two times with reaction 
buffer containing: 50 mM Hepes pH 7.5, 100 mM NaCl, 0.1 mg/ml BSA, 
and 2.5 mM MgCl2). After that, 200 µg of purified protein (or protein 
complex) diluted in the reaction buffer were loaded on the beads and 
left mixing at 4 °C for 30-60 minutes with constant rotation. The beads 
were then spinned down and the un-bound protein fraction discarded. 
The beads were after washed 3-4 times with 0.5-1 ml wash buffer not 
containing BSA, and then the Poly(U)  was separated from the beads 
by the addition of 30 µl of 6x SDS-PAGE loading buffer and boiled for 
5 minutes at 95 °C. The samples were then centrifuged spanned down 
for 1 minute and supernatants loaded on 10% SDS-PAGE or analysis. 
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3.8.2. Pull down assay 
On a small scale, 100-200 µg of tagged bait protein lysate 
obtained after small-scale expression and small-scale purification as 
described earlier (section 3.3.1, 3.4.1) was incubated with 70-100 µl of 
beads previously washed and equilibrated for around 30 minutes at 4 
°C with constant rotation. The type of beads used depended on the 
type of tag fused to the bait protein. Afterwards, the beads were 
washed with 1 ml SE buffer to remove un-bound protein fraction by 
centrifugation and discarding supernatants. The prey protein was then 
added to the beads in equimolar concentrations and left on a rotator 
for additional 30 minutes. It has to be noted that the prey protein 
would not have the same tag as the bait protein. Supernatants were 
then discarded and unbound protein fraction removed by washing the 
beads 3-4 times with 1ml fresh SE buffer each time. Finally, the beads –
bound protein fraction was eluted by adding 30 µl of 6x SDS-PAGE 
sample buffer and boiled for 10 minutes at 95 °C. 
On a large scale however, after sonication and centrifugation 
the soluble fraction of the bait protein in the supernatants was loaded 
on a 5ml column depending on the tag of the protein. The column was 
then washed with Buffer A to remove any unbound protein and the 
prey protein supernatant was then loaded onto the column. The prey 
protein would have no tag, or a tag different than that of the bait 
protein. The column was additionally thoroughly washed with Buffer 
A and then eluted depending on the type of the protein tag used to 
catch the bait protein as explained earlier.  
The samples from the pull down, in the case of small scale or 
large scale were then prepared and analyzed on 10% SDS-PAGE gel as 
explained in section 3.7. The gel was then visualized to check what 
protein bands are seen in the elution fractions to assess the binding of 
the protein(s). 
 
Materials and Methods 
75 
 
3.8.3. Bio-layer Interferometry  
The Bio-layer interferometry system (Pall ForteBio) was used 
to evaluate molecular interactions and calculate binding affinities. To 
calculate the binding affinity of different protein constructs to a 15 
residues long Poly(U) RNA (Sigma Aldrich), Streptavidin sensors 
(ForteBio) were used to capture the 5’ Biotinylated Poly(U) RNA of 15 
residues. The streptavidin biosensors were hydrated for 10 minutes 
before use in a buffer containing 50 mM Hepes pH 7.5, 150 mM NaCl, 
5% Glycerol, 1 mM BME, 0.5 mg/ml BSA. The advanced kinetics setup 
of the BLItz software was used, and a concentration of 50 µg/ml of the 
bait biotinylated Poly(U) RNA used for immobilization to the 
biosensors. On the other hand, 4 µl of at least 3 or 4 different 
increasing concentrations (0.25-20 µM) of each prey protein were 
utilized to estimate the binding affinity. The prey proteins were 
diluted in the same hydration buffer containing 0.5 mg/ml BSA that 
was used throughout the experiment in order to eliminate non-
specific binding of the prey protein to the Streptavidin sensor if 
present. This negative control was in turn used as a reference to 
calculate the binding affinity. Curve fitting, association constant (Ka), 
dissociation constant (Kd), and KD calculations were done using BLItz 
Pro 1.2 software. 
On the other hand, for assessing the binding of different GST 
tagged Mex67 constructs to Mip6, the bait protein was immobilized 
on an anti-GST bionsensors (ForteBio). The anti-GST biosensors were 
also hydrated in the same buffer mentioned earlier for 10 minutes 
before use. Then different concentrations of the prey protein were 
used to evaluate the association and dissociation steps. 0.5 mg/ml of 
BSA in the buffer used throughout the experiment was utilized to 
eliminate non-specific binding. The curve fitting and the binding 
affinity was calculated using the BLItz Pro 1.2 software. 
During the different biolayer interferometry experiments, the 
duration of the loading, association, and dissociation steps depended 
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on the saturation of the signal obtained. Additionally, the Streptavidin 
biosensors were regenerated with 0.5 mM NaOH, while the anti-GST 
biosensors were regenerated by using 10 mM glycine pH 1.9. The 
biosensors were then dehydrated by incubating them in 15% 
Saccharose solution prepared in PBS 1x before being dry stored at 
room temperature. 
3.8.4. Isothermal Titration Calorimetry (ITC)   
For the ITC experiments, purified proteins were used. The 
proteins were dialyzed using Slide-A-Lyzer Dialysis Cassettes (Thermo 
Scientific) in the same buffer before performing the experiment. Nano 
ITC from TA instruments was then used to perform the 
measurements. All samples were spinned down and degassed for 10 
minutes using the degassing work station before being slowly and 
carefully loaded in the cell (200-250 µl) with a Hamilton syringe or in 
the titration syringe (50 µl). All experiments were performed at 15 °C, 
and consisted of a serious of 20-30 serial injections depending on each 
case. The concentration of proteins used either in the syringe or in the 
cell, plus the number of injections and the volume of injections for the 
experimental results shown in this study is summarized in table 3.7. A 
blank experiment where the titrant was used against buffer was used 
as data reference, as the heat peaks produced from it are the results of 
dilution effect to be excluded when analyzing the data.  The data 
fitting and analysis was performed using NanoAnalyze v.3.7.0. software 
(TA Instruments). 
Experiment Syringe Cell Injections number 
Injection 
volume 
Mex67(528-599)/ 
Mip6(111-480) 
Mex67(528-599): 
800 µM Mip6(111-480): 25 µM 25 2 µl (1.96 µl) 
Mex67(528-599)/ Mip6 
RRM4(390-480) 
Mex67(528-599): 
690 µM 
Mip6 RRM4(390-480): 
50, 70 25 2 µl (1.96 µl) 
Mip6 RRM4(390-480)/ 
Mex67(528-599) 
Mip6 
RRM4(390-480): 
700 µM 
Mex67(528-599): 50 
µM 30 1.5 µl 
Mex67(528-599)/ Mip6 
RRM4 W442A 
Mex67(528-599): 
690 µM 
Mip6 RRM4 
W442A: 50 µM 25 2 µl (1.96 µl) 
GST-Mex67 UBA/ 
Mip6 RRM4(390-480) 
GST-Mex67 
UBA: 612-
Mip6 RRM4(390-480): 
20-80 µM 20 or 25 
2.4 µl (2.38 µl) 
or 2 µl (1.96 µl) 
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1800 µM 
Mex67(528-599)/Pes4 
RRM34 
Mex67(528-599): 
800 µM 
Pes4 RRM3/4: 25 
µM 25 2 µl (1.96 µl) 
 
Table 3.7. ITC conditions and protein concentrations used for the experiments 
mentioned in this study. 
3.8.5. Protein Cross-linking 
200 µg of the stable complex Mex67(528-599)/Mip6 RRM4(390-480) 
obtained from gel filtration was mixed with different concentration of 
Sulfo-SMPB (sulfosuccinimidyl 4-maleimidophenyl)butyrate) cross-
linker (Thermo Scientific) for 30, 60, 120 minutes at room 
temperature. Both the protein and the cross-linker were dissolved in 
SE buffer (refer to table 3.6) into a total volume of 25 µl. The reaction 
was stopped by adding 1 µl of Tris-HCL pH 8 (0.5M), and samples were 
heated at 95°C for 10 minutes with the 6x sample buffer and run on 
15% SDS-polyacrylamide gel. After visualizing the gel, the cross-linked 
protein band of interest was extracted from the gel and sent to mass 
spectrometry analysis service at the University of Valencia, Burjassot, 
Valencia. 
3.9. Protein crystallization and structure resolution 
3.9.1. Crystals of Mip6 RRM3(313-389) 
After size exclusion chromatography, the protein was 
concentrated to final concentration and different concentrations were 
used to set up crystallization screening plates. The crystallization 
plates were set up using sitting drops vapor diffusion crystallization in 
96-well plates at 21 °C using commercial crystal screens available. 
Crystals were obtained in drops containing 8-10 mg/ml of protein in 
drops containing 0.5 µl of protein and 0.5 µl of reservoir. The initial 
crystals were cylinder in shape and diffracted up to 8 Å or needle-like 
crystals that were not unique. In order to improve the needle crystals, 
some conditions were chosen to do additive screening with Hampton 
additives kit. The drop from which the first structure was solved 
contained 0.5 µl of protein sample, 0.5 µl of reservoir, and 0.1 µl of 
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each added additive. On the other hand, some crystallization plates 
were set by mixing Mip6 RRM3(313-389) protein with Poly(U) RNA 7 
residues long purchased from Sigma Aldrich in a 1:1.2 protein to RNA 
ratio. 
The obtained crystals were flash-cooled in liquid nitrogen and 
diffracted at XALOC beam line of ALBA Synchrotron (Barcelona, 
Spain) at a wavelength of 0.97934 or 0.9795. Data were processed using 
XDS (X-Ray Detector Software) (Kabsch, 2010), then merged and 
scaled in Scala from CCP4 (Winn et al., 2011). Molecular replacement 
was then carried out using Phaser-MR module in Phenix (Adams et al., 
2010). The PDB model used for the molecular replacement of the first 
structure of Mip6 RRM3 was the RNA recognition motif of the Cap 
binding complex (CBC) subunit 2 (PDB ID: 3FEY). The initial phases 
were then used for additional model building using AutoBuild module 
from Phenix. Further structural refinement was achieved using a 
combination of Phenix refine suite and manual refinements in COOT 
(Emsley, Lohkamp, Scott, & Cowtan, 2010). The first structure was 
deposited in the Protein Data Bank (PDB) with PDB ID: 5D77. It was 
then used as a model for the molecular replacement of the later 
structure deposited with PDB ID: 5D78. 
3.9.2. Crystals of Mex67(528-599) 
The crystallization screening plates were set either with 
purified Mex67(528-599) alone or by mixing 1:1 ratio with different Mip6 
constructs. The crystallization plates were set at 21 °C using the sitting 
drop vapour diffusion method and crystals were obtained by vapour 
diffusion using sitting drop method after few months in different 
conditions (table 4.3). The crystals were cryo-cooled in nitrogen and 
diffracted at Diamond light source (Harwell, UK) I03 and I04 beam 
lines. Best crystals diffracted up to 1.3 Å and data were automatically 
processed at Diamond by xia2 pipeline. Data were then scaled using 
Aimless from CCP4. BALBES automatic molecular replacement 
pipeline available online was used to search for a model for molecular 
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replacement (Long, Vagin, Young, & Murshudov, 2007). The search 
model identified by BALBES was that of the UBA domain from the 
human homolog of Mex67 (PDB ID: 1OAI) and it was used for 
molecular replacement utilizing Phaser-MR module from Phenix. The 
MR was successful and the obtained initial phases were used to build 
the rest of the structure using AutoBuild from Phenix and additional 
manual building. Cycles of Phenix refine and COOT were used further 
structural improvements and refinements. Also, the first structure of 
Mex67(528-599) obtained was used as a MR model for the subsequent 
structure.  
3.9.3. Crystals from Pes4 RRM3/4 
3.9.3.1. Crystal structure of Pes4 RRM3 
The crystals from which the structure was solved were 
obtained from a pH screen of an initial condition containing 0.2 M 
Ammonium sulphate and 20% Polyethylene glycol (PEG) 8000 where 
initial bundle of needle-like crystals were obtained. The crystals were 
flash-cooled with liquid nitrogen directly or cryo-protected with 
paratone oil and were diffracted at Diamond light source (Harwell, 
UK) I03 beam line where the best diffracted to 1.7 Å. Data were 
automatically processed with auto-PROC and further scaled using 
Aimless from CCP4 where the resolution was cut to 1.9 Å. Initial 
phases were obtained by using Mip6 RRM3 (section 3.9.1) as a model 
for molecular replacement using Phaser-MR from Phenix. Next, 
AutoBuild from Phenix was used to build the structure. Cycles of 
Phenix refine and COOT was utilized in order to obtain the final 
structure. TLS parameters refinement was utilized in the refinement 
strategy.  
3.9.3.2. Crystal structure of Pes4 RRM4 
One 0f the crystals obtained during the additive screening of 
the initial needle clusters in a condition containing 0.2 M Ammonium 
Nitrate, 20% PEG 3350, and 0.1 M Betaine Monohydrate as an additive, 
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belonged to P212121 space group with cell dimensions: a= 27.501, b= 
36.162, c=73.583 Å; α=β=γ= 90°. The crystal diffracted up to 1.1 Å at 
XALOC beam line of ALBA synchrotron (Barcelona, Spain). The Data 
were processed by XDS and further merged and scaled using Aimless 
from CCP4. Mathews coefficient in CCP4 was also used to assess the 
size of the molecule in the crystal and how many molecules to be 
expected in the asymmetric unit. Since the obtained resolution was 
very high, ARCIMBOLDO suite (D. Rodríguez et al., 2012) in CCP4 was 
used to obtain the initial phases. Buccaneer (Cowtan, 2006) from CCP4 
was further used to build the structure. The model manual refinement 
was done using COOT and further refined using Phenix refine for 
anisotropic refinement until final good R factors were obtained.  
3.9.3.3. Crystal structure of RNA-free Pes4 RRM3/4 
Crystals of Pes4 RM3/4 grew in 10% PEG 4000, 10% 2-Propanol, 
100 mM Sodium citrate pH 5.6, or in 0.2M Ammonium sulfate, 0.1 M 
Sodium Cacodylate trihydrate pH 6.5, 30% PEG 8000 at 21 °C at a 
purified protein concentration of 11 mg/ml with 1:1 equal volumes of 
protein and precipitant (0.5 µl). The crystals were flash-cooled in 
liquid nitrogen and diffracted at XALOC beam line of ALBA 
synchrotron (Barcelona, Spain). The crystals diffracted poorly t0 2.6-
2.8 Å and data were processed by XDS and further merged and scaled 
using Aimless from CCP4. Mathews coefficient from CCP4 was used to 
assess the expected number of molecules in the asymmetric unit. 
Molecular replacement was successful using Pes4 RRM4 as a model. 
However, the solution was only partial and only RRM4 domain was 
placed by the program in the structure. The linker and RRM3 had to 
be placed and fitted manually with consecutive cycles of fitting 
corrections and refinement with COOT followed by Phenix Refine. TLS 
parameters where used in the refinement strategy until the R factors 
mentioned in this study were reached.  
 
 
Materials and Methods 
81 
 
3.9.3.4. Crystal structure of Pes4 RRM3/4 with RNA 
The purified protein of Pes4 RRM3/4 obtained from gel 
filtration was mixed with HPLC purified Poly(U) RNA of 11 residues 
purchased from Sigma Aldrich at 1:1 or 1.2:1 molar ratio RNA:protein 
before setting the crystallization screening plates or mixed directly in 
drop. The crystals obtained by vapor diffusion using sitting drops were 
small plates that were flash-frozen with nitrogen and diffracted at 
XALOC beam line of ALBA synchrotron (Barcelona, Spain). The 
crystals diffracted poorly and the data obtained was processed with 
both XDS and iMosflm (Battye, Kontogiannis, Johnson, Powell, & 
Leslie, 2011). The data was integrated either in the monoclinic P1211 
(no. 3) or in I121 (c2, no. 5) space groups and Molrep self rotation 
function from CCP4 was checked. The MR module from Phenix was 
used for molecular replacement trials with Pes4 RRM3/4, Pes4 RRM3, 
or Pes4 RRM4 as a model. Also BALBES was tried to search for a model 
for molecular replacement.  
3.10. Structure surface electrostatic potential  
The surface electrostatic potential of the structures was 
calculated using PDB2PQR & APBS (Adaptive Poisson-Boltzmann 
Solver) online server version 2.1.1 (Dolinsky et al., 2007) and visualized 
using Chimera software (Pettersen et al., 2004). Structure figures as 
well as figures of superposed structures were generated either by 
COOT or using Chimera.  
3.11. NMR spectroscopy titration  
The NMR (Nuclear Magnetic Resonance) experiments were 
done and analyzed in Dr. Jose Manuel Pérez Cañadillas lab (Institute 
of physical chemistry Rocasolano, CSIC, Madrid, Spain). NMR data 
were acquired in a Bruker AV-600 or AV-800 spectrometers equipped 
with a z-gradient triple resonance cryoprobe at 20 °C. Protein samples 
were prepared at concentrations of 50-150 µM in NMR buffer 
containing 25 mM potassium phosphate pH 7.0, 150 mM NaCl, 2.5 mM 
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DTT. Backbone triple 1H, 13C and 15N resonance assignments of 
Mex67(528-599) and Mip6 RRM4 were recorded on a double-labelled 
protein samples to assign their 2D 1H,15N-heteronuclear single 
quantum coherence (HSQC). NMR spectra were processed and 
analyzed with NMRPipe (Delaglio et al., 1995) and CCPN-Analysis 
software (Vranken et al., 2005). 
For the NMR titration experiment, 15N HSQC spectra were 
recorded at 20 °C for 15N, 13C-labeled Mip6 RRM4 protein (250 μM) 
titrated with unlabeled Mex67(528-599) protein in the same buffer 
containing 25 mM potassium phosphate pH 7.0, 150 mM NaCl, 2.5 mM 
DTT. Three titration points were recorded at 125 μM, 250 μM, and 375 
μM of Mex67 allowing the follow of the signals in fast exchange from 
the free to bound state. The chemical shift perturbation (CSP) was 
calculated for each amide signal and normalized using ΣΔδ = |Δδ(1H)| 
+ |(0.2)Δδ(15N)|, where Δδ(1H) and Δδ(15N) represent the chemical 
shift differences between the free and bound states. The titration of 
unlabeled Mip6 RRM4 into 15N,13C-labeled Mex67(580-599) could not be 
analyzed by the CSP as most of the signals exchange in the 
intermediated regime (broad signals) during the titration experiment. 
Instead the effects of Mip6 RRM4 on the Mex67(528-599) were analyzed 
by monitoring the change of intensity of the signals in series of 15N 
HSQC spectra taken at low saturation values (< 15% of Mip6 RRM4). 
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4.1. Mip6 protein expression and purification 
To better understand the structure and function of Mip6, the initial 
step was to try to express and purify the full length protein of Mip6. For this 
purpose, the full length recombinant Mip6 FL(1-659) protein was cloned in a 
variety of plasmids with different range of N-terminally fused soluble 
protein tags (6XHis, GST, or MBP tags) as shown in table 3.5. The Mip6 FL(1-
659) protein was then expressed in E. coli in Bl21  (DE3) and Bl21 codon plus 
(DE3) RIPL competent cells using different culture media (LB or ZY media), 
and expression systems (IPTG induction and Auto-induction). The 
baculovirus-insect cells expression system was also tried in order to obtain 
soluble protein. Unfortunately, the protein could not be expressed in a 
soluble form, even when co-transformed with chaperones (GroEL/GroES 
system and DnaK-DnaJ-GrpE system) in an attempt to aid the proper folding 
of the protein.  
Only a small fraction of soluble Mip6 FL(1-659) was obtained from a 
fused N-terminal MBP tag, expressed with Auto-induction in Bl21 (DE3) 
codon plus E. coli cells at 16°C during a 48-72 hours duration, and purified 
with affinity chromatography on an amylose resin packed gravity flow 
column. The eluted protein fractions were visualized on a 10% 
polyacrylamide SDS-PAGE gel, and the small soluble fraction obtained was 
further concentrated and loaded in a gel filtration (Superdex 200 16/60) 
column. From size exclusion chromatography, the protein eluted in the void 
volume of the column in a single peak, indicating an aggregated form of the 
protein (figure 4.1). We suspected that a co-purification of nucleic acids with 
the protein might be the cause, but the addition of RNase A or DNase to the 
lysis buffer of the protein did not resolve the aggregation. Also several 
solution additives used frequently for protein stabilization against 
aggregation such as 200mM L-arginine, 5-10% glycerol, or different salts 
(KCl instead of NaCl) were used but didn’t improve the result. 
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Figure 4.1. (a) The gel filtration chromatogram corresponding to the elution profile of MBP 
tagged Mip6 FL(1-659) as a single peak aggregate eluting in the void volume of the Superdex 200 
16/60 column. (b) The fractions corresponding to the elution peak containing Mip6 FL(1-659) 
protein were visualized on a 10% SDS-PAGE and are highlighted with the red bar. 
4.2. MIP6 is an RNA binding protein that binds RNA with high 
affinity 
Due to the challenges we faced getting a soluble, non-
aggregating Mip6 FL protein, constructing a shorter more stable form 
of the protein was therefore considered. Running the protein sequence 
on the RONN disorder prediction server (Yang, Thomson, McNeil, & 
Esnouf, 2005), predicted the existence of some disordered regions in 
the protein sequence mainly on its N-terminal region (figure 4.2). 
 
Figure 4.2. Prediction of disordered regions in Mip6 FL sequence. RONN server (Yang et al., 
2005) indicated high disordered regions in the N-term of the protein reaching residue 110, and 
also on the C-term of the protein residues (488-585) and (635-659) which might highlight regions 
more prone to proteolysis and consequently less stable. 
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Additionally, as Mip6 was previously suggested to be an RNA 
binding protein, using Mip6 Fasta sequence to check for conserved 
domain utilizing the NCBI conserved domain database (CDD) 
predicted the presence of three RNA recognition motifs (RRMs) and 
an additional possible fourth RNA binding domain (RBD) in Mip6 
protein sequence (figure 4.3) which also goes in agreement with the 
secondary structure prediction. However though, it was previously 
reported in literature that Mip6 contained only three RNA binding 
domains (Segref et al., 1997). 
Taking these information into consideration, we generated a 
construct Mip6(111-480) that contains all four of the predicted RRMs. This 
construct was then used to characterize the RNA binding of MIP6 
protein. 
 
Figure 4.3. Domain organization scheme of Mip6. NCBI domain prediction server predicted 
the presence of four RRMs where a short linker connects RRM1and2 and RRM3and4 respectively, 
while a longer linker seems to exist between RRM2 and RRM3. 
4.2.1. Expression and purification of Mip6 (111-480) 
The GST tagged construct that combines all the predicted 
RRMs was successfully expressed and purified by affinity 
chromatography on a GSTrap. The fused GST tag on the N-terminus of 
the eluted protein was then digested by PreScission protease at 4°C 
overnight, and the protein was further purified using size exclusion 
chromatography on a Superdex 75 (16/60) size exclusion column. All 
the purification steps after the affinity chromatography were carefully 
completed to prevent the degradation of the obtained protein as the 
protein was prone to proteolysis (as shown in figure 4.4) possibly due 
to the presence of relatively long, unstructured linkers between the 
predicted RRMs. The protein eluted from the gel filtration column at 
54.1 ml as a single peak suggesting that Mip6(111-480) behaves as a 
monomer in solution (Figure 4.5). The purified protein was then 
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concentrated and flash frozen in liquid nitrogen before being stored at 
-80°C for further use.  
 
   
 
   
Figure 4.5. Mip6(111-480) elution profile from size exclusion chromatography and its 
corresponding 10% SDS-PAGE gel. Mip6(111-480) eluted as a single peak corresponding to a 
monomer that is marked by a red bar on both the chromatogram and the corresponding SDS-
PAGE gel where the protein band at 43.52 KDa is visualized.  
4.2.2. Mip6(111-480) binds RNA in vitro  
To investigate whether Mip6 is able to bind RNA in vitro, the 
RNA binding affinity of Mip6(111-480) was assessed using the Bio-layer 
interferometry system, where an N-terminal 5´ biotinylated general 15-
nucleotide long poly(U) RNA was immobilized on streptavidin 
biosensors. Different concentrations of the purified Mip6(111-480) protein 
(0.5, 0.75, 1, and 1.25µM) were used as prey protein to calculate the 
Figure 4.4. Purification of Mip6(111-480). 
Samples from the different steps: Supernatants 
(S), non-soluble pellet fraction (P), fraction 
non-bound to the affinity column (Ft), wash of 
the affinity column (W), and elutions of affinity 
chromatography purification of GST-MIP6(111-480) 
as visualized on a coomassie-stained  10% SDS-
PAGE gel. The protein was mostly soluble; some 
degradation and possible proteolysis is noticed 
in the most concentrated elution fractions as 
indicated with the arrows. 
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binding affinity to the poly(U) in vitro (figure 4.6). Non-specific 
binding of the prey protein to the streptavidin sensors was minimized 
to almost no detection by adding 0.5 mg/ml of BSA to the buffer 
solution used in the experiment. The association and dissociation 
phases were well fitted with the interaction having a binding affinity 
in nano-molar range KD= 0.345 µM proving a high binding affinity to a 
rather non-specific RNA which supports a role of Mip6 as a universal 
RNA binding protein. The experiment was repeated confirming the 
result. 
 
Figure 4.6. Mip6 binds RNA with high affinity. Association and dissociation steps from the 
Bio-layer interferometry experiment using different molar concentrations (in µM) of Mip6(111-480) 
depicted in the figure with different colors. The binding affinity to general Poly(U) RNA 
immobilized on streptavidin sensors was calculated in the nanomolar range.  
4.3. MIP6 has a fourth RNA recognition motif 
In literature, it was suggested that Mip6 harbours three RNA 
recognition motifs. To investigate whether this hypothesis is true, we 
decided to verify the RNA binding abilities of the separate predicted 
RRMs and check whether an additional fourth RRM exist. In order to 
evaluate this hypothesis, different constructs harboring separate 
predicted RRMs were generated: Mip6 RRM1/2(111-279), Mip6 
RRM3/4(313—480), Mip6 RRM3(313-480), and several truncations of the 
predicted Mip6 RRM4 as shown in figure 4.7 below. These truncations 
were then tested for their ability to recognize and bind RNA 
independently. 
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Figure 4.7. The different Mip6 constructs generated to include individual or combination of the 
predicted RNA binding motifs. 
4.3.1. Expression and purification of Mip6 RRM1/2 and MIP6 
RRM3/4 
  Mip6 RRM1/2 and Mip6 RRM3/4 containing residues 111-279 
and 313-480 respectively were cloned in a plasmid with an N-terminal 
GST tag. The plasmids transformed into the bacterial Bl21 codonPlus 
RIPL strain were then successfully expressed using the Auto-induction 
expression system at 18°C overnight. The expressed proteins were then 
purified using affinity chromatography on a GSTrap. A good amount 
of soluble protein was obtained from both construct. The fused GST 
tag of the purified proteins was digested afterwards using PreScision 
protease and the obtained proteins were further purified using size 
exclusion chromatography. Both proteins eluted from gel filtration as 
a single, monomeric peak in which its corresponding protein fractions 
were then concentrated to final concentration and used for further 
experiments or stored at -80 (figure 4.8).    
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Figure 4.8. 
(a). Elution profile from the size exclusion chromatography purification of Mip6 
RRM1/2(111-279). The protein eluted as a monomer at 99.1 ml from Superdex 200 16/60 gel filtration 
column. The fractions corresponding to the peak were visualized on a 10% SDS-PAGE gel and 
marked with a red bar.  
(b). the chromatogram showing the elution profile of Mip6 RRM3/4(313-480) protein from 
the gel filtration Superdex 75 16/60 column. The protein of 19.92 KDa eluted as at 77 ml of 
volume as a single, monomeric peak. The corresponding fractions were visualized on a 10% SDS-
PAGE gel where the purified protein is marked with a red bar, while the fractions with a slightly 
higher band corresponded to the excess free GST (marked in dark blue) after the GST tag 
digestion. 
 
4.3.2. Expression and purification of Mip6 RRM3(313-389) 
Mip6 RRM3(313-389) was expressed in BL21 codon plus (DE3) 
RIPL bacterial cells using the Auto-induction expression system in ZY 
medium at 20°C overnight. The cells were collected, lysed, and 
purified using affinity chromatography on a 5 ml GSTrap. A good 
soluble amount of the protein was obtained. The proteins’ N-terminal 
GST tag was then removed by incubating it with PreScision protease at 
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4°C overnight. The protein was further purified with size exclusion 
chromatography where it eluted in a single peak. Analysis of the 
purified Mip6 RRM3(313-389) showed more than 95% purity and the 
protein was then concentrated and flash frozen in liquid nitrogen and 
stored at -80 °C (figure 4.9).  
             
Figure 4.9. Gel filtration elution profile of Mip6 RRM3(313-480). The protein eluted in a single 
peak in a volume corresponding to the monomeric size of the protein. A 10% SDS-PAGE showed 
a good amount of the protein as clean and pure. The protein peak and its correspondence on the 
gel are represented by the red bar. The additional peak shown with an arrow was corresponding 
to excess free GST after tag removal. 
4.3.3. Expression and purification of Mip6 RRM4 
On the other hand, due to the lack of previous characterization 
of a fourth RRM on Mip6 and the subsequent lack of information on 
the possible boundaries, three constructs containing RRM4 were 
expressed and purified: 6xHis tagged Mip6 RRM4(390-495), 6xHis-Mip6 
RRM4(390-480), and GST- Mip6 RRM4(401-480). The proteins were purified, 
depending on its fused tag, using affinity chromatography on either 
HisTrap column or GSTrap followed by exclusion chromatography on 
Superdex 75 (16/60). The proteins then were either digested with 
PreScession protease or left non-digested depending on the 
requirements of the subsequent experiments.  
It has to be noted that in the case of the 6xHis tagged Mip6 
RRM4(390-495), the major part of the protein eluted from gel filtration in 
the volume ( ̴76.79 ml) corresponding to a monomer, while in the case 
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of the other two constructs (Mip6 RRM4(390-480) and Mip6 RRM4(401-480)) 
the protein did not elute from gel filtration in the volume expected for 
its size, instead it eluted in the retention volume of the column after 
the expected size possibly due to non-specific interaction with the 
column matrix or maybe due to a possible compact conformation 
making the protein behave as if it was of a lower molecular weight. 
Only a very small portion eluted in a smaller peak corresponding to a 
dimer. This was noticed especially when the protein was in higher 
concentrations. Increasing ionic strength by using higher 
concentrations of NaCl salt in the solution buffer did not help resolve 
the retention problem. On some occasions, when the protein co-
purified with nucleic acids, an additional step of HiTrap Heparin 
purification was used to remove any co-purifically bound nucleic acid 
and to get cleaner protein. 
          
 
(a) 
(b) 
53 
41 
32 
23 
14 
10 
 
23 
14 
10 
Results 
94  
 
 
Figure 4.10. Size exclusion chromatography elution profile of Mip6 RRM4. 
(a). Gel filtration chromatogram corresponding to the elution profile of 6xHis tagged Mip6 
RRM4(390-495) and the 10% SDS-PAGE gel corresponding to the obtained protein. The protein 
eluted mostly in the volume corresponding to its monomeric size. 
(b). The gel filtration elution profile of Mip6 RRM4(390-480) with 6xHis tag eluted from gel 
filtration after the elution volume for its expected size. The fractions corresponding to the 
highest peak are marked in red. 
 (c). The elution profile of Mip6 RRM4(401-480) after 6xHis tag removal consisted of three peaks: a 
smaller peak where the elution volume corresponds to a dimer but the amount of protein in this 
peak was very small, and another two peaks after the protein expected elution volume. The 
corresponding fractions were visualized on a 10% SDS-PAGE gel and marked with a red bar that 
corresponds to each peak. 
 
4.3.4. Mip6 RNA recognition motifs independently bind poly-
uridylic acid in vitro 
After expressing and purifying the constructs of Mip6 containing 
the different RRMs, their separate ability to recognize and bind RNA 
in vitro was evaluated. For this purpose, polyuridylic acid (PolyU) 
agarose beads were used. The proteins in the purified form were 
incubated at 200 µg with the beads for one hour with constant 
rotation and then washed 3-4 times with buffer containing (50mM 
Hepes pH 7.5, 100mM NaCl, 2.5mM MgCl2) prior to elution. As shown 
in figure 4.11, binding to the Poly(U) of the predicted RRMs: Mip6 
RRM1/2(111-279), RRM3/4(313-480), RRM3(313-389), and RRM4(390-480) was 
verified as the proteins were visualized bound to the Poly(U) RNA on 
polyacrylamide gel indicating a clear RNA binding. However, the 
binding of Mip6 RRM3 to Poly(U)-agarose was notably lower than the 
other RRMs or RRM4 as the intensity of the band corresponding to 
Mip6 RRM3(313-389) as seen on the SDS-PAGE was much lower. 
(c) 
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Although, unlike RRM3 and RRM4, Mip6 RRM1 and RRM2 were not 
tested for RNA binding separately, but rather joined in the Mip6 
RRM1/2(111-279) construct and thus our results were not indicative if each 
of them on its own would be able to bind RNA, it is most probably the 
case. Thus, our results confirm Mip6 as an RNA binding protein 
containing multiple RRM domains, most likely four, capable of 
binding RNA independently. For this experiment, BSA was used as a 
negative control. 
 
A.       B.        C.      D.  
Figure 4.11. Mip6 has four RNA binding domains.  
Truncations containing RRM domains of Mip6 were incubated with poly(U) beads (1: protein 
input), beads were then washed thoroughly (2: wash), and then eluted (3: proteins that were 
attached to the beads after washing) and samples were visualized on 10% SDS-PAGE gel stained 
with Coomassie. Proteins co-eluted from resin together with polyU indicating binding. 
A. Mip6 RRM1/2(111-279) B. Mip6 RRM3/4(313-480) C. Mip6 RRM3(313-389) D. 6xHis-Mip6 RRM4(390-480) 
 
4.3.5. Mip6 RRM4 binds RNA with high affinity 
After characterizing a fourth RNA binding domain in Mip6, we 
decided to go further and precisely measure the binding affinity of the 
protein truncation containing the boundaries of the expected Mip6 
RRM4(390-480) to a general 15-nucleotide long Poly(U) RNA immobilized 
on streptavidin sensors using Bio-layer interferometry. Mip6 RRM4 
was able to bind Poly(U) RNA with a good micro molar affinity of KD = 
5.7 µM assuring its position as an RNA binding motif (figure 4.12). 
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Additionally, From the intensities of the bands visualized on the 
polyacrylamide gel in the Poly(U) beads binding experiment, we could 
not assess whether the binding to RNA is better when two RRMs are 
joined rather than independent, therefore the binding affinity of Mip6 
RRM3/4(313-480) to the biotinylated Poly(U) RNA was also measured. A 
binding affinity of KD 0.31 µM was obtained indicating a stronger 
interaction with the two RRMs combined (figure 4.12). This possibly 
suggests the presence of an additional RRM may provide a larger 
binding platform for a better cooperative recognition and interaction 
with RNA. 
(a) Mip6 RRM3/4(313-480) 
 
(b) Mip6 RRM4(390-480) 
 
Figure 4.12. RNA binding affinity calculations for Mip6 RRM3/4 and Mip6 RRM4 using 
Bio-layer interferometry. Association and dissociation curves obtained for Mip6 RRM3/4(313-480)  
(a) and Mip6 RRM4(390-480) (b) showed a high affinity binding to the general biotinylated Poly(U) 
RNA of 15 residues immobilized on streptavidin sensors. The curve corresponding to each protein 
concentration used (in µM) is depicted in different colors. 
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Crystallization trials of all the above utilized constructs 
comprising different RRM combinations from Mip6 with or without 
poly(U) RNA was carried out, but till the day crystals that led to 
structure solving were only obtained from Mip6 RRM3(313-389).  
However, our attempts to crystallize Mip6 RRM1/2 with 
Poly(A) RNA of 11 residues rapidly produced crystals that diffracted to 
1.25-1.35 Å and a high quality data was collected. Yet, the solved 
structure did not contain any protein, instead the structure turned out 
to be that of a parallel RNA double-helix formed by Poly(A) with one 
double-helix in the asymmetric unit (figure 4.13). In the structure, the 
double-helix was formed by two symmetric adenine nucleotides 
stabilized by hydrogen bonds formed between the hydrogen atom of 
the amino group of one adenine and the Nitrogen N7 atom of the 
symmetric adenine on one hand, and another hydrogen bond between 
the oxygen atom of the phosphate backbone of one strand and the 
hydrogen atom of the amino group of the opposite adenine on the 
other strand (figure 4.13.b). Interestingly, the terminal unpaired 
nucleotides of the helix were pairing with the symmetry-related 
unpaired nucleotide thus forming inter-duplex base pairing which 
resulted in a continuous double helical structure (figure 4.13.a). 
Unfortunately, comparing our data with previously solved 
structures on the protein data base (PDB) led us to the knowledge that 
the structure of parallel double helix poly(A) was published shortly 
before we obtained our result (Safaee et al., 2013) (PDB ID: 4JRD), after 
a high order helical Poly(A) RNA structure was just a prediction for 
more than 50 years.   
Results 
98  
 
                                 
Figure 4.13. Poly(A) double helix crystal structure. (a) The continuous Poly(A) double helix 
formed by three individual helices shown in different colours. (b) 2F0-Fc map countered at 1.20 δ 
showing the electron density surrounding the A-A base pairing responsible for the double helix 
formation with their formed hydrogen bonds formed between the amino groups and Nitrogen 
atome of symmetrical adenines on one hand and between the oxygen group of the phosphate 
backbone and the amino group of the opposite adenine on the other hand. The environmental 
distances are also shown. (c) An overview of the symmetrical double-stranded Poly(A) helix as 
present in the asymmetric unit of the crystal where one nucleotide is overhanging on each end. 
Each strand in the double-helix is represented in distinct colour. 
Resolution (Å) 1.25 
Space group P41212 
Unit-cell 
parameters  
a,b,c (Å) 22.89, 22.89, 163.673 
α, β, γ (°) 90, 90, 90 
Wavelength (Å) 0.97949 
Total reflections 129468 (3230) 
Unique reflections 12847 (1059) 
Completeness (%) 98.04 (84.45) 
Si
ng
le
 P
ol
y(
A
) d
ou
bl
e 
he
li
x 
(a) 
(c) 
(b) 
Results 
99 
 
Multiplicity 10.1 (3.1) 
Mean I/Sigma(I) 14.82 (2.29) 
Rmerge 0.1031 (0.6267) 
Rmeas 0.1083 
Rwork/Rfree 0.1448/0.1957 
CC1/2 0.999(0.72) 
Water molecules 65 
Clashscore 0 
Average B factors 11.20 
 
Table 4.1. Data collection and refinement statistics from a crystal of Poly(A) double helix 
structure. The refinement statistics shown are obtained after two rounds of refinement using 
Phenix.refine module. Statistics from the highest resolution shell are indicated in parenthesis. 
4.4. Crystal structure of Mip6 RRM3(313-389)  
4.4.1. Crystallization  
Crystals of purified Mip6 RRM3(313-389) started to appear few 
days after setting the crystallization screening plates at 21°C. Different 
forms of crystals were obtained in different growth conditions. Some 
crystals diffracted poorly to 8 Å, but other crystals in forms of needles 
diffracted to a better resolution. The conditions where clusters of 
needles grew were used for additive screening, where single crystals 
were consequently obtained. Additionally, co-crystallizations with 
Poly(U) RNA was also tried. Table 4.2 summarizes the crystallization 
conditions where the crystals were obtained with the corresponding 
resolution obtained when X-ray diffracted.  
Crystallization 
condition Screen Additive Resolution Crystals form 
1.6M Sodium citrate 
tribasic dihydrate pH 
6.5 
Crystal screen I 
and II (CSIYII) 
(Hampton) 
 2-2.5 Å 
 
3 M Sodium formate 
 
JBSII (Jena 
Bioscience)  8 Å 
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1.6M Sodium citrate 
tribasic dihydrate pH 
6.5 
CSIYII  
(Hampton) 
 
2M 
Ammonium 
Nitrate 
1.3 Å 
 
0.2M Lithium sulfate, 
0.1M Tris Ph 8.5, 40% 
PEG 400 
JCSG 
(molecular 
dimensions) 
 1.25 Å  
 
Table 4.2. Mip6 RRM3(313-389) crystals growth conditions where different crystal forms with 
varying x-ray diffraction resolution were obtained. 
4.4.2. Data collection and processing 
Subsequently, complete data sets were collected from the 
highest diffracting crystals without RNA at 1.3 Å and with added 
Poly(U) RNA at 1.25Å were used for scaling and further processing in 
the aim to solve the structure of Mip6 RRM3(313-489). The crystals 
belonged to the tetragonal P43212 and monoclinic P1211 space groups 
respectively. Due to the prior characterization of Mip6 RRM3(313-389) as 
a RNA recognition motif (RRM), an RRM model from the PDB (PDB 
ID: 3FEY) was initially used for molecular replacement using MR 
Phaser from Phenix. Unit cell dimensions from both datasets 
belonging to different space groups indicated the presence of one 
molecule of Mip6 RRM3(313-389) in the asymmetric unit with no RNA in 
the structure in the case where RNA was added. The structures from 
both crystals were further refined using Phenix.refine. The final models 
were 97 and 99% Ramachandran favoured with no Ramachandran 
outliers.  
 Crystal 1 Crystal 2 (RNA added) 
Resolution (Å) 1.3 1.25 
Space group P43212 P1211 
Unit-cell 
parameters   
a,b,c (Å) 36.310, 36.310, 91.816 25.842, 47.023, 30.563 
α, β, γ (°) 90, 90, 90 90, 109.9, 90 
Wavelength (Å) 0.97934 0.9795 
Total reflections 178972 (6700) 56990 (350) 
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Unique reflections 15749 (1444) 14119 (206) 
Completeness (%) 99.29 74.01 
Multiplicity 11.4 (4.6) 4.0 (1.7) 
Mean I/Sigma(I) 26.38 (2.74) 25.88 (3.16) 
Rmerge 0.04538 (0.4646) 0.03091 (0.2076) 
Rmeas 0.04746 0.03519 
Rwork/Rfree 0.1514/0.1818 0.1371/0.1771 
CC1/2 0.999(0.919) 0.999(0.924) 
Ligands 22 13 
Water molecules 51 99 
Protein residues 86 81 
Ramachandran plot   
Favoured (%) 99 97 
Outliers (%) 0 0 
Clashscore 0 0 
Average B factors 24.60 14.80 
PDB code 5D77 5D78 
 
Table 4.3. Data collection and refinement statistics from two crystals of Mip6 RRM3(313-389). 
Statistics from the highest resolution shell are indicated in parenthesis. 
4.4.3. Mip6 RRM3(313-389) structures reveal different loop 
conformations 
The high resolution structures of Mip6 RRM3(313-389) showed a 
typical canonical RRM fold of βαββαβ with four stranded antiparallel 
β sheets, and two alpha helices packed against the β-sheet (figure 
4.14). The β sheets formed a hydrophobic core especially β1 and β3 that 
were entirely hydrophobic. These two central β sheets, β3 and β1 are 
known to be involved in the hydrophobic interaction with nucleic 
acids in other RRMs. Indeed, analyzing the electrostatic potential of 
the domain, the surface of one side of Mip6 RRM3 structure showed a 
positive charged surface. This indicates a possible site of RNA 
interaction as we already have shown to exist in vitro (figure 4.15). 
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(a) (b) 
Figure 4.14.Crystal structure of Mip6 RRM3(313-389). (a) An overview of Mip6 RRM3(313-389) 
structure we crystallized. It consists of two alpha helices (shown in pink), and four anti-parallel 
beta sheets (shown in blue). (b) A schematic representation of the secondary structure 
arrangement in the Mip6 RRM3 structure.  
 
 
Figure 4.15. Positively charged surface of Mip6 RRM3. Electrostatic potential calculated with 
APBS software and visualized using Chimera software shows the positively charged surface of 
Mip6 RRM3 domain in blue, which indicates a possible site for binding nucleic acids. The 
negatively charged areas are depicted in red. 
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Superposing the two structures of Mip6 RRM3 obtained from 
two different datasets of crystals obtained from different conditions 
showed two different loop conformations. The two structures were 
essentially similar with R.M.S.D of 1.42 Å with 76 aligned residues, but 
the obvious difference was the flexibility and movement of loop 3 (β2-
β3 loop) primarily, and to a lower extent in loop 5 (α2-β4 loop) as 
shown in (figure 4.16). It is worth mentioning here that loop3 
definitely had higher B-factors than the rest of the structure which is 
probably due to the flexibility and movement of that loop. The 
flexibility of the loop might be due to the change of the position of this 
loop in the free form or bound to different nucleic acid sequences.  
 
   
By comparing the Mip6 RRM3 structures we obtained to that 
of RRM1 from Sex lethal protein (Sxl) of Drosophila melanogaster 
bound to RNA (PDB code: 1B7F), which the advanced sequence search 
on the PDB identified as having high sequence similarity with Mip6 
RRM3, we could see an overall conservation on the protein folding of 
the RRM excluding loop 3 (β2-β3 loop) that showed high degree of 
movement and also in loop 5 (α2-β4 loop) in lower degree. These 
loops are in some RRMs involved in the recognition of RNA, in 
addition to the major role of ß1 and ß3 that typically forms the 
Figure 4.16. Mip6 RRM3 crystal 
structure showed two different 
structural conformations. Superposing 
the two structures obtained from Mip6 
RRM3 domain showed different 
conformation in loop3 (linking ß2 and ß3) 
and in loop 5 (linking α2 to ß4) to a lower 
degree. 
Loop3 
Loop5 
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platform for RNA binding like seen in the Sxl RRM1/RNA crystal 
structure as shown in figure 4.17.  
     
Figure 4.17. Conformational movement in Mip6 RRM3 loops. Superposition of Mip6 RRM3 
two structures (represented in salmon and green colours) with RRM1 of Sxl protein (shown in 
blue) bound to RNA (PDB code: 1B7F). The comparison revealed general domain homology, but 
major flexibility in loop 3 and to a lesser extend in loop5. As visible in the figure, ß2 and ß3 of Sxl 
RRM1 are majorly involved in the RNA binding as well as loop 3. 
4.5. Characterizing the interaction between Mex67 and Mip6 
 A previous study (Segref et al., 1997), where a yeast two hybrid 
experiment was performed, suggested the possible involvement of the 
C-terminal domain of Mex67 in the interaction with Mip6. To verify 
these claims, we designed and primarily worked with a construct that 
includes the C-terminal domain of Mex67 due to the fact that the full 
length Mex67 protein was big in size and tricky to get large amounts 
of soluble protein from in bacterial cells. 
4.5.1. Expression and purification of Mex67 C-term 
GST-tagged Mex67 C-term (528-599) of interest was successfully 
expressed in E. coli using Auto-induction as an expression system. A 
good amount of soluble protein was obtained after the purification of 
Loop3 
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the expressed protein on GSTrap. The fused GST tag was then digested 
using PreScission protease, and the obtained protein was further 
purified using size exclusion chromatography (Figure 4.18). In gel 
filtration, the protein eluted as a single peak where its corresponding 
protein fractions were pure as visualized in acrylamide gel. Good 
amounts of the protein were obtained and were concentrated to a final 
concentration of 30 mg/ml then flash frozen in liquid nitrogen and 
stored at -80°C for further use. 
             
        
Figure 4.18. Purification of Mex67 C-term (528-599) using size exclusion chromatography. (a) 
A scheme depicting the full length Mex67 protein and its C-terminal domain boundaries used in 
this study. (b) Chromatogram obtained from Superdex 75 16/60 shows the elution profile of the 
Mex67 C-term(528-599) as a single peak at   ̴72.4 ml. the corresponding fractions were visualized on 
a 10% SDS-PAGE gel highlights the purely obtained protein marked with the red bar. 
4.5.2. Mex67 binds Mip6 in vitro with high affinity 
To assess the interaction between Mex67 and Mip6 in vitro, 
Mip6(111-480) was tested for the binding of the C-terminal domain of 
(a) 
(b) 
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Mex67(528-599) where both protein were expressed and purified as 
mentioned earlier and Isothermal Titration Calorimetry (ITC) was 
used to assess the interaction. 56 µM of purified Mip6(111-480) (section 
4.2.1) was used in sample cell and 800µM of purified Mex67 C-term(528-
599) (section 4.5.1) as a ligand. As shown in figure4.19, our results 
showed an exothermic reaction between the two proteins and a good 
binding profile with a calculated affinity of KD= 1.067 µM when 
Mex67(528-599) was titrated into Mip6(111-480) thus confirming the protein-
protein interaction and complex formation between both proteins. 
Other interaction parameters were also determined with ∆H (Kj/mol) 
of -29.85 and ∆S (J/mol-k) of 10.74 were given. 
 
Figure 4.19.  . Mex67(528-599) interacts with Mip6. ITC experiment with 800 µM of Mex67 C-
term(528-599) titrated into 56 µM Mip6(111-480) showed micro molar binding affinity. Raw heat peaks 
from injections are shown consecutively in pink, in addition to the curve obtained after 
integration and fitting of data obtained over the time course of the experiment. A binding affinity 
of 1.067 µM was calculated. Nanoanalyze software was used to fit the data and generate the 
figure. 
 
4.5.3. Mex67 interacts with Mip6 through its RRM4  
Going a step further to narrow down the possible sites of 
Mex67 binding on Mip6 and define the interaction boundaries, a 
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series of subsequent deletions of Mip6, as shown in the figure 4.20 
below, were generated and tested for Mex67 binding. 
                    
Figure 4.20. A scheme depicting the full length Mip6 protein and the generated protein 
truncations used to map the minimal boundaries for the site of binding of  Mex67 C-terminal 
domain(528-599) on Mip6. 
We commenced with small scale purification of MBP tagged 
Mip6 construct comprising the whole C-term of Mip6 (MBP-Mip6390-
659) and GST tagged Mex67 C-term(528-599) co-tranformed in Bl21 codon 
plus bacterial cells and expressed at 20°C overnight. The small scale 
purification was carried out as indicatd in section 3.4.1 on either 
glutathione sepharose beads to capture the GST-Mex67(528-599) or 
amylose resin to capture the MBP-Mip6(390-659). The bound proteins 
were seperated from the beads by the addition of 6x loading buffer 
and boiling for 10 minutes at 95°C. The samples were then visualized 
on a 10% SDS-PAGE gel (figure 4.21). The two proteins eluted together 
from either beads indicating binding, although noticibly the Mip6(390-
659) showed signs of degradation and also a lower band appeared of the 
protein appeared on the SDS-PAGE probably due to cleavage 
(proteolysis).  
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Figure 4.21. Small scale purification of co-expressed Mip6(390-659) and Mex67(528-599). (a) 
Control small scale purification of MBP tagged Mip6(390-659) on amylose resin shows the band 
corresponding to the protein at the expected size. (b) Small scale purification of the co-expressed 
protein on glutathione sepharose beads and amylose resin respectively showing the co-elution of 
both proteins which indicates interaction. A possible cleavage in the Mip6(390-659) protein is visible 
(red arrows). Aliquots from the different step of the pull down assay of Supernatants (S), Pellets 
(P), non-bound fraction (FT), wash of the beads (W), and finally elution of the protein bound to 
the beads (E) were visualized on 10% SDS-PAGE. 
On the other hand, a purified Mip6 RRM3/4(313-480) that 
comprised both RRM3 and RRM4 (section 4.3.1) was used to determine 
whether it interacts with Mex67(528-599) 0r not. For this purpose, the 
Bio-layer interferometry system where 80 µg/ml of GST-tagged Mex67 
C-term(528-599) immobilized on anti-GST biosensors was used as a bait, 
while an increasing concentrations of Mip6 RRM3/4(313-480) were used 
to establish the association and dissociation steps. A good binding 
profile was observed between the two proteins enabled us to calculate 
the binding affinity between both proteins (figure 4.22).  A calculated 
micro molar binding affinity of KD= 1.42 µM was obtained, which 
indicates high affinity between both proteins. An addition of 0.5 
mg/ml of BSA was used in the buffer used in this experiment to 
eliminate any non-specific binding of the Mip6 RRM3/4(313-480) protein 
to the anti-GST sensors. 
S     P    FT    W     E 
S       P    FT    W    E S    P     FT    W    E 
Glutathione 
sepharose beads Amylose resin 
GST-Mex67(528-599) 
MBP-Mip6(390-659) 
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Figure 4.22. Mip6 RRM3/4(313-480) binds Mex67 C-term(528-599) with high affinity. Association 
and dissociation steps of Bio-layer interferometry using increasing concentrations of Mip6 
RRM3/4(313-480) depicted in distinctive colours shows the interaction profile between the two 
proteins. The calculated global binding affinity calculated is shown. 
 Taking these attained results into account, it started to 
seem relevant to think that RRM4 of Mip6 is the domain with the 
minimal boundaries required for the interaction with Mex67, 
especially that Mip6 RRM3(313-389) did not co-elute with Mex67(528-599)  
from gel filtration after both proteins were mixed in equimolar 
concentration and injected in size exclusion chromatography (figure 
4.23) which indicates that the two proteins were not holding together. 
To prove this hypothesis we decided to go a step further to investigate 
whether truly Mip6 RRM4 alone was sufficient for the formation of the 
complex. For this purpose, different constructs of MiP6 RRM4 with 
different boundaries were investigated: Mip6 RRM4(390-495); Mip6 
RRM4(390-480); Mip6 RRM4(401-480) respectively (section 4.3.3).  
 A small scale pull down assay was carried out on 
glutathione sepharose beads, using GST-Mex67 C-term(528-599) as a bait 
protein while His tagged Mip6 RRM4(390-495) and Mip6 RRM4(390-480) 
were used as prey proteins.  The beads were washed thoroughly four 
times to remove any non-bound protein, before retaining the protein 
in the beads by adding 6x sample buffer and heating the samples for 10 
minutes at 95°C. Both Mip6 RRM4(390-495) and Mip6 RRM4(390-480) eluted 
together from the beads with the GST-Mex67 C-term(528-599) showing 
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interaction (figure 4.23). Subsequent large scale purifications 
confirmed the results on a larger scale.                 
 
 
 
Figure 4.23. (a) No interaction between Mex67(528-599) and Mip6 RRM3(313-389). Performing size 
exclusion chromatography with pre-incubated equimolar concentration of Mex67(528-599) and 
Mip6 RRM3(313-389) using Superdex 75 16/60 column showed that the proteins did not hold 
together, instead each protein eluted in a separate peak, GST-Mex67(528-599) (blue) and Mip6 
RRM3(313-389) (red)as visualized on both the chromatogram and the 10% SDS-PAGE. 
 (b) Pull down assay shows co-elution of Mex67(528-599) with Mip6 RRM4. 10% SDS-PAGE gel 
representing the different pull down assay steps: supernatant (S), pellet (P), non-bound(FT), 
wash (W), and Elution (E), done one glutathione sepharose beads using GST tagged Mex67(528-599) 
and His tagged Mip6 RRM4(390-495) and Mip6 RRM4(390-480) respectively showed the co-elution of 
both proteins together in the elution fraction. 
 
Subsequently, each of the Mip6 RRM4 constructs: Mip6 
RRM4(390-495), Mip6 RRM4(390-480), and Mip6 RRM4(401-480) was over-
expressed and purified as described earlier (section 4.3.3), then mixed 
with equimolar concentration with a purified Mex67 C-term(528-599) 
(section 4.5.1) and injected in a gel filtration column Superdex 75 
16/60. The formation of a stable complexes even with the shortest 
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deletion construct Mip6 RRM4(401-480) was confirmed as the two 
proteins co-eluted from the gel filtration column in a single peak 
corresponding to a higher molecular weight than that of the elution 
profile of each protein alone. A shift in the peak when alone or in 
complex was discrete. This was confirmed by visualizing the gel 
filtration fractions on a 10% SDS-PAGE gel (figure 4.24) and consistent 
with a stable complex formation with the minimal Mip6 RRM4 
boundaries utilized. 
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Figure 4.24. Stable complex formation between Mex67(528-599) and Mip6 RRM4 in gel 
filtration. Superposition of chromatograms representing the elution profile of the complex 
formed between Mex67(528-599) and several truncations of Mip6 RRM4: 390-495 (a), 390-480 (b), 
and 401-480 (c) from 16/60 Superdex 75 gel filtration column with the elution profile previously 
obtained of each of the  proteins separately .The elution peak of the complex is demonstrated in 
blue and the corresponding fractions visualized on 10% SDS-PAGE gel are marked with a red bar. 
On the other hand, the light green peak corresponds to the separate elution peak of Mex67 C-
term(528-599), while the pink peak corresponds to the elution profile of the truncated Mip6 RRM4 
construct. 
 
Furthermore, ITC biophysical technique was used in order to 
quantify the interaction between Mex67(528-599) and Mip6 RRM4(390-480) 
and determine the kinetics of the interaction. Both proteins tags were 
removed and both proteins were dialyzed overnight in the same 
buffer. 690 µM of Mex67(528-599) was used as a titrant in the syringe, 
while 50 µM or 70 µM of Mip6 RRM4(390-480) in the sample cell. The 
experiment was carried out at 15°C. The analysis and fitting of the 
resulting data from each injection, calculated a good binding affinity 
in the low micro molar range with KD =1.717 µM with a stoichiometric 
ratio n= 0.965 indicating a probable 1:1 binding ratio (figure 4.25). 
However, the calculated stoichiometric ratio was slightly lower when 
higher concentration of Mip6(390-480) was used (n=0.72 or n=0.8 at 
70µM of concentration) . Interestingly, the binding affinity obtained is 
almost identical to those obtained between Mex67(528-599) and Mip6(111-
480) and Mip6(313-480) which clearly suggests that Mip6 RRM4 boundaries 
are sufficient for the interaction and complex formation.  
(c) 
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Figure 4.25. Mex67(528-599) ) binds Mip6 RRM4(390-480) with high affinity. Overlapping results 
from two ITC experiments with two different concentrations of Mip6 RRM4(390-480) in the sample 
cell (70 and 50 µM consecutively). Raw heat peaks from the injections are shown consecutively in 
pink (50 µM) and cyan (70 µM), in addition to the fitting curves obtained that allowed the 
calculation of a binding affinity of 1.717 µM and 2.21 µM respectively. The thermodynamic 
parameters for the experiment with 50 µM Mip6 RRM4(390-480) are shown on the graph. The 
Nanoanalyze software was used to fit the data and generate the figure. 
4.6. Crystal structure of Mex67 C-term(528-599) 
4.6.1. Crystallization and data processing 
The stably formed complexes between Mex67 C-term(528-599) 
and Mip6 RRM4, obtained from the previously indicated size 
exclusion chromatography (figure 4.24) were used to set 
crystallization screening plates in an attempt to get a crystal structure 
of the complex. Other attempts were carried out through forming the 
complexes with different Mip6 constructs by mixing directly before 
setting the screening plates. Also, limited in situ proteolysis of the 
complex using different enzymes trypsin, chymotrypsin, or subtilisin 
was carried out in the attempt to obtain a more stable complex by 
digesting any flexible regions. During our attempts to crystallize the 
Mex67(528-599)/Mip6RRM4 complex, few crystals containing only Mex67 
C-terminal domain were obtained, but none comprising the complex. 
KD (µM)= 1.717 
n= 0.965 
∆H (KJ/mol)= -41.88 
∆S (J/mol-K)= -34.95 
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Crystals containing Mex67(528-599) appeared at 21°C in a range of 
different growth conditions where some them are summarized in table 
4.4 below. 
Condition Proteins in drop Resolution (Å) 
0.1M Bicine pH 9; 20% PEG 6000 Mex67 C-term(528-599) 8 
0.01M Nickel(II) chloride 
hexahydrate; 0.1M Tris pH 8.5; 1M 
Lithium sulfate monohydrate 
Mex67 C-term(528-599)/Mip6 RRM3/4 1.42 
35% Tacsimate pH 7 Mex67 C-term(528-599)/Mip6 RRM3/4 1.3 
3M Sodium formate Mex67 C-term(528-599)/Mip6 RRM4(390-495) 1.5 
1.5M Ammonium sulfate; 0.1M 
Tris pH 8.5; 12% Glycerol Mex67 C-term(528-599)/Mip6 RRM4(401-480) 1.5 
0.1M MES monohydrate pH 6.5, 
1.6M Magnesium sulfate 
heptahydrate 
Mex67 C-term(528-599)/Mip6 RRM4(401-480) - 
1.5 M Ammonium sulfate, 0.1 M 
Tris pH 8.5, 12% glycerol Mex67 C-term(528-599)/Mip6 RRM4(401-480) - 
 
                     
Table 4.4. Crystallization conditions in which crystals containing Mex67 C-term(528-599) were 
obtained and the resolution to which each crystal diffracted. Additionally, images of two 
obtained crystals of Mex67 C-term(528-599) are shown.  
Complete data sets were collected from crystals that diffracted 
up to 1.42 and 1.3 Å (mentioned in table 4.4) and were further scaled 
and processed in order to solve the structure of Mex67(528-599). The 
crystals belonged to the hexagonal space groups P65 and P61 
respectively. The molecular replacement for the first 1.42Å structure 
was performed with the MR Phaser module from Phenix initially using 
the PDB structure of the C-terminal UBA domain from the human 
TAP (Nxf1) protein, the human homologue of Mex67, as a model for 
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molecular replacement (PDB code: 1OAI), the attained structure in 
turn served as a molecular replacement model for the later crystal. 
Good initial phases were obtained, and the structures obtained 
indicated one molecule of Mex67(528-599) in the asymmetric unit in both 
crystals. In the 1.3 Å, hydrogen atoms were added since resolution was 
high enough and map showing hydrogen densities was clear. 
Superposing both structures did not show any major differences or 
different conformations. The two structures were overlapping with an 
R.M.S.D. of 1.054 Å from the 67 identical residues with only a slight 
movement on the N-terminal part of the Mex67 UBA domain noted. 
Table 4.5 summarizes the data collection and final refinement 
statistics from both crystals of Mex67(528-599). 
 Crystal 1 Crystal 2 
Resolution (Å) 1.42 1.3 
Space group P65 P61 
Unit-cell 
parameters   
a,b,c (Å) 37.65, 37.65, 74.745 71.42, 71.42, 20.34 
α, β, γ (°) 90, 90, 120 90, 90, 120 
Wavelength (Å) 0.97624 0.9795 
Total reflections 296733(23933) 284363 (28535) 
Unique reflections 11287 (1117) 14960 (1491) 
Completeness (%) 99.47 100 
Multiplicity 26.2 (20.1) 19 (19.1) 
Mean I/Sigma(I) 17.56 (2.62) 25.5 (1.7) 
Rmerge 0.09804 (1.362) 0.04496(1.83) 
Rmeas 0.09997 0.04623 
Rwork/Rfree 0.1856/0.2098 0.2098/0.2465 
CC1/2 1(0.823) 1(0.616) 
Ligands 6 3 
Water molecules 29 31 
Protein residues 68 68 
Ramachandran 
plot   
Favoured (%) 99 98 
Outliers (%) 1.5 0 
Clashscore 4.51 2.74 
Average B factors 26.40 24.50 
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Table 4.5. Data collection and refinement statistics from two crystals of Mex67 C-term(528-
599). Statistics from the highest resolution shell are indicated in parenthesis. 
4.6.2. Mex67 C-term structure made of alpha helices 
The crystal structure of Mex67 C-term(528-599) included the 
Mex67 UBA domain plus an additional 17 residues on its N-terminus. 
The structure is made of six alpha helices connected with short loops, 
in which four of these helices formed the Mex67 UBA domain. The N-
terminal part is formed of one two turn helix and a shorter one turn 
helix, while the UBA domain is formed by three complete helices in 
addition to a C-terminal small one turn fourth helix that is said to 
undergo conformational changes when UBA binds its partners 
stabilizing the interaction (Hobeika et al., 2009) (figure 4.26). 
 
 
Figure 4.26. Crystal structure of Mex67 C-term(528-599). (a) A general overview of the Mex67 C-
terminal domain structure that crystallized. It is made of six alpha helices linked by short linkers. 
The alpha helices that form the Mex67 UBA domain are shown in yellow while the additional N-
term in the structure formed by two alpha helices are seen in blue. (b) A scheme of the sequence 
of Mex67 C-terminal domain(528-599) we crystallized representing the different characteristics of 
the protein mentioned in (a), the first three residues and the last one shown in grey are not 
visible in the structure. 
C-term 
N-term 
(a) 
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4.6.3. Evolutionary conservation of the Mex67 C-term UBA 
domain  
The C-terminal domain of yeast Mex67 structure was then 
compared to the PDB X-ray structures of the UBA domain alone from 
the homologues of Mex67 in Homo sapiens (PDB code: 1OAI) and 
Chaetomium thermophilum (PDB code: 4WP2). Regardless of the weak 
conservation in the sequence of the UBA domain between the three 
species, the structural alignment showed a high structural 
conservation (figure 4.27). Using TM-align (Yang Zhang & Skolnick, 
2005) as a calculation tool for structural comparison, Mex67 UBA 
domain structure from S. cerevisiae presented the highest 
conservation to that of H. sapiens with R.M.S.D of 0.89 Å from 57 
aligned residues, while it revealed a higher variation and lower 
conservation with that of C. thermophilum with R.M.S.D of 2.08 with 
55 aligned resides. The UBA domain from the C. thermophilum 
homologue presented a C-terminal extension that doesn´t exist both 
in yeast and human Mex67 UBA, and a slightly longer first helix with a 
longer protruding loop connecting helix 2 and helix 3 of the domain 
(known to play an important role in the interaction with the FG 
repeats of nucleoporins) (figure 4.27). The reason to these differences 
in the C. thermophilum structure is still not clear although it might has 
a role in the increased thermo-stability known for proteins from C. 
thermophilum . 
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Figure 4.27. Evolutionary structural conservation of Mex67 UBA domain. (a) Superposition 
between Mex67 C-term(528-599) structure from S. cerevisiae  (shown in red), The UBA domain 
structure of its homologue from H. sapiens (shown in blue), and the UBA domain structure of the 
C. thermophilum homologue (shown in yellow). The C-terminal extension in the C. 
thermophilum UBA structure and the longer protruding loop between helix 2 and helix 3 are 
highlighted in the dotted red box. (b) The sequence alignment of Mex67 UBA domain across the 
three species highlighted with the colour corresponding to each structure. 
4.6.4. Mex67 C-term(528-599) electrostatic surface is not positively 
charged 
The electrostatic surface potential of Mex67 C-term(528-599) 
calculated using PDB2PQR & APBS software did not show any 
significant positively charged patches on the surface of the structure. 
On the contrary, the overall structure was neutral with one side of the 
structure showing a clear negatively charged pocket just above the 
FXFG and Hpr1 binding pocket (figure 4.28).  
(b) 
(a) 
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Figure 4.28. Mex67 C-term(528-599) surface is not positively charged. Surface Electrostatic 
Potential calculations visualized using Chimera shows the negatively electrostatic patches (in 
red) and the positively charged areas (in blue) on the Mex67 C-terminal domain surface (a) with 
the corresponding structural fold (b) and its other side surface when rotated 180°. Neutral 
patches are shown in white. 
This led us to predict that the C-terminal domain of Mex67 did 
not have the capacity to bind nucleic acids on its own in vitro. To 
elaborate on this, 200 µg of purified Mex67 C-term(528-599) (section 4.5.1) 
were incubated with polyuridylic acid (PolyU) agaorse beads for 1 hour 
at 4°C with constant mixing. Later, the non bound fraction was 
removed, and the beads were washed three times before adding 6x 
sample buffer and boiling for 10 minutes at 95°C to separate from the 
beads any Poly(U) bound protein. The result showed that indeed 
Mex67 C-term(528-599) was not binding RNA in vitro since it did not co-
purify with Poly (U)from the beads, instead it was seen in the non 
bound fraction (figure 4.29). Furthermore, Mex67(528-599) showed no 
180° 
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FXFG and Hpr1 
binding pocket  
10 10 
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binding to a biotinylated Poly (U) of 15 residues immobilized on 
streptavidin sensor using the Bio-layer interferometry system thus 
confirming the inability of Mex67 C-terminal region to bind RNA 
independently in vitro (figure 4.39).  
                  
      A.       B.  
4.7. Mex67 UBA domain is the binding site of Mip6 
Additionally, to investigate whether the UBA domain of Mex67 
required for proper mRNA export and previously shown to be the site 
of binding of the FG nucleoporins and Hpr1 is also the site of binding 
of Mip6, two additional constructs of Mex67 C-term were generated: 
Mex67 UBA(545-599) comprising exclusively the C-terminal UBA domain 
of Mex67, and Mex67 ∆UBA(481-544) composed of the N-terminal region 
of the UBA domain starting just after the NTF2 domain. 
4.7.1. Expression and purification 
The same protocol used for expressing and purifying Mex67 C-
term(528-599) (section 4.5.1) was followed to express and purify Mex67 
UBA(545-599) and Mex67 ∆UBA(481-544). Both construct showed good 
solubility, although Mex67 ∆UBA(481-544) appeared to be a bit less 
soluble and stable especially when trials to remove its GST tag were 
performed possibly affected by its location in a disordered region. The 
Figure 4.29. Mex67 c-term(528-599) 
does not bind RNA in vitro. A. 200 
µg o Mex67(528-599) (1: input) were 
incubated with polyuridylic acid 
agarose beads for 1 h at 4°C, then 
washed three times (2: wash), and 
finally eluted (3: separation from 
beads). The samples were then 
visualized on a 10% SDS-PAGE gel 
and no Mex67(528-599) was not seen in 
the  bound to the Poly(U) beads. B. 
BSA was used as a negative control. 
1        2       3 
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GST tag was kept or was further removed by using PreScission 
protease depending on the requirement of latter experiments. 
Additionally, Size exclusion chromatography was used as a final 
purification step for both protein constructs. In both cases the protein 
eluted in a single peak in a volume reflecting a possible dimerization 
of the proteins.  
       
                   
       
Figure 4.30. Purification of Mex67 ∆UBA(481-544) and Mex67 UBA(545-599). (a) An illustration 
showin the boundaries of Mex67 ∆UBA(481-544) and Mex67 UBA(545-599) constructs used. (b) 10% 
SDS-PAGE gel with GST-Mex67 ∆UBA(481-544) samples from the affinity chromatography 
purification on a 5ml GSTrap. (c) 10% SDS-PAGE gel with samples of GST-Mex67 UBA(545-599) 
purified on GSTrap affinity chromatography column. (d) Chromatogram showing Mex67 UBA(545-
599) elution profile from size exclusion Superdex 75 16/60 column after the GST tag digestion and 
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the corresponding 10% SDS-PAGE gel with the Mex67 UBA(545-599) protein fractions highlighted in 
red. 
4.7.2. Removing Mex67 UBA domain disrupts the interaction 
with Mip6 
A small scale pull down assay using GST-Mex67 ∆UBA(481-544) on 
one hand and 6xHis tagged Mip6 RRM4(401-480) or 6xHis tagged Mip6 
RRM3/4(313-480) on the other hand was performed on nickel agarose 
beads to capture the His tag. Proteins were expressed on a small scale 
using autoinduction at 20°C overnight, and their cells were then lysed 
separately. The soluble fraction obtained from 6xHis- RRM4(401-480) or  
Mip6 RRM3/4(313-480) were incubated solely with the nickel charged  
agarose beads respectively for 15 minutes at 4°C prior to the addition 
of the second GST-Mex67 ∆UBA(481-544)  protein. After an additional 
incubation of 1 hour, the beads were washed extensively four times 
with buffer prior to elution. The two proteins did not elute together 
from the beads, instead 6xHis tagged Mip6 RRM4(401-480) and 6xHis 
tagged Mip6 RRM3/4(313-480) each eluted alone from the Nickel agarose 
beads with no detection of Mex67 ∆UBA(481-544). As a control, the same 
procedure was carried out using GST-Mex67 C-term(528-599) shown 
earlier to form a complex with Mip6 (section 4.5). Our result indicates 
that Mex67 ∆UBA(481-544) was not sufficient on its own to achieve 
interaction with Mip6 RRM4 and the removal of the UBA domain 
disrupted the binding (figure 4.31). The experiment pointed out the 
fact that indeed Mex67 UBA is required for the complex formation. 
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Figure 4.31. Mex67 UBA domain deletion disrupts the interaction with Mip6. (a) 10% SDS-
PAGE gel with samples from the pull down assay on Ni-NTA beads using His tagged Mip6 
RRM4(401-480) or Mip6 RRM3/4(313-480) constructs as a bait while GST-Mex67 ∆UBA(481-544) as a prey. 
S: the supernatants fraction, P: the insoluble pellet fraction, W: wash, and E: the elution of the 
beads. Interaction lost and only the His tagged Mip6 RRM4 constructs eluted from the beads. (b) 
As a control, pull down assay on Nickel beads using GST-Mex67 C-term(528-599) as a prey and His-
Mip6 RRM4(401-480) or Mip6 RRM3/4(313-480) as bait proteins. Both proteins co-eluted from the beads 
indicating interaction. 
4.7.3. Mex67 UBA domain is the site of binding of Mip6 
To verify that Mex67 UBA domain was necessarily required for 
Mip6 interaction, purified protein of either GST-Mex67 ∆UBA(481-544) or 
GST-Mex67 UBA(545-599) (section 4.7.1) were tested using Bio-layer 
interferometry for binding Mip6 RRM3/4(313-480). However, the Bio-layer 
interferometry system required tagged proteins to carry on the 
experiment, so the GST tag fused N-terminally to Mex67 constructs 
was not removed and the GST-tagged proteins were immobilized on 
anti-GST sensors. For this experiment, increasing concentrations of 
purified Mip6 RRM3/4(313-480) (section 4.3.1) were used as a prey protein 
since Mip6 RRM4(401-480) size was on the lower range of the 
recommended detectable sizes for this technique. While we did not 
detect interaction of GST-Mex67 ∆UBA(481-544) to Mip6 RRM3/4(313-480), 
interestingly GST-Mex67 UBA(545-599) was binding with an affinity 
Mex67 UBA(545-599) comparable to that obtained for Mex67(528-599) (figure 
4.32), and almost identical to that calculated for the binding GST-
Mex67 C-term(528-599) to Mip6 RRM3/4(313-480) (figure 4.22) with no 
significant difference in the association and dissociation constants.  
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Figure 4.32. Mex67 UBA domain is sufficient for the interaction with Mip6 RRM4. (a) The 
association/dissociation profile of Mip6 RMM3/4(313-480) to GST-Mex67 UBA(545-599) immobilized on 
an anti-GST sensor. (b) The association/dissociation profile of Mip6 RRM(313-480) at the same 
concentration, binding to the three different GST tagged Mex67 c-terminal constructs 
immobilized on anti-GST sensor using Bio-layer interferometry. The binding affinity in molar 
calculated for each experiment is shown in the table (c) showing clearly that the binding affinity 
obtained with GST-MEX67 UBA(545-599) is almost identical to that calculated with GST-MEX67 C-
term(528-599). 
4.7.4. Mex67 UBA domain needs to be in a specific conformation 
to be able to bind Mip6 
Afterwards, we decided to reconstruct the complex Mex67 
UBA(545-599)/Mip6 RRM4 in vitro to check whether it can stably hold 
together in gel filtration which consequently indicates strong binding. 
For this purpose, equimolar concentration of purified non-tagged 
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protein from both Mex67(545-599) and Mip6 RRM4(401-480) were mixed and 
left on ice half an hour before injecting in gel filtration superdex75 
16/60 column. To our surprise, the two proteins eluted from gel 
filtration independently in two separate peaks (figure 4.33) which 
indicated that the removal of the N-terminal GST tag of Mex67(545-599) 
was possibly disrupting the binding. The elution of Mex67 UBA(545-599) 
as shown in figure 4.33 preceded the elution of Mip6 RRM4(401-480) 
however its lower molecular weight, due to the fact that  Mex67 
UBA(545-599) was eluting from gel filtration in a volume corresponding 
to a possible dimer formation while Mip6 RRM4(401-480) was eluting 
after its expected elution volume as discussed earlier in section 4.3.3. 
    
 
 
 
 
Figure. 4.33. (a) Gel filtration chromatogram showing the elution profile after the injection of 
the equimolar pre-mixing of Mex67 UBA(545-599) with Mip6 RRM4(401-480). The protein eluted in two 
separate peaks. (b) The input proteins when injected (1) and the samples corresponding to the 
gel filtration elution peaks were visualized on a 10% SDS-PAGE gel. The bands corresponding to 
Mex67 UBA(545-599) elution peak is shown in dark blue, while that of RRM4(401-480) elution is marked 
in red. 
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To elaborate on these results and better understand the effect 
on the N-terminal tag fused to the Mex67 UBA(545-599), ITC experiments 
were carried out to study the binding kinetics of a GST- Mex67 
UBA(545-599) or a non-tagged Mex67 UBA(545-599) to Mip6 RRM4(390-480). To 
our surprise, increasing concentrations up to 1 mM of no tag Mex67 
UBA(545-599) (GST tag was removed using PreScission protease (section 
4.7.1) titrated into 40 µM of Mip6 RRM4(390-480) in the sample cell at 
15°C did not show any binding (figure 4.34). The experiment was 
repeated several times with different concentrations and the same no 
binding result was obtained. However, since the previous Bio-layer 
interfermotry assay necessitated a tagged protein immobilized on 
corresponding sensors for the experiment to be carried out, and hence 
a GST tagged Mex67 UBA(545-599) was subsequently used (section 4.7.3), 
the ITC experiment was repeated with the same concentration of Mip6 
RRM4(390-480) in the sample cell but this time using the tagged GST- 
Mex67 UBA(545-599) as a titrant. The kinetically determined values were 
consistent with those obtained from Bio-layer interferometry, 
replacing the endogenous N-terminal residues of the Mex67 UBA 
domain with another coming from the fused N-terminal GST tag 
replenished the binding of Mex67 UBA(545-599) to Mip6(390-480) with an 
affinity of KD= 3.3 µM comparable to that of Mex67 Nt-UBA(528-599) 
(figure 4.32 c). The experiment was also repeated using different 
concentration and the same result was secured. Therefore, our results 
demonstrate that Mex67 UBA was the site of binding of Mip6 but 
where a mandatory N-terminal extension on the UBA domain is 
required, not necessarily sequence specific but more likely for certain 
conformational purposes putting the Mex67 UBA domain in a 
conformation required for Mip6 identification or maybe for a role in 
stabilizing the interaction once Mip6 is actually bound. 
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Figure 4.34. Mex67 UBA domain needs an N-terminal extension to be able to bind Mip6. 
Graph showing the difference in binding profile between the obtained raw heat peaks and the 
corresponding integrated binding curve over the course of time obtained from ITC experiment 
between Mip6 RRM4(390-480) and GST-Mex67(545-599) (green), and the no binding obtained when no 
tag Mex67 UBA(545-599) was used as a titrant instead (blue). The calculated binding affinity of GST-
Mex67(545-599) to Mip6 RRM4(390-480) was 3.3 µM comparable for that of non-tagged Mex67(528-599). 
4.8. Chemical cross-linking  
To complement the results, we proceeded with a cross-linking 
experiment, a process where two proteins or two regions of a protein 
are linked by covalent bonds formed by a chemical reaction between 
the reactive group of a chosen cross-linker and a functional group of 
the protein. This procedure aimed to stably link the two proteins 
Mex67(528-599) and Mip6 RRM4(390-480) in the attempt to have a closer 
look on the exact sites of interaction. Since the sequence of Mex67(528-
599) had lysines (-NH2 amine group) and no cysteines, while Mip6 
RRM4(390-480) sequence contained two cysteines (-SH thiol group), 
Sulfo-SMPB (sulfosuccinimidyl 4-maleimidophenyl)butyrate) was our 
cross-linker of choice as it is a water soluble amine to sulfhydryl 
crosslinker (figure 4.35).  
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Different concentrations of the cross-linker were incubated 
with 200 µg of the stably formed Mex67(528-599)/Mip6 RRM4(390-480) 
complex, obtained after size exclusion chromatography (figure 4.24. 
b), for 1 hour at 25°C. The reaction was stopped by adding 1 µl of Tris-
HCl 0.5M, and samples were heated at 95°C for 10 minutes with the 6x 
sample buffer and run on 15% SDS-PAGE gel. The cross-linked shifted 
band visualized on the SDS-PAGE corresponding to the size of the 
cross-linked complex was then gel extracted and sent for mass 
spectrometry analysis (University of Valencia, Burjassot, Valencia). 
The samples were digested with trypsin and analyzed using MALDI 
TOFTOF. The resulting MS and MS/MS data were then analyzed using 
MASCOT software (Matrix-Science) for peptide identification.  
             
 
Figure. 4.35. Cross-linking Mex67(528-599) to Mip6 RRM4(390-480). 
(a) Chemical structure of the cross-linker Sulfo-SMPB used for the experiment. (b) 15% SDS-
PAGE gel showing the input Mex67(528-599)/ Mip6 RRM4(390-480) complex before adding the cross-
linker (I), and the obtained result after adding the cross-linker (CL). The resulting band (  ̴20 
KDa) sent for mass spectrometry is shown with a red arrow. 
 
The peptides identified by MASCOT in either Mex67(528-599) or 
Mip6 RRM4(390-480), representing the regions not involved in the 
interaction, were residues 528-554 and 583-593 of Mex67; and residues 
408-415 and 459-480 of Mip6 RRM4 respectively (figure 4.36). This 
meant that the site of Mex67 binding to Mip6 RRM4 was most 
probably somewhere between residues 555-582 of the UBA domain 
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(figure 4.36). Interestingly, when the residues were visualized on the 
obtained Mex67 C-term(528-599) structure, the central α helix 2 of the 
UBA domain is seen as the core site involved in interaction. These 
results complemented our results and ensured that role of Mex67 UBA 
domain as the platform of physical interaction with Mip6. Although 
the results obtained from this experiment were not ideal as it couldn’t 
provide us with an exact site of binding but it emphasized our 
previous results and gave us a better idea on the mechanism of 
interaction. 
(a) 
Mip6 RRM4:          
GPLGSMKPVHNQIGTNKKTKVYLKNLSFNCNKEFISQLCLQEKIRFSEIKITNYNS 
LNWTFCGHVECFSRSDAERLFNILDRRLIGSSLVEASWSKN 
Mex67: 
GPLGSMVMAPTLQLPPDVQSRLNPVQLELLNKLHLETKLNAEYTFMLAEQSNWNYE
VAIKGFQSSMNGIPREAFVQF 
 
       
 
4.9. Mip6 RRM4 RNA binding interfere with its interaction with 
Mex67 
We then asked whether the binding of Mip6 RRM4 to RNA 
(section 4.3.5) interferes with its ability to interact with Mex67 or vice 
Figure 4.36. MASCOT search results. 
(a) The matched peptides, after trypsin 
treatment, identified by MASCOT for 
each protein are highlighted in red. 
Residues in grey are additional due to 
the cloning technique and not part of 
the protein sequence.  
(b) Structural representation of the 
results on Mex67(528-599) structure, 
where the regions that represent the 
probable site of binding as deducted 
from MASCOT results are highlighted 
in red. As shown on figure, these 
include majorly whole alpha helix 2 of 
the UBA, the last part of the first α helix 
of the UBA domain, and the beginning 
of α3.  
(b) 
Results 
130  
 
versa. To answer this question, the pre-formed stable complexes of 
Mex67(528-599)/Mip6 RRM4(390-480) or Mex67(528-599)/Mip6 RRM4(401-480) 
obtained directly from gel filtration (section 4.5.3; figure 4.24) were 
checked for the ability to bind RNA in vitro. This was determined by 
incubating 100 or 200 µg of each pre-formed complex with polyuridylic 
acid (PolyU) agarose beads for one hour on a rotator at 4°C. The non-
bound fraction was then removed, and the beads washed extensively 
three times. Notably, The incubation of a preformed Mip6 
RRM4/Mex67(528-599) complex with the Poly(U) agarose beads hindered 
the binding of Mip6 RRM4 to the Poly (U) (figure 4.37). On the other 
hand, incubating Mip6 RRM4 with the Poly(U) agarose beads first for 
20 minutes before the addition of equimolar concentration of 
Mex67(528-599) and further incubation for an additional 45 minutes 
resulted in the elution of Mip6 RRM4 alone bound to the Poly(U). A 
control fraction showed the co-elution of Mip6 RRM4(390-480) with 
poly(U) when incubated separately with the Poly(U) agarose beads. 
The same results were obtained when the experiments were repeated. 
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          B.                                           C.  
Figure 4.37. The complex formation with Mex67 affects binding of Mip6 RRM4 to RNA in 
vitro.  A. As a control for the experiment incubation of Mip6 RRM4(390-480) or Mex67 C-term(528-599) 
separately with the Poly (U) agarose beads showed binding of Mip6 RRM4(390-480) but no binding 
of Mex67 C-term(528-599) as expected. B. The incubation of preformed complexes Mex67(528-
599)/Mip6 RRM4(390-480) or Mex67(528-599)/Mip6 RRM4(401-480) with Poly (U) beads showed no co-
elution with Poly (U) from the agarose beads in both cases as visualized on the coomassie stained 
10% SDS-PAGE, while the primarily incubation with Mip6 RRM4(390-480) for 20 minutes before the 
addition of Mex67(528-599) for further incubation before the beads being washed and eluted lead to 
the elution of  Mip6 RRM4(390-480) solely with the Poly (U) (C) . All samples were visualized on 10% 
SDS-PAGE gels.  
1: Input; 2: wash; 3: protein eluting with Poly(U) from beads 
 
Additionally, the native gel electrophoresis gel was employed 
using a pre-formed complex Mex67(528-599)/Mip6 RRM4(390-480) and 
adding increasing concentration  of total cell RNA extract. On the 
native PAGE Mex67(528-599) appeared as clear band while the complex 
Mex67(528-599)/Mip6 RRM4(390-480) appeared as a higher smeared band 
and a Mip6 RRM4(390-480) band was not visible probably due to the close 
pI of the protein to the pH of running native. The isoelectric point (pI) 
of Mip6 RRM4(390-480) was on the basic side pI= 9.39, the isoelectric 
point of Mex67(528-599) was pI=5.13, while the theoretical calculation of 
pI for the complex was around 9. Due to this difference in isoelectric 
points between the proteins, obtaining a good native gel was tricky 
and after several trials the best result were from a 10% native gel 
electrophoresis of pH 8.3 is shown in figure 4.38. However, the 
presence of RNA extract in increasing concentrations did not affect 
the smeared band of the complex and no shift was seen. Although the 
native gel result was not brilliant, but it was compatible with the 
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results obtained from the Poly(U) pull down experiment indicating 
that Mex67(528-599) and RNA were not binding simultaneously to Mip6 
RRM4, nor competing for the binding although the binding affinity of 
both partners to Mip6 RRM4 was comparable, instead the binding of 
one partner first was inhibiting the binding of the other.  
 
 
Nevertheless, a Mip6 construct (Mip6 RRM3/4(313-480)) 
containing an additional RRM other than RRM4 was still able to 
interact with RNA when Mex67 was bound when tested using Bio-
layer interferometry. Indeed, forming an Mip6 RRM3/4(313-480)/ 
Mex67(528-599) of  1:1, 1:2, or 1:4 molar ratio respectively did not affect its 
binding the biotinylated Poly(U) RNA immobilized on the streptavidin 
biosensors (figure 4.39). Instead, the calculated binding affinity of all 
was a slightly lower but similar to the binding of just RRM3/4(313-480) to 
the Poly(U) RNA. A negative control showed no binding to the 
Poly(U) by Mex67(528-599). This suggests that although Mex67 binding 
affected the RNA binding of Mip6 RRM4, the protein was still able to 
bind RNA probably through its other RRM domain. 
Figure 4.38. Native gel 
electrophoresis showed no change 
nor shift in the smeared band of the 
complex Mex67(528-599)/Mip6 RRM4(390-
480) upon increasing concentrations of 
RNA. P represents the protein band of 
Mex67(528-599) when run independently 
on the gel.  
 p     50   100  150  200 250  ng/µl 
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Sample ID Concentration (µM) KD (µM) 
Btn-PolyU15/MIP6RRM3/4(313-480) (Positive 
control) 3 1.456 
Btn-PolyU15:MIP6RRM3/4(313-480)/MEX67(528-599) 
1:1 ratio 3 1.337 
Btn-PolyU15:MIP6RRM3/4(313-480)/MEX67(528-599) 
1:2 ratio 3 1.305 
Btn-PolyU15:MIP6RRM3/4(313-480)/MEX67(528-599) 
1:4 ratio 3 1.002 
Btn-PolyU15:MEX67(528-599) 10 
No binding 
detected 
 
Figure 4.39. Mex67(528-599) did not interfere with Mip6 RRM3/4 interaction with RNA. (a) 
association and dissociation profiles obtained from the interaction of Mip6 RRM3/4(313-480) to 
sensor immobilized Btn-Poly(U) RNA of 15 residues (violet), plus when complexed with 
Mex67(528-599) at 1:1, 1:2, and 1:4 molar ratio (blue, grey, and green respectively). Mex67(528-599) 
showed no binding on its own to Poly(U) (red). (b) Table summarizing the concentrations used 
for each experiment with the calculated binding affinity in micro molar corresponding to each. 
4.10. Pes4, a Mip6 Paralogue, is also an RNA binding protein 
  Pes4, also known as DNA polymerase epsilon suppressor 4, is a 
yeast protein from Saccharomyces cerevisiae that was said to show 
high homology to Mip6 (Segref et al., 1997). A sequence alignment 
indeed showed high sequence homology. The two proteins share ̴ 
52.45% of sequence similarity and ̴ 37% of percentage identity.  The 
ordered RRMs regions show the highest similarity that gets lower in 
the not ordered regions in the N and C term (figure 4.40).  
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Figure 4.40. Sequence alignment between Mip6 and Pes4. (a) Alignment was obtained from 
using T-coffee multiple sequence alignment server. RRM 1 and 2 are shown in the blue box, while 
RRM3 is shown green box, and RRM4 shown in red. (b) A graph representing the similarity scale 
shows the highest percentage similarity in RRM1 and 2 by about 60%, while RRM3 and RRM4 
show 30% and 40% similarity respectively. Computation was done using Expasy SIM alignment 
tool and visualized graphically using LALNVIEW program. 
4.10.1. Expression and purification of Pes4 RRM3/4 
Due to the difficulty of producing a soluble full length Pes4 
protein and since our interest was more on RRM3 and RRM4 of the 
protein, a 6xHis tagged Pes4 RRM3/4(303-473) was obtained by over 
expression in a large scale ZY media using the auto-induction 
expression system. After cell lysis, the soluble fraction of the protein 
was purified on a 5 ml HisTrap affinity column. A good amount of 
soluble protein was obtained from the affinity chromatography. The 
protein was then incubated with PreScission protease overnight in 
order to remove the tag and was further purified using size exclusion 
(a) 
(b) 
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chromatography on a superdex 75 16/60 gel filtration column. The 
protein eluted from gel filtration as a single peak at ̴58 ml 
corresponding to the size of a dimer. The corresponding protein 
fractions visualized on 10% SDS-PAGE gel reflected pure protein 
(figure 4.41) that was then concentrated and flash -frozen in liquid 
nitrogen before being stored at -80% for further use.  
 
 
Figure 4.41. Size exclusion chromatography elution profile of Pes4 RRM3/4. (a) Illustration 
showing the boundaries of the Pes4 construct used in this study. (b) The protein eluted from gel 
filtration as a single peak at  ̴ 58ml of volume. The corresponding fractions were visualized on a 
10% SDS-PAGE gel. The protein appeared at its proper size and is highlighted with a red bar. 
4.10.2. Pes4 binds RNA in vitro with high affinity  
The purified Pes4 RRM3/4 containing the predicted RRM3 and 
RRM4 as aligned with Mip6 was then used to investigate whether Pes4 
is also an RNA binding protein. A biotinylated Poly (U) RNA of 15 
residues immobilized on streptavidin sensors was used as bait using 
the biolayer interfermotry system. Increasing concentrations of Pes4 
RRM3/4 (0.25, 0.5, 0.75, and 1 µM) were then used as a prey to see the 
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binding profile. The obtained results showed a good binding affinity of 
KD= 1.212 µM of the protein to the Poly (U), similar to that obtained 
from the Mip6 RRM3/4 (figure 4.42). 0.5 mg/ml of BSA was added to 
the buffer used for this experiment in order to diminish any non 
specific bindings. Association constant were Ka (1/Ms)= 3.108 e4 M 
while dissociation constant Kd (1/s)= 3.108 e-2 M respectively. 
 
Figure 4.42. Pes4 is binds RNA with micro molar affinity in vitro. The graph representing 
the association and dissociation profile of each used concentration of Pes4 RRM3/4 to the sensor 
associated Poly (U) depicted in different colours. A binding affinity of KD= 1.212 µM was 
calculated. 
4.11. Pes4 RRM3/4 does not interact with Mex67 in vitro 
Due to the fact that Pes4 shared a big sequence similarity with 
Mip6 as mentioned earlier especially in the ordered regions where the 
RNA recognition motifs exist (40% sequencing similarity for RRM4), it 
seemed logical and intriguing for us to check whether Pes4 RRM3/4 
region was also able to interact with Mex67.  
For this purpose, an equimolar concentrations of Mex67(528-599) 
and Pes4 RRM3/4 were incubated for half an hour before being 
injected in a Superdex 75 16/60 gel filtration column. Each protein 
eluted from gel filtration in independent peaks as the chromatogram 
shown in figure 4.43 illustrates. Corresponding fractions run on SDS-
PAGE gel assured the result. This pointed to that Pes4 and Mex67 did 
not have the ability to form any stable complex in vitro. 
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Figure 4.43. Pes4 RRM3/4 does not hold to Mex67(528-599) in gel filtration. The figure shows a 
superposition of the elution profile of Pes4 RRM3/4 and Mex67(528-599) when incubated then 
injected together in Superdex 75 16/60 gel filtration column in blue with the elution profiles of 
each protein when injected separately (pink for the elution profile of Pes4 RRM3/4 and light 
green for that of Mex67(528-599)). The 10% SDS-PAGE gel shows the input containing both proteins 
as injected in gel filtration, and the fractions where each protein eluted as demonstrated. 
To make sure that this was indeed the case, we utilized ITC as 
a more accurate and sensitive approach for assessing interactions and 
studying its kinetics. The experiment was carried out at 15°C, where 25 
µM of Pes4 RRM3/4 was placed in the sample cell and titrated with 
800 µM of Mex67(528-599). The experiment was repeated using different 
concentrations of both proteins in order to be certain of the result 
obtained. As expected, no binding heat was detected between both 
proteins confirming that no interaction was happening and that 
indeed Pes4 RRM3/4 did not have the ability to bind Mex67 or at least 
the binding was very weak to be detected (figure 4.44). 
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Figure 4.44. No interaction between Pes4 RRM3/4 and Mex67(528-599). Graph showing the 
binding heat peaks (grey) and the corresponding fitted curve (red) of Mip6 RRM4(390-480) when 
titrated by Mex67(528-599) compared to the no binding profile (red peaks and the corresponding 
blue line) obtained when was done using Pes4 RRM3/4 instead. 
4.12. Crystal structures of Pes4 
Pes4 RRM4 shared 42% percent of identical sequence with 
Mip6 RRM4, yet it was not able to interact with Mex67 C-term. To 
have a structural insight on Pes4, which in turn would give us an 
insight on the conserved regions with Mip6 RRM4, screening plates 
were set with Pes4 RRM3/4 in an attempt to crystallize it. And indeed 
crystals were obtained and structures solved. 
4.12.1. Crystal structure of Pes4 RRM3 
4.12.1.1. Crystallization and data processing 
Initial crystals obtained from Pes4 RRM3/4 were clusters of 
needles that were not unique (figure 4.45).  
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Figure 4.45. Pes4 RRM3/4 crystals. Some crystallization drops showing the form of the initial 
needle like crystals obtained from Pes4 RRM3/4 in different growth conditions. 
Optimizations of the crystals were attempted by varying 
additive screens of some initial conditions. However, the crystals 
appearance did not improve much, but one pHs screen resulted in 
crystals that belonged to the P3221 space group and diffracted up to 2.8 
or 1.7 Å. In other growth conditions some crystals with similar unit cell 
dimensions diffracted to 2.4-2.8 Å: 
Growth condition Resolution 
30% PEG 8000, 200 mM Ammonium Sulfate, 1M MES/NaOH pH 7.4 1.7 Å 
30% PEG 8000, 200 mM Ammonium Sulfate, K2HPO4/NaH2PO4 pH 8.6 2.8 Å 
1.26 M Sodium phosphate monobasic monohydrate, 0.14 M Potassium 
phosphate dibasic pH 5.6 2.4-2.8 Å 
 
The best diffracting crystals belonged to the trigonal space 
group P3221. Preliminary data analysis suggested that the unit cell 
volume wasn’t big enough to fit the two RRM domains in the Pes4 
RRM3/4 protein used initially to set the crystallization plates, instead 
it suggested enough space for only one RRM domain in the 
asymmetric unit. Data from the best diffracting crystal were processed 
with XDS and scaled with Aimless in CCP4. Resolution was cut at 1.9 Å 
and phases were obtained by molecular replacement using the 
coordinates of Mip6 RRM3 structure (section 4.4.3) as a model. The 
structure turned out to be that of Pes4 RRM3 with one molecule in the 
asymmetric unit and no sufficient cell volume to accommodate RRM4. 
This was probably due to some kind of in situ proteolysis of the 
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protein in the most vulnerable and flexible linker region between both 
RRMs.  
 Pes4 RRM3 
Resolution (Å) 1.9 
Space group P3221 
Unit-cell parameters  
a,b,c (Å) 82.826, 82.826, 31.985  
α, β, γ (°) 90, 90, 120 
Wavelength (Å) 0.97623 
Total reflections 198116 (19105) 
Unique reflections 10165 (1003) 
Completeness (%) 100 
Multiplicity 19.5 (19) 
Mean I/Sigma(I) 10.52 (1.74) 
Rmerge 0.3853 (2.211) 
Rmeas 0.3957 
Rwork/Rfree 0.1899/0.2308 
CC1/2 0.974(0.521) 
Ligands 14 
Water molecules 37 
Protein residues 81 
Ramachandran plot  
Favoured (%) 100 
Outliers (%) 0 
Clashscore 4.31 
Average B factors 33.90 
 
Table 4.6. Data collection and refinement statistics of Pes4 RRM3 crystal. Statistics from 
the highest resolution outer shell are indicated in parenthesis. 
4.12.1.2. Pes4 RRM3 reveals a canonical RRM structure 
Like Mip6 RRM3 (section 4.4.3), the structure of Pes4 RRM3 
was that of an RRM with a β1α1β2β3α2β4 topology that forms a four 
stranded anti-parallel β sheets, packed against two alpha helices. The 
structure included additional 8 residues from the linker that connects 
Pes4 RRM3 to RRM4 (residues 377-384) that were probably the site of 
the proteolysis that led to the crystallization of RRM3 on its own 
(figure 4.46).  
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4.12.2. Crystal structure of Pes4 RRM4 
4.12.2.1. Crystallization and data processing 
Other types of crystals were obtained from the optimization 
with additive screens of some initial conditions. One crystal obtained 
in crystallization conditions containing 0.2 M Ammonium Nitrate, 
20% PEG 3350, and 0.1 M Betaine Monohydrate as an additive, 
diffracted to a resolution of 1.1 Å. The crystal belonged to the 
orthorhombic space group P212121. Data were processed using XDS and 
further scaled using Aimless from CCP4 software. Mathews coefficient 
calculations indicated that the unit cell was big enough to fit only of 
the domains of the initial construct used to set the plates. Since the 
resolution obtained was high at 1.1 Å, we used ARCIMBOLDO program 
(D. Rodríguez et al., 2012; D. D. Rodríguez et al., 2009) to obtain 
phases and find a protein solution. The initial phases obtained from 
ARCIMBOLDO were then used for further model building using 
Buccaneer (Cowtan, 2006) . The structure obtained was that of Pes4 
RRM4 with residues (391-469), possibly due to a proteolytic cleavage 
of the protein with only one molecule of Pes4 RRM4 present in the 
Figure 4.46. Pes4 RRM3 crystal structure. 
An overview of Pes4 RRM3 structure 
consists of two alpha helices (shown in 
blue), and four anti-parallel beta sheets 
(shown in light green), with additional 
eight residues of the unstructured linker 
extending at its c-term. 
 
ß1 
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asymmetric unit. The structure model was further built in COOT and 
refined using Phenix.refine. Table 4.7 summarizes the final Data 
collection and refinement statistics of the structure. 
  It is most likely that the proteolysis event that led to the 
crystal formation of both Pes4 RRM3 and Pes4 RRM4 independently 
occurred during the crystallization process considering that the 
crystallization plates were set at 21°C for several weeks with the 
probability of the presence of proteases in any of the crystallization. 
 Pes4 RRM4 
Resolution (Å) 1.1 
Space group P212121 
Unit-cell parameters  
a,b,c (Å) 27.501, 36.162, 73.583  
α, β, γ (°) 90, 90, 90 
Wavelength (Å) 0.97921 
Total reflections 376258 (37012) 
Unique reflections 30588 (3013) 
Completeness (%) 100 
Multiplicity 12.3 (12.3) 
Mean I/Sigma(I) 21.51 (3.64) 
Rmerge 0.05842(0.6737) 
Rmeas 0.06103 
Rwork/Rfree 0.1464/0.1725 
CC1/2 0.999(0.888) 
Ligands 4 
Water molecules 94 
Protein residues 79 
Ramachandran plot  
Favoured (%) 100 
Outliers (%) 0 
Clashscore 0 
Average B factors 12.90 
 
Table 4.7. Data collection and refinement statistics of Pes4 RRM4 crystal structure. 
Statistics from the outer shell are indicated in parenthesis. 
4.12.2.2. Pes4 RRM4 shows a difference!  
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The structure of Pes4 RRM4 also has an RRM fold with four 
stranded anti-parallel β sheets, and two alpha helices packed against 
the β-sheet (figure 4.47). However, the very obvious and striking 
difference is the extended ß2 and ß3 with the shortened loop3 that 
links them. As mentioned earlier, and as seen in the previous RRM3 
domain structures from Mip6, Pes4, and Sxl (figure 4.17, 4.46), this 
loop is usually long, extended, flexible loop that in some cases play a 
significant role in the RNA binding of the protein. Instead, in Pes4 
RRM4 ß2 and ß3 are longer at the expense of the much shortened loop 
(loop3), but ß2 and ß3 typically forms the surface for RNA binding so it 
is possible that this feature might aid in extending the RNA binding 
surface. Consequently, loop 2 is longer in RRM4 and α1 is pushed to a 
different conformation (figure 4.48). It is not sure though if this 
feature also extends to the structure of Mip6 RRM4 since our attempts 
to solve its structure was not successful yet, or if this feature plays any 
role in the ability of the protein to bind Mex67. However, the 
sequence corresponding to this particular region is seen to be the least 
conserved between Mip6 RRM4 and Pes4 RRM4 sequence. 
Figure 4.47. Pes4 RRM4 crystal structure. (a) An overview of Pes4 RRM4 structure consists of 
two alpha helices (shown in pink), and four anti-parallel beta sheets (shown in blue). ß2 and ß3 
are visibly longer and more extended with a shortened small loop connecting them. (b) The 
quality of the obtained 2F0-Fc map contoured at 1 δ showing the electron density around amino 
acids with their hydrogen atoms and water molecules around it. 
(a) (b) 
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Figure 4.48. Superposition of RRM3 and RRM4 from PES4. The β2 andβ3 strands are more 
extended in RRM4 (in dark slate blue) than RRM3 (magenta), making loop 3 shorter and loop2 
longer in Pes4 RRM4, while much longer and flexible loop3 seen in RRM3. This loop, however, 
along with ß2 and ß3 are said to be involved in the RNA binding in many RNA recognition motifs 
(RRMs). 
4.12.3. Crystal structure of Pes4 RRM3/4 
4.12.3.1. Crystallization and data processing  
 Additionally, some other crystals belonged to a distinct space 
group with larger unit cell dimensions. Some of these crystals were 
from the initially obtained crystals (figure 4.45) that were not unique. 
Growth condition amplifications and additive screens were carried out 
in an attempt to improve the crystals. The best crystals were obtained 
in 10% PEG 4000, 10% 2-Propanol, 100 mM Sodium citrate pH 5.6, or 
in 0.2M Ammonium sulfate, 0.1 M Sodium Cacodylate trihydrate pH 
6.5, 30% PEG 8000, and diffracted up to 2.6 or 2.8 Å consecutively and 
belonged to the orthorhombic P212121 space group. The data from the 
better diffracted crystal at 2.6Å were processed with XDS and further 
scaled with Aimless from CCP4. Mathews coefficient with solvent 
content analysis indicated unit cell volume sufficient for one molecule 
of Pes4 RRM3/4 in the asymmetric unit.  
Before solving the individual structures of Pes4 RRM3 or Pes4 
RRM4 (section 4.12.1 and 4.12.2), getting phases with molecular 
α helix 1 
Loop 3 
Loop 2 
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replacement using other PDB models was not successful. However, 
using the solved Pes4 RRM4 structure coordinates as a search model 
for molecular replacement was successful for obtaining phases and 
RRM4 could be modelled in the electron density map.  Yet, obtaining 
phases for RRM3 and tracing it in the map was extremely challenging 
due to the flexibility and movement of RRM3 in the structure, 
especially that the diffraction data was poor. The electron density map 
around RRM3 was poor, especially for tracing long side chains. 
Additionally, few residues especially in the loop areas and in the linker 
connecting it to RRM4 were hard to trace or missing. RRM4 domain in 
the structure had more crystal packing contacts and therefore was 
stabilizing and maintaining the crystal, whereas RRM3 in the structure 
was involved in few crystal contacts and therefore more disordered 
and flexible. This flexibility was translated in high B-factors on RRM3, 
with average B-factors of 107.2 for RRM3 while 60.74 on RRM4 and 
also implicated high final R factors. TLS parameters were refined in 
multiple cycles with Phenix refine and manually tuned with COOT. 
 Pes4 RRM3/4 
Resolution (Å) 2.6 
Space group P212121 
Unit-cell parameters  
a,b,c (Å) 27.539, 50.29, 125.01 
α, β, γ (°) 90, 90, 90 
Wavelength (Å) 0.97921 
Total reflections 70646 (7225) 
Unique reflections 5766 (563) 
Completeness (%) 100 
Multiplicity 12.3 (12.8) 
Mean I/Sigma(I) 15.01 (2.11) 
Rmerge 0.1331 (1.851) 
Rmeas 0.1391 
Rwork/Rfree 0.2566/0.3402 
CC1/2 0.999(0.763) 
Protein residues 159 
Ramachandran plot  
Favoured (%) 72 
Outliers (%) 9 
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Average B factors 95.20 
 
Table 4.8. Data collection and refinement statistics of Pes4 RRM3/4 solved structure. 
4.12.3.2. Pes4 RRM3 and RRM4 have no contact between each 
other 
The structure of Pes4 RRM3/4 as illustrated in figure 4.49. 
displayed two RRM domains, each consisting of a four-stranded anti-
parallel β sheet backed by two α helices, arranged in tandem 
connected by a non-structured 15 residue long domain linker (residues 
377-392). Few residues of the linker as it connects RRM3 are not visible 
in the structure though. Interestingly, the two domains do not interact 
with each other and are positioned in a way that there was no intra-
molecular crystal contact between them. The two RRMs have their ß 
sheet platforms facing opposite directions in a V-shape like clamp 
formed by the linker between them. No intermolecular crystal 
contacts maintained between RRM3 and the linker neither. It is 
known from other few solved RRM structures, that the flexibility of 
the linker and that the subsequent positioning of both RRMs with 
respect to each other might change depending on the free form or the 
RNA bound form upon RNA induced conformational changes. This 
conformational change between multiple RRMs might also affect RNA 
topology upon binding which can be functionally important. 
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Figure 4.49.  Overview of the solution structure of Pes4 RRM3/4 and its topology. Figure 
was generated using Chimera. 
On the surface, the electrostatic potential calculated using the 
APBS server, showed a strongly electropositive inter-domain cleft on 
one side of the structure extending to the surface on one side of RRM3 
and RRM4, while the other face of the structure was relatively neutral. 
This positivity on one side might point to a possible surface for RNA 
binding (Figure 4.50). Typically RRMs contain two conserved 
sequences called RNP1 and RNP2, on their ß2 and ß3 bearing 
hydrophobic and positively charged residues that respectively 
recognize the bases and negatively charged backbones of nucleic 
acids.  
RRM3 
RRM4 
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Figure 4.50.  The surface electrostatic potential of Pes4 RRM3/4. The positive charge 
extends  from RRM3 to RRM4  including the linker on one side, while the other side shows no 
positivity and is mostly neutral. The positive surface of the structure might point to the possible 
RNA binding interface. The electrostatic potential was calculated with PDB2PQR server followed 
by APBS and was visualized using Chimera.  
4.12.4. Towards the crystal structure of Pes4 RRM3/4 bound to 
RNA 
After demonstrating the ability of Pes4 RRM3/4 to bind RNA in 
vitro with good micro molar affinity, we attempted to crystallize Pes4 
RRM3/4 with RNA bound. For this purpose, HPLC purified Poly(U) 
RNA of 11 residues was purchased from Sigma Aldrich and mixed in 1:1 
or 1.2:1 molar ratio with Pes4 RRM3/4 before setting crystallization 
plates or mixed directly in drop. It has to be noted that mixing the 
protein with RNA before setting the crystallization plates caused a 
significant white precipitation. In that case, the sample was 
centrifuged before being added to the sitting drops. Few crystals in the 
180° 
RRM3 
RRM4 
RRM3 
10 10 
Results 
149 
 
form of very small, fragile plates appeared in a range of conditions at 
21°C (figure 4.51, table 4.9). 
          
Figure 4.51. Crystals from Pes4 RRM3/4 when co-crystallized with Poly(U) RNA. The small 
plate like crystals obtained are pointed to by an arrow. 
Growth conditions Screen Resolution Unit cell dimensions 
10% PEG 8000, 100 mM 
MES sodium salt pH 6.5, 
200 mM Zinc acetate 
JBSI (Jena 
bioscience) 1.95 Å 
a,b,c (Å):  86.89, 94.32, 111.44 
α, β, γ (°):  90, 94.76, 90 
0.1 M Succinid acid, pH 7, 
15% PEG 3350 
JCSG-plus 
(molecular 
dimensions) 
2.7 Å a,b,c (Å):  87.79, 93.84, 110.50 
α, β, γ (°):  90, 94.99, 90 
0.15 m DL-Malic acid, pH 7, 
20% PEG 3350 
JCSG-plus 
(molecular 
dimensions) 
2.3 Å a,b,c (Å):  146.82, 83.29, 184.46 
α, β, γ (°):  90, 90, 90 
0.1 M Bicine pH 9, 10% PEG 
6000 
JCSG-plus 
(molecular 
dimensions) 
3 Å a,b,c (Å):  86.73, 93.504, 110.215 
α, β, γ (°):  90, 94.718, 90 
 
Table 4.9. Growth conditions where crystals were obtained in crystallization drops containing 
Pes4 RRM3/4 mixed with RNA, and the resolution to which the crystals were collected. 
Some crystals diffracted poorly than others and data 
processing and scaling was challenging due to the low quality data. 
Both XDS and iMosflm were used for indexing and integration of the 
data. The data from the crystals mentioned in table 4.9 were 
integrated in either the monoclinic P1211 (no. 3) or in I121 (c2, no. 5) 
space groups. Table 4.10 summarizes the data integration and scaling 
results from two different crystals.  
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 Crystal 1 Crystal 2 
Resolution (Å) 1.95 2.7 
Space group P1211 I121 
Unit-cell 
parameters 
  
a,b,c (Å) 87.18, 94.63, 111.69 88.36, 94.58, 111.50 
α, β, γ (°) 89.93, 94.82, 90.05 90, 94.99, 90 
Wavelength (Å) 0.97925 1.07178 
Total reflections 1828025 (40520) 110082 (15702) 
Unique reflections 131270 (6509) 24831 (3322) 
Completeness (%) 99.6 99.5 
Multiplicity 6.3 (6.2) 4.4 (4.7) 
Mean I/Sigma(I) 15.3 (2.1) 16.1 (2.3) 
Rmerge 0.351 (2.752) 0.802 (1.848) 
Rmeas 0.405 1.016 
CC1/2 0.995(0.069) 0.994(0.205) 
 
Table 4.10. Data collection and processing of Pes4 RRM3/4/RNA crystals. Statistics from the 
outer shell are indicated in parenthesis. 
Preliminary Data analysis Mathews coefficient calculations 
suggested a unit cell where many copies of the RNA bound Pes4 
RRM3/4 may be present in the asymmetric unit but it was not 
conclusive especially due to the uncertainty of the space group and 
whether the protein in the crystal was indeed bound to RNA. Mathews 
calculations indicated a high probability for 4-8 molecules in the 
asymmetric unit depending on whether it’s a P1211 or I121 crystal. This 
number of molecules was compatible with the results of the self 
rotation function calculated by Molrep from CCP4 with a resolution 
cut off at 6 Å (figure 4.52). The data from either the P1211 or I121 space 
group showed similar stereographic projections of the self rotation 
function that might be of two binary axis in addition to a 5 axis 
perpendicular to the crystallographic binary axis. However, the self 
rotation did not provide a definitive answer on the number of 
molecules in asymmetric unit neither, but might be indicating the 
presence of at least four or five molecules per asymmetric unit. 
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Figure 4.52. Stereographic projections of the self orientation function of the monoclinic crystals 
integrated in either P1211 (a) and I121 space groups (b) 
Unfortunately, the collected data did not allow us to obtain 
phases using molecular replacement even when the previously solved 
Pes4 RRM3/4 was used as a model possibly due to a different 
conformation or folding inside the crystal and the uncertainty about 
the angle between both domains in the crystal caused by the flexible 
loop, especially if it was indeed RNA bound and thus our effort for 
structure solution of Pes4 RRM3/4 bound to RNA was not until the 
moment successful. Meanwhile, attempts to obtain phases for 
structure determination are still ongoing and amplification plates for 
better crystals for future experimental phasing using heavy metals are 
attempted. 
4.13. Mip6 RRM4 model building  
Since our interest was more focused on the structure of Mip6 
RRM4 as the binding platform for Mex67, and considering that our 
attempts to get Mip6 RRM4 crystals were not in the meantime 
productive, the structure of Pes4 RRM4 we solved earlier, as both are 
RRMs and share a good 42% of identical sequence, was used as a 
model to build a prediction model for Mip6 RRM4 structure. For this 
(a) (b) 
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purpose, I-TASSER protein structure predication server was utilized, 
where Pes4 RRM4 structure was specified as a template. The overall 
predicted structure model showed a very similar fold as the Pes4 
RRM4 with an R.M.S.D. value of 1.29 when both structures were 
superposed (figure 4.53). 
 
Figure 4.53. overview of Mip6 RRM4 predicted structure and its sequence conservation 
with Pes4 RRM4. (a) Superposition of Pes4 RRM4 structure (in cyan) with the Mip6 RRM4 
structure predicted by I-TASSER (in blue). Illustration was generated with COOT (b) Sequence 
alignment of Mip6 RRM4 and Pes4 RRM4 using PRALINE multiple sequence alignment server 
where the results are color coded for amino acid conservation. The scoring scheme works from 0 
for the least conserved alignment position, up to 10 (*) for the most conserved alignment 
position. 
4.14. NMR titration analysis of Mip6 RRM4 upon complexation 
with Mex67(528-599)  
To elucidate further on the details of Mip6 RRM4 binding to 
Mex67, a chemical shift perturbation mapping by Nuclear Magnetic 
Resonance (NMR) spectroscopy was employed in collaboration with 
Dr. José Manuel Pérez Cañadillas (ICFR-CSIC, Madrid). Analysis of the 
chemical shift changes on the protein upon the addition of the protein 
partner and thus complex formation was used as a sensitive method to 
give us information on the binding interface between the two protein 
and defining residues that might be directly involved in the binding. 
(a) 
(b) 
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The heteronuclear single quantum coherence (HSQC) spectra 
assignment for the 15N labelled Mex67(528-599) alone resulted in an good 
monomeric NMR structure calculations. Moreover, titration with 
increasing concentrations of Mip6 RRM4 resulted in obvious chemical 
shifts; some signals were lost due to chemical exchange while the 
remaining visible resonance peaks map was indicating amino acids not 
involved in the interaction. Our previously obtained crystal structure 
of Mex67(528-599) (figure 4.26) was used to interpret the obtained HSQC 
spectra and to map the obtained chemical shifts perturbations on the 
structure.  The most notable resonance signal was that of Tryptophan 
Trp 575, the unique tryptophan residue in the Mex67(528-599) sequence, 
which was gradually lost as the concentration of Mip6 RRM4 
increased, which signifies a high probable involvement of this amino 
acid in the interaction with Mip6 RRM4 (figure 4.54). Analysis of the 
chemical shift perturbation map indicated that these changes were 
mainly affecting the core alpha helix 2 of the Mex67 UBA domain and 
its N-term to a lower degree (figure 4.54) which coincides with the 
results obtained from the cross-linking experiment (figure 4.36) 
indicating that helix 2 of the UBA domain of Mex67 is central and 
crucial for maintaining the interaction with Mip6 RRM4.  
 
(a) 
Results 
154  
 
                   
Figure 4.54. (a) NMR titration experiment showing the changes in the 1H-15N HSQC spectrum 
of free Mex67(528-599) upon the addition of increasing concentrations of Mip6 RRM4 until 300%. 
One of the most pronounced resonance changes was that of Trp 575 highlighted with a red circle. 
(b) Histogram of the overall chemical shift changes on Mex67(528-599) upon increasing Mip6 RRM4 
concentrations, with the corresponding possible area of binding shown on Mex67(528-599) structure 
we solved shown in red. 
On the other hand, GST-Mex67(528-599) was also titrated into 
Mip6 RRM4. The HSQC spectra of the 15N labelled Mip6 RRM4 were 
then assigned and recorded in the free form of the protein and in its 
bound form upon the addition of increasing concentrations of the 
unlabelled Mex67(528-599) protein. During the titration, Shifting and 
displacement of amino acids resonance of the unbound state of 
Mex67(528-599) was visible. Figure 4.55 shows plots of chemical shift 
changes between free and Mex67-bound Mip6 RRM4. In the lower left 
part of the resonance spectrum, the resonance of two tryptophan 
indoles, that correspond to the two tryptophan residues in the Mip6 
RRM4 sequence, are highlighted. A comparison of the spectra 
chemical shifts in the absence and presence of Mex67 clearly indicated 
that one tryptophan did not show any modification and its resonance 
from the free and Mex67-bound overlapped. On the other hand, the 
other tryptophan was unmistakably affected by the interaction as it 
showed a chemical shift changes and resonance position was displaced 
in the bound form. 
5% Mip6 RRM4 
10% Mip6 RRM4 
20% Mip6 RRM4 
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Figure 4.55. NMR titration experiment of Mip6 RRM4 titrated with Mex67(528-599). (a) 
Superposition of  1H-15N HSQC spectra of Mip6 RRM4 alone in the free form (in black) and upon 
the addition of increasing concentrations of GST- Mex67(528-599) (in red) where resonance 
displacements are visible. A selected area in the lower left region of the spectra is highlighted. It 
indicates the resonance of the two tryptophan indoles, Trp1 and Trp2 where one of them showed 
no shift at all while the other was clearly displaced. (b) Histogram representing the 
quantification of the chemical shift perturbations of Mip6 RRM4 individual amino acid 
resonances upon binding Mex67(528-599). Some resonances could not be observed in the spectrum 
of free and peptide bound Mip6 RRM4.  
4.15. A Mip6 mutant that disrupts the interaction with Mex67 
To investigate the effect of disrupting Mex67/Mip6 complex 
formation, we searched for a Mip6 RRM4 mutant that disrupts the 
interaction. Mip6 RRM4 sequence had two tryptophan residues, where 
one of them was clearly involved in binding with Mex67 as the NMR 
titration experiment have shown (figure 4.55). Aided by the 
information provided by the NMR titration experiment, and also by 
the information obtained from the chemical cross-linking experiment 
15N
 (ppm
) 
1H (ppm) 
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(section 4.8) that where in turn compatible with the NMR results, Trp 
477 was excluded as a residue involved in binding, while Trp 442 was 
within the probable site of binding expected from the cross-
linking/MASCOT experiment (figure 4.36). Additionally, Trp 442 was 
not conserved between Mip6 RRM4 and Pes4 RRM4 sequence, which 
does not bind Mex67, while the other Trp 477 was conserved as the 
structural and sequence alignment in figure 4.53 indicates and 
structural analysis of the Mip6 RRM4 structural model provided by I-
TASSER (figure 4.56) showed Trp 442 as an exposed residue located in 
loop3 more probable to be involved in protein-protein binding. 
Therefore, we identified the Tryptophan 442 on Mip6 as a possible 
amino acid involved in the interaction with Mex67 and a good 
candidate for mutagenesis.  
            
4.15.1. Expression and purification of Mip6 W442A mutant 
Subsequently, a mutant of Mip6 RRM4 where Trp442 is 
substituted by Alanine was constructed. The His-tagged mutant Mip6 
RRM4 W442A was expressed in E-coli cells using IPTG induction in LB 
media as a protein expression system. The protein was expressed at 12 
°C for 72 hours before the cells were collected. The soluble fraction of 
the protein was then purified with affinity chromatography on a 5 ml 
HisTrap column where the eluted fractions of the protein were 
Figure 4.56. Mip6 RRM4 
structure predicted by I-
TASSER with tryptophan 
residues Trp 442 (in loop 3) 
and Trp 477 highlighted in 
pink. 
Trp 442 
Trp 477 
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dialyzed and the tag digested using TEV protease overnight. After 
that, the protein was additionally purified with size exclusion 
chromatography on Superdex 75 (16/60) gel filtration column. The 
Mip6 W442A mutant eluted from gel filtration in a single peak in the 
volume expected for its size. The W442A mutation on Mip6 RRM4 did 
not seem to affect or disrupt the folding of the domain as the yield of 
production of the protein did not decrease. The protein obtained was 
more than 90% pure as visualized on coomassie stained acrylamide gel 
(figure 4.57). 
       
Figure 4.57. Gel filtration chromatogram representing the elution profile of Mip6 RRM4 
W442A. The protein eluted in a single peak. The protein fractions corresponding to the peak 
were visualized on 10% SDS-PAGE gel and highlighted with a red bar. 
4.15.2. Mip6 RRM4 W442A do not bind Mex67(528-599) 
Next, we tested the Mip6 RRM4 W442A mutant for its 
interaction with Mex67(528-599) using ITC technique. 50 µM of the 
purified Mip6 RRM4 W442A protein (section 4.15.1) in the sample cell 
was titrated with the same concentration of 690 µM of Mex67(528-599) 
used previously to assess its binding to the wild type Mip6 RRM4. No 
binding was detected and the peaks of heat were only those resulting 
from the dilution effect (figure 4.58). The experiment was repeated 
and the result was confirmed, the point mutation on Mip6 RRM4 
where the Tryptophan 442 was mutated into Alanine was enough to 
abolish the complex formation and render Mip6 incapable of 
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interacting with Mex67 or at least decrease its binding affinity to 
undetectable values.  
 
Figure 4.58. Mip6 RRM4 W442A mutant lost the ability to bind Mex67(528-599). The graph 
shows the ITC raw heat peaks from Mex67(528-599) when titrated into Mip6 RRM4(390-480) in violet or 
when titrated into Mip6 RRM4 W442A in green, and the corresponding curves obtained from 
fitting and analyzing the obtained data using Nanoanalyze. A flat no-binding line corresponds to 
the data obtained from Mip6 RRM4 W442A. 
Additionally, the NMR titration analysis and HSQC spectrum 
assignment when the Mip6 RRM4 W442A was titrated into Mex67(528-
599) confirmed the result where no resonance displacements were 
observed on the residues of Mex67(528-599) structure, previously 
observed with Mip6 RRM4 wild type titration (figure 4.55). The 
resonance peaks overlapped perfectly between the free form and the 
Mip6 RRM4 W442A titrated form of Mex67(528-599) (figure 4.59). 
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Figure 4.59. NMR titration assignment of Mip6 RRM4 W442A titrated into Mex67(528-599). (a) 
1H-15N HSQC spectra of the free form of Mex67(528-599) (in black) and upon the addition of 
increasing concentrations of Mip6 RRM4 W442A up to 360% (in red) showed no resonance 
displacements and the peaks perfectly coincided. (b) Histogram representing the chemical shift 
perturbations of Mex67(528-599)  individual amino acid resonances upon increasing concentrations 
of Mip6 RRM4 W442A. 
4.15.3. Mip6 RRM4 W442A mutant disrupts the ability to bind 
Mex67 but not RNA 
Finally, to inspect whether the mutation that rendered Mip6 
RRM4 unable to bind Mex67(528-599) might also affect its ability to bind 
RNA we resorted to the Bio-layer interferometry system where a 
biotinlylated 15 residues of Poly(U) were immobilized on streptavidin 
sensors, while different concentrations of Mip6 RRM4 W442A was 
used as prey protein. Interestingly, the mutation did not affect the 
ability of Mip6 RRM4 to bind RNA as the Mip6 RRM4 W442A protein 
was still able to interact with the Poly(U) with comparable affinity 
even when it has lost the ability to interact with Mex67. The binding 
affinity of Mip6 RRM4 W442A to Poly(U) calculated was KD   ̴3.55 µM, 
a similar binding affinity of that of Mip6 RRM4  indicating no loss or 
decrease in binding affinity to RNA (figure 4.60). Additionally, no big 
difference in either association or dissociation constant was evident. 
5% Mip6 RRM4 W442A 
10% Mip6 RRM4 W442A 
20% Mip6 RRM4 W442A 
 
+ 360% of Mip6 RRM4 W442A 
15N
 (ppm
) 
1H (ppm) 
(a) 
(b) 
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Construct Binding affinity (KD) Ka/Kd 
Mip6 RRM4(401-480) 2.8 µM 3.47 e4/ 9.75 e-2 M 
Mip6 RRM4 W442A 3.55 µM 1.31 e4/ 4.67 e-2 M 
    
Figure 4.60. Mip6 RRM4 W442A binds RNA. (a) Bio-layer interferometry association and 
dissociation steps shows binding profile to the sensor immobilized Poly(U) when using 
increasing concentrations of Mip6 RRM4 W442A shown in the figure in different colours. (b) 
Table comparing the binding affinities calculated for Mip6 RRM wild type or Mip6 RRM4 W442A 
mutant to Poly(U) RNA with the association (ka) and dissociation constant (Kd) values in each 
case indicted. 
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The proteins subject of this study: Mex67, Mip6, and Pes4 are 
yeast (Saccharomyces cerevisiae) proteins. Mex67 is a well-studied 
protein, due to its evolutionary conserved cellular importance where 
its function is critical to proper mRNA export specifically and to rRNA 
export to a lower degree as recently discovered and consequently cell 
survival. However though, much about Mex67 interaction dynamics 
and the overall nuclear RNA export mechanism is still to be learned 
and better understood. On another hand, practically very little, if 
anything, is known about the structure and function of either Mip6 or 
Pes4. Therefore our focus in this study was on learning more about 
Mip6, Pes4, and studying the Mip6/Mex67 relation for a better 
understanding not only of these proteins, but also of the consequent 
role in cellular function and the dynamics of mRNA export 
mechanism. 
5.1. Mip6 and Pes4 protein expression and solubility 
In the course of this study, we faced difficulties in the aim to 
express and purify the full length Mip6 and Pes4 proteins. For Mip6, 
the presence of the N- and C- terms, outside the ordered RRM 
domains, displayed very poor solubility and also aggregation in 
standard buffers. Both prokaryotic and eukaryotic expression systems 
were thus approached involving the addition of a range of additives, 
but only tagging the protein with a MBP tag known to enhance 
protein solubility was helpful in getting a slight amount of soluble 
Mip6 FL protein. However, even the small soluble quantity obtained 
was aggregating after size exclusion chromatography. But with our 
over-expression and purification approaches, we successfully obtained 
soluble protein from shorter constructs of both Mip6 and Pes4 
proteins containing a combination of the ordered RRM domains or 
even the four RRM domains all together in case of Mip6 which 
constitutes around 56% of the full length sequence in good quantities 
in the prokaryotic system. Thus, it is tempting to think that the 
disordered, unstructured, regions on Mip6 especially on its N-term 
and C-term (figure 4.2) were greatly affecting its solubility and 
Discussion 
164 
 
tendency to aggregate or it might be simply that the in vivo expression 
and folding of the protein is aided by chaperones that we could not 
reconstruct in vitro. Additionally, the long disordered linkers 
connecting the small RRM domains of the protein made it more prone 
to proteolysis and degradation. However, our expression systems and 
purification techniques used in this study were suitable and proved 
successful for obtaining good amounts of soluble truncated proteins 
which allowed us to analyze structural and functional properties of 
both proteins even if it was not the full length protein.  
5.2. Mip6 and Pes4 are RNA binding proteins with multiple RNA 
recognition motifs 
A common feature in the diverse RNA binding proteins (RBPs) 
is containing RNA binding domains (RBDs) also known as RNA 
recognition motifs (RRMs) or ribonucleoprotein domain (RNP). This 
domain, which recognizes RNA sequences (canonically single stranded 
RNA), and binds them, is the most abundant RNA-binding domain in 
eukaryotes (Clé Ry, Blatter, Dé Ric, & Allain, 2008; Maris, Dominguez, 
& Allain, 2005). The diversity of RBPs and the number of highly 
dynamic RNA binding domains they contain renders them 
multifunctional, playing dynamic roles in the different steps of RNA 
biogenesis and thus regulating gene expression. When it comes to 
mRNA export, this feature is of extreme importance as the fate of 
mRNA, whether to be exported and therefore translated or not, is 
dependent on the proper formation of mature messenger 
ribonucleoprotein (mRNP). 
In the very few literature references on Mip6 or Pes4, the 
proteins were usually referred to as putative RNA binding proteins 
containing three RRMs (Bolognesi et al., 2016; Jin, Zhang, Sternglanz, 
& Neiman, 2017; Segref et al., 1997). In the only two papers on the 
subject, The “predicted” RRM domains of Mip6 or both Mip6 and 
Pes4, are said to be critical for their function: formation of cytoplasmic 
foci containing RNA when Mip6 is over-expressed (Bolognesi et al., 
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2016), and the role of both Mip6 and Pes4 in mRNA protection and 
localization in stress conditions (Jin et al., 2017). However though, no 
one had actually demonstrated the ability of these proteins to bind 
RNA in vitro or in vivo or looked closer at the number and diversity of 
RRMs they contained.  
We are the first to actually demonstrate, by using biochemical 
and biophysical techniques (Poly(U) agarose beads pull downs and 
Bio-layer interferometry system), the RNA binding properties of Mip6 
and Pes4 proteins where they physically bind RNA with high affinity. 
Although we used a general Poly(U) RNA to measure the binding, 
since until the moment the recognition or preference for any specific 
RNA motif sequence is not yet known, it still showed a good micro-
molar or even nano-molar affinities. That indicates not only that these 
proteins can physically bind RNA, but also that they are capable of  
binding non-specific RNA with high affinity, that might differ in case 
of any specific RNA sequence recognition knowing that RRMs are 
usually highly plastic domains. 
Although we did not put much emphasis on the first two 
RRMs of Mip6 or Pes4, since we were more interested with the later 
two as the interaction platform of Mex67, these first two RRM 
sequences showed the most conservation in terms of sequence with 
66% comparing sequences of Mip6 and Pes4 (figure 5.1). A PDB search 
looking for sequence similarity in the data bank solved structures gave 
us the highest score with percentage identity (36%) with Mip6 RRM1/2 
for RRMs 1 and 2 of the human Poly(A) binding protein (PABC) 
(UniProtKB - P11940). For this reason, crystallization trial of Mip6 
RRM1/2 were carried out with Poly(U) and Poly(A) but none was 
successful until the moment, and in many occasions Poly(A) double 
helix crystals were obtained.  
However, it seems that the addition/mix of the Mip6 RRM1/2 
protein with Poly(A) in the crystallization drop was crucial for the 
crystallization of the Poly(A) in the form of a double helix as crystals 
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were obtained only upon the addition of the protein and never with 
Poly(A) on its own. A similar case is seen in the paper where the 
Poly(A) double helix structure was previously published. Just like in 
our case the Poly(A) duplex structure was obtained while the group 
was attempting to crystallize a similar RRM containing fragment of a 
Poly(A) binding protein (PABP) bound to RNA, and also in their case 
obtaining crystals required the presence of the protein fragment. It 
might be therefore suggested that in vitro and possibly in vivo, the 
occurrence and function of Poly(A) duplexes might be regulated by 
the added protein that may be playing the role of a chaperone for the 
Poly(A) thus shaping it and enhancing its duplex formation, possibly 
in a concentration related manner. This might be relevant under 
cellular conditions where accumulation of Poly(A) occurs such as 
cytoplasmic granules formation upon cellular stress. 
Additionally, Safaee et al. suggested that the NH4+ ions in their 
structure had a role in stabilizing the duplex and provided evidence 
for the duplex increased thermal stability upon the addition of NH4+ 
(Safaee et al., 2013). It is true that also in our case, the Poly(A) double 
helix crystals were obtained mostly in crystallization conditions where 
high concentration of Ammonium was present, however it did not 
seem to make part of our structure. On the contrary, the electron 
densities located where Safaee group suggested ammonium ions, were 
more probably for water molecules instead.  
 
Figure 5.1. Sequence alignment between Mip6 RRM1/2 and Pes4 RRM1/4 with 
66% identical sequence identity. 
On the other hand, we managed to solve several structures 
from Mip6 or Pes4: Mip6 RRM3(313-389), Pes4 RRM3(377-384), Pes4 
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RRM4(391-469), Pes4 RRM3/4(303-473).  All turned out to be a typical 
ordered RRM structures that adopt a typical ß1α1ß2ß3α2ß4 topology 
formed by four anti-parallel ß sheets and two α helices packed against 
the ß sheets.  
Canonically, RRMs contain two conserved sequences located 
on their central ß sheet of the domain, named RNP1 (on ß3) and RNP2 
(on ß1) exposing three aromatic side chains on the surface that would 
form the most common RNA binding platform of an RRM. The two 
aromatic rings in RNP2 (position 2) and RNP1 (position 1) are 
traditionally involved in the stacking of two deoxynucleotides, while 
the third aromatic residue located in RNP1 (position 3) often interacts 
with the sugar rings of a dinucleotide. However though, not all 
residues of RNP2 and RNP1 are conserved in all RRMs. Some RRMs 
will have only one or two exposed aromatic residues on their central ß 
sheet (Allain, Bouvet, Dieckmann, & Feigon, 2000).  The most frequent 
conserved residues, though, are the aromatic residues in RNP2 
position 2 and RNP1 position 5. 
Even though we couldn’t get any RRM structure with RNA 
bound yet, looking closer at the RNP2 and RNP1 sequences in RRMs 3 
and 4 from Mip6 or Pes4 we see that the RNP2 sequence in all is 
conserved in all 6 positions except for Mip6 RRM3 missing a key 
aromatic residue in position 2 (figure 5.2). As for RNP1, it also showed 
a good level of general conservation. Additionally, loops in an RRM 
can be sometimes also involved in RNA recognition and can be used to 
modulate the binding affinity and specificity of the RNA, and as we 
have seen in the structures we solved (Mip6 RRM3, Pes4 RRM3), these 
loops are usually long and flexible, adopting variable conformations 
(figure 4.17). But how these Mip6 or Pes4 RRMs exactly bind RNA, 
whether on the most preferred canonical beta sheet surface or not-so-
common non-canonical way involving other mechanism, is still to be 
learned and we are working on it. 
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     1         2        3      4   5  6 
RNP2:         [ILV]-[FY]-[ILV]-X-N-L         
 
Mip6 RRM3:  I        L*     V      K  N L 
Pes4 RRM3:   I        F        I      K   N L 
Mip6 RRM4: V       Y        L     K   N L 
Pes4 RRM4:   L       F        L     E   N L 
 
                          1      2     3       4        5        6      7     8 
RNP1 (ß3):   [RK]-G-[FY]-[GA]-[FY]-[ILV]-X-[FY] 
 
Mip6 RRM3:   P     P     H    KA      F       V      T    Y 
Pes4 RRM3:    Y     L    W       A      F       V      T    Y 
Mip6 RRM4:  W    T     F     CG     H       V    EC   F 
Pes4 RRM4:    S     T     Y     SG      F        I      K    F 
 
Figure 5.2. A closer look on the RNP2 and RNP1 sequences in RRM3 and RRM4 of both 
Mip6 and Pes4, and a scheme showing the organization of the key conserved aromatic 
residues on the central ß sheet of the RRM. A general conservation in the sequences is 
learned, except for Mip6 RRM3 missing the key aromatic residue on the second position of RNP2. 
5.3. Pes4 RRM3/4 structure and the role of multiple RRMs 
Although the RRM domain is one of the most existent domains 
in eukaryotes, only a handful of structures for tandem RRMs in 
complex with nucleic acid are solved. A big part of the reason might be 
the fact that individual RRMs not only comprise flexible loops (figure 
4.17), but also usually connected by long flexible linkers, which in 
general contribute to these domains high plasticity and dynamicity 
but also makes them more difficult to crystallize.  
In the Pes4 RRM3/4 structure we solved, the RRM3 and RRM4 
do not contact each other. The linker connecting both domains is 
extended and disordered keeping the two RRMs tumbling 
independently in a V-shaped cleft (figure 4.49). Of course, RRMs can 
function alone, or in tandem giving them an extended binding 
interface for the recognition of longer RNA sequences cooperatively. 
2 
3 
5 
8 
ß4 ß1 ß3 ß2 
RNP2 RNP1 
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From the few crystal structures available for free or RNA bound two 
tandem RRMs, the free tandem RRMs frequently convene an open 
conformation with no-interdomain contacts with a disordered linker 
as seen also in Pes4 RRM3/4 structure (figure 4.49). Yet, this 
conformational change when RNA is bound takes a more closed and 
fixed conformation bringing the two RRMs closer together and 
making the linker more ordered. This is true for most protein 
structures where tandem RRMs were solved bound to RNA, like in sex 
lethal (Sxl) protein (PDB ID: 3SXL; 1B7F), human RNA binding HuR 
protein (PDB ID: 4EGL; 4ED5), or even the Poly U binding (Pub) 
protein (Crowder, Kanaar, Rio, & Alber, 1999; Li et al., 2010; Wang et 
al., 2013; Yokoyama et al., 1999) .  
This is interesting since it gives the domains plasticity due to 
the range of new possible conformations, as the protein recognizes 
different RNA molecules with different sequence specificity, length, or 
binding affinity. However, when RRMs are separated by a very long 
disordered linker making two patch or RRMs clearly independent, like 
in the case of the big distance between RRM1/2 and RRM3/4 of Mip6 
or Pes4, might indicate a possible recognition of different RNA 
sequences and perhaps increase the probability of the protein 
encountering their different binding sequences (Cléry & Allain, 2013). 
It is plausible that the presence of a very long flexible linker between 
RRM1/2 on one side and RRM3/4 on the other, in addition to the other 
disordered inter-domain linkers and flexible domain loops might also 
be a contributing factor to the fact that we couldn’t get crystals of the 
Mip6 construct containing all its four RRMs (Mip6(111-480)) until the 
moment.  
Bearing this in mind, we tried to crystallize Mip6 RRM3/4 and 
Pes4 RRM3/4 with added RNA in an attempt to get a more ordered 
stable structure when RNA bound. Crystals from Pes4 RRM3/4 bound 
to Poly(U) were obtained. The crystals shape was distinct from those 
of free Pes4 RRM3/4 (needles, monoclinic) and belonged to another 
space group (orthorhombic). Even so, we were not able to obtain 
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phases to solve the structure especially that the resolution was poor at 
2.7 Å in some crystals and many copies were to be expected in the 
asymmetric unit. Nevertheless, ongoing amplifications to obtain better 
crystals for heavy metal phasing are being carried out.  
Additionally, sometimes the cooperation between two RRMs 
to bind RNA might mean more contribution in RNA binding of one 
RRM than the other. For example, As seen in the RRM-bound HuD 
RRM1 and RRM2 protein structure (Wang et al., 2013), the RRM1 
primarily recognizes the RNA (PDB ID: 4ED5). The consequent RNA-
binding induced conformational changes in the structure bring RRM2 
and the inter-domain linker in contact to the RNA substrate. So, while 
RRM1, the initial recognition RRM, interacts with five RNA 
nucleotides making it the critical RNA binding domain, RRM2 only 
recognizes two nucleotides stabilizing the complex.  
This, however, might also be the case of Mip6 RRM3 as it could 
explain the weaker binding of individual Mip6 RRM3 seen to the 
Poly(U) agarose beads with correspondence to the strong Mip6 RRM4 
band co-eluting with Poly(U) from the beads as visualized on SDS-
PAGE (figure 4.11,c). Also, what supports this hypothesis  is, as 
discussed in figure 5.2, the fact that Mip6 RRM3 sequence is missing a 
key, typically conserved, aromatic residue of RNP2 position 2 (ß2) 
while having only one fully exposed aromatic residue in RNP1 (ß3) 
regardless of having other exposed residues on ß2 and ß4 respectively 
(figure 5.3). So in case RRM3 binds RNA in a canonical manner, this 
might have an effect on the number of nucleotides it would be able to 
stack on its beta surface. A similar case is seen in the complex 
structure of RNA-bound nucleolin RRM1/2 (Allain et al., 2000), where 
nucleolin RRM2 is also missing an exposed aromatic residue in RNP2 
position 2. Upon RNA binding, while RRM1 contributed to most of the 
nucleotide interactions (six nucleotides), RRM2 in the structure only 
interacted with two nucleotides. On the other hand, looking at Mip6 
RRM4 sequence and its predicted structure we obtained using I-
TASSER, it had three exposed residues of RNP1 and RNP2 respectively. 
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This is also consistent with the high affinity of Mip6 RRM3/4 to RNA 
we measured using the Bio-layer interferometry that calculated a 
binding affinity of 0.318 µM, with an RNA binding affinity of 5.7 µM for 
Mip6 RRM4 alone (figure 4.12) (Wang et al., 2013). 
      
Figure 5.3. Aromatic residues exposed on Mip6 RRM3 beta sheet. The three conserved 
aromatic residues on RNP1 and their position are shown in blue, where only one of them exposed 
to the solvent (position 5). On the other hand, no aromatic residues are found on ß1 in the RNP2 
sequence, instead RNP2 position 2 harbours a leucine instead of the typical conserved aromatic 
residue. Other aromatic residues found on ß2 and ß4 not part of the RNP1 and RNP2 are shown 
in pink. 
5.4. Mip6 RRM4 is the binding surface for Mex67  
Contrary to the previously held thought, we demonstrated that 
Mip6 has a fourth RNA binding domain instead three using different 
techniques: with Poly(U) agarose beads pull down experiments and 
also with Bio-layer interferometry (section 4.3.4 and 4.3.5). Thus, we 
characterized a novel RRM4 on Mip6. Moreover, we proved this 
particular RRM4 is also the site of binding of a protein, Mex67 (section 
4.5.3). In the unique study where the Mip6/Mex67 interaction was first 
tackled using the yeast two hybrid system, they suggested that the 
RNA binding of Mip6 has nothing to do with its interaction with 
Mex67 since a Mip6 construct lacking all the putative RNA binding 
domains was still able to interact with Mex67 (Segref et al., 1997). 
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However, now we know that Mex67 actually binds an RNA binding 
domain of Mip6 that was not previously recognized. Also, the fact that 
Mex67(528-599) eluted together with Mip6 RRM4 from size-exclusion 
chromatography column, a technique rather used for protein 
separation, in a single peak indicated that the two proteins were 
holding together tightly in a stable complex with rather good affinity 
(figure 4.24).  
Additionally, using ITC biophysical technique we showed that 
the obtained low micro molar binding affinity of Mex67 to Mip6 
RRM4 was almost equivalent to that of Mip6(111-480) containing all four 
RRMs (figure 4.25), so we conclude that Mip6 RRM4 is sufficient to 
achieve the interaction with Mex67 . We then looked closer at the ITC 
kinetic parameters to get an overview on the type of interaction we 
would expect between the two proteins. In the ITC interaction 
between Mip6 RRM4 and Mex67, neither enthalpy nor entropy 
appeared to be dominating the interaction as the enthalpy (∆H) and 
entropy (∆S) changes both gave negative values although ∆H was 
slightly more negative (figure 4.25). However, In ITC experiments 
where Mip6(111-480) was used instead of Mip6 RRM4(390-480) in the cell, or 
when GST-Mex67 UBA was used instead of Mex67(528-599) in the 
syringe, the entropy change (∆S) was positive while ∆H was negative. 
So it seems that the interaction might probably be a more polar 
protein-protein interaction or maybe a mixture of polar and 
hydrophobic interactions. 
Although RRMs are known for their RNA binding abilities, 
recently structural and functional studies showed that some RRMs are 
capable of protein binding as well. Yet, the protein recognition had no 
general mechanism of interaction. In general, the RNA-binding RRMs 
that are involved in protein-protein binding use different platforms on 
their structure to bind both the RNA and the protein simultaneously 
(Nagai, Price, & Evans, 1998; Rideau et al., 2006).  
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On another hand, a class of RRM domains is involved in 
protein binding but not RNA binding. This class of non-RNA binding 
RRMs either have their ß sheet surface exposed but generally lack the 
conserved aromatic residues on RNP1 and RNP2 sequences important 
for RNA connection like the non-canonical U2AF homology motif 
family (UHM) (Kielkopf, Lücke, & Green, 2004), or have similar 
sequences to canonical RRMs but achieves protein interaction through 
its entire ß sheet instead of RNA interaction . This is not the case of 
Mip6 RRM4 as it has conserved aromatic residues in RNP1 and RNP2 
sequences like canonical RRMs and we also proved that it is indeed 
involved in RNA binding and protein binding in vitro with high 
affinity. 
5.5. Pes4 RRM4 binds RNA but not Mex67 
Mip6 and Pes4 are homologs sharing  ̴ 40% sequence identity 
(figure 4.39), and are said to be paralogs that arose due to an ancient 
yeast whole genome duplication (Byrne & Wolfe, 2005; Wolfe & 
Shields, 1997). While Mip6 was binding to Mex67 through its RRM4 as 
we showed and discussed earlier, the homologous Pes4 RRM4 did not 
have the ability to interact with Mex67. It is not clear, however, 
whether Mip6 RRM4 have evolved its ability to interact with Mex67 
separately or is it that Pes4 that have lost it. On all cases our finding 
suggest, that although both Mip6 and Pes4 have all four ordered RRM 
domains in the structure, and share the function of RNA binding, they 
did not share the ability of their RRM4 to bind Mex67 which went 
exclusively to Mip6 RRM4 domain. It might be criticized that Mex67 
perhaps may bind on another region on Pes4 not necessarily its RRM4. 
This, of course, could be taken as a possibility that we consider but 
hugely doubt if we take into account the high sequence identity 
between the two proteins, the high conservation of their domain 
organization, their secondary structure organization, and the fact that 
RRM4 is a well ordered domain as seen in Pes4 RRM4 structure that 
shares 42% of identical sequence with Mip6, while other domain like 
RRM1 and RRM2 had an even higher degree of sequence conservation 
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(figure 5.1). If this is indeed the case, it would suggest that Mip6 and 
Pes4 evolved their sequence for divergent functions through time. 
Future experiment using the full length Pes4 to check interaction with 
Mex67 would then set the case to rest, however the difficulty of 
getting a soluble full length Pes4 prevented us from carrying out the 
experiment at the moment.  
 Additionally, a protein cleavage due to proteolysis that led to 
the independent crystallization of Pes4 RRM3 and Pes4 RRM4 seems 
to have most probably occurred during the crystallization process and 
not before, thus excluding the possibility of any proteolytic event that 
might have affected the function of the protein in Mex67 binding, 
especially that from the same purified protein sample, crystals of the 
whole Pes4 RRM3/4 were obtained.  
5.6. Mip6 RRM4 Mex67 binding affects its ability to bind RNA 
Since Mip6 RRM4 can bind both nucleic acids (RNA) and 
Mex67 protein as we showed with similar affinity, the imperative 
question was whether the Mip6 RRM4 bind both partners 
simultaneously or perhaps competitively. For this reason, we checked 
the ability of a pre-formed Mip6 RRM4/Mex67(528-599) to bind to 
Poly(U) agarose beads in vitro (section 4.9, figure 4.37). The pre-
formed complex did not elute with the Poly(U) from the beads 
indicating no binding of Mip6 RRM4 to the Poly(U) once the Mex67 
was bound, although Mip6 RRM4 on its own, as a control, was clearly 
binding. The experiment was repeated several times with different 
boundaries of Mip6 RRM4 complex with Mex67(528-599) with the same 
results obtained. On the other hand, when Mip6 RRM4 was added 
first to the Poly(U) agarose before adding Mex67(528-599), only Mip6 
RRM4 co-eluted with Poly(U). This finding was suggesting that 
whoever was binding first to Mip6 RRM4 was affecting its ability to 
bind the other. A native gel electrophoresis with a pre-formed Mip6 
RRM4/Mex67(528-599) and increasing concentrations of RNA also 
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pointed to the same direction, as no band shift was seen upon adding 
increasing concentration of RNA (figure 4.38).  
A point mutation W442A in Mip6 RRM4 loop3, however, 
disrupted the interaction with Mex67 but not with RNA (section 
4.15.3). This severe interaction disruption caused by a single mutated 
Tryptophan 442, indicates that this exposed polar and aromatic 
residue might be involved directly in the interaction with Mex67, 
which suggests its possible location in the direct site of binding. This 
Tryptophan however, is not located on an ordered alpha helix or beta 
sheet, instead it is located on the loop3 (connecting ß2 and ß3) which 
as we discussed earlier is usually flexible in movement and diverse in 
length that might have an effect on the function of the RRM domain. 
In some RRMs this loop might even be involved in RNA binding.  
To our knowledge, there is not any known protein-binding 
RRM that binds protein in this manner. As discussed in section 5.4, 
the protein-binding RRMs bind the protein and RNA simultaneously, 
bind protein through RNA, or are protein-binding RRMs that lost the 
ability to bind RNA, but an RRM that interacts with both RNA or 
protein not competitively but rather where one conditions the binding 
of the other is not, to our knowledge, characterized yet in literature. In 
the first case, the protein and the RNA usually bind simultaneously on 
opposite interfaces of the RRM. The RNA canonically and stably 
interacts with the ß sheet platform as we explained earlier especially 
as the hydrophobic aromatic residues on RNP1 and RNP2 are 
conserved (as in the case of Mip6 RRM4), on the other hand the 
protein typically interacts with the α helices positioned behind the ß 
sheet as illustrated in Figure 5.4. For all the structures that we know 
of, this is the case for RRM structures binding both RNA and proteins 
as seen in the structure of the nuclear Cap-binding protein complex 
for example, or that of the splicesomal U2B”-U2A’ protein complex 
bound to small nuclear RNA illustrated in figure 5.4, 5.6) (Mazza, 
Segref, Mattaj, & Cusack, 2002; Nagai et al., 1998) .  
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This does not seem to be the case of Mip6 RRM4 however. 
Mip6 RRM4 was certainly not binding Mex67 through RNA, as 
Mex67(528-599) was not binding RNA on its own as our results show 
(figure 4.29, 4.39), and both proteins were still physically interacting 
in the absence of added RNA 0r even when RNase was added. 
Moreover, looking at the Mip6 RRM4 predicted structure; the alpha 
helices interface is quite distant from the position of the Trp442 on the 
loop3 to the opposite direction. The measured distance between Trp 
442 and the closest residue from the first alpha or the second alpha 
helix in the domain is approximately 16.74 and 19.44 Å respectively. So, 
apart from the non-simultaneous binding to Mex67 and RNA, it seems 
like the mechanism of binding itself might be different as the 
canonical RNA binding site on an RRM is very close to the expected 
Mex67 binding site than other characterized protein binding sites.  
             
Figure 5.4. The protein-binding RRM interfaces for binding both a protein partner and 
RNA. (a) The crystal structure of U2B”-U2A’ potein complex bound to a fragment of U2 small 
nuclear RNA. In the illustration, a model compisition where the U2B” RRM is replaced with Mip6 
RRM4 (dark blue) in the structure to show how would it apply to Mip6 RRM4 as the folding in 
both is highly conserved. As shown in the structure, U2A’ interacts with U2B” hydrophobically 
through its alpha helix 1 majorly, while the RNA binds to the RRMs’ ß sheet on the opposite side. 
Additionally, the two exposed aromatic residues in RNP1 and RNP2 on the central beta sheet 
(highlighted in pink),conserved in both U2B” RRM and Mip6 RRM4 , as shown in the structure, 
are directly involved in the interaction with two deoxynucleotides of the RNA. (b) A closer look 
U2A’ protein 
Trp 442 Trp 442 Loop 3 
α helix 2 
α helix2 
(a) (b) 
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on the RRM4 central ß sheet that constitute the binding platform for RNA. In both figures, the 
Tryptophan Trp 442 located on loop3 is highlighted in pink. 
Combining the results of the chemical cross-linking 
experiment (figure 4.36), and the comparison of sequence alignment 
with Pes4 RRM4 in which the conserved residues with Pes4 RRM4 are 
excluded (figure 4.53), also comes in line with this hypothesis 
indicating a Mex67-binding interface on Mip6 RRM4 involving loop3, 
in close proximity to the expected RNA binding surface. Interestingly, 
this loop, loop3, as seen in Pes4 RRM4 structure which did not have 
the ability to bind Mex67 is very short and is stable with no room for 
flexibility. Additionally, as we demonstrated earlier that Trp442 
mutation to Alanine would have a tremendous effect on the complex 
formation, which reflects its central role in the interaction, and Trp442 
is not conserved in Pes4 RRM4 sequence. Actually, comparing the 
aligned Mip6 RRM4 and Pes4 RRM4 sequences, a distinctive overall 
low degree in sequence conservation is noticed in the area of ß2 and 
ß3 and loop3 connecting them as figure 5.5 shows. All this information 
given from different experimental results indicates the likelihood that 
the location of this residue on a loop may reflect that this loop 
flexibility might play a role in the ability of Mip6 RRM4 to recognize 
or bind Mex67 on one hand, and also the ability to interact with RNA 
on the other due to the close proximity of the expected binding areas 
for the partners. 
                                                                                      
 
 
 
Figure 5.5. Sequence alignment between Mip6 RRM4 and Pes4 RRM4 with the secondary 
structure arrangement as seen in Pes4 RRM4 crystal structure. The alignment residues are 
coloured from the least conserved residues up to the most conserved ones. As visible, the area 
between ß2 and ß3 including loop3 shows very little sequence conservation, unlike the alpha 
ß3 
Loop3 ß2 ß1 ß4 α2 α1 ß3 
* 
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helices regions. The Trp 442 in Mip6 RRM4 is highlighted with a star where it shows n0 
conservation. 
Thus, If what we suggest is the case, this indicates that Mip6 
RRM4 is a novel RRM demonstrating a distinctive RRM-protein 
interaction manner, in which the protein partner, not only binds the 
RRM on newly characterized interface, but also located on a close 
proximity to the RNA binding site, so that the binding of the RRM to 
either the protein or the RNA as a first partner conditions its ability to 
bind the other especially when both Mex67 and Poly(U) RNA had very 
similar micro molar binding affinities to Mip6 RRM4. 
But how exactly Mex67 binding to Mip6 RRM4 is disrubting it 
interaction with RNA or vice versa? Of course, a future detailed 
structural studies would clarify this point but unfortunetly until the 
moment our crystallization trials to get a Mip6 RRM4/Mex67 complex 
structure were not yet succesful. Nevertheless, one possibility is that 
the close proximity of the expected binding surface for Mex67 on one 
hand, and RNA on the other hand as illustrated in the figure 5.4 and 
figure 5.6.b might indicate a partial overlapping of binding sites of 
both partners. This would be supported by the fact that loop3 in most 
RRM structures, and as seen also in Mip6 RRM3 and Pes4 RRM3 
structure is a flexible, dynamic, and changing conformations, where 
some conformations might be favorable for specific RNA binding 
while others not. Also as seen in figure 5.6.a, sunstituting U2B” RRM in 
the structure with Mip6 RRM4 structure shows clearly the different 
conformations a long loop3 can adopt regardless of the conserved 
overall structure. Knowing the level of high plasticity RRMs generally 
have, we suggest that the binding of one partner whether it is Mex67 
or RNA might induce some conformational changes, probably 
involving loop3, on Mip6 RRM4 rendering the binding of the other 
partener less favorable, espcially when the binding sites are such of 
close proximity (figure 5.6.b).  
Discussion 
179 
 
   
Figure 5.6. The flexible loop of Mip6 RRM4 and the close proximity to the canonical RNA-
binding site. (a) Superposing U2B” structure with Mip6 RRM4 shows the different loop3 
conformations (b) Mip6 RRM4 surface (in blue) with hydrophobicity shown in green. The 
hydrophobic site of canonical RRM protein-binding site where U2A’ is binding, on the other 
hand the RNA binding site is also pointed to, whereas the position of loop3 with Trp442 
highlighted in pink shows how it’s possible different conformations may interfere with RNA 
binding or vice versa. 
In addition to the dynamics of Mip6 RRM4 domain itself, 
another possibility would be an equilibrium between a 
monomer/homodimer association of Mip6 RRM4. This equilibrium 
may help regulate the function of the domain, increasing specificity or 
affinity or both for one partner but not the other. Some RRM domains 
are known to form homodimers generating extended binding surface 
to increase their specific RNA recognition properties or/and increasing 
the binding affinity too (Lunde, Moore, & Varani, 2007; Ye, Malinina, 
& Patel, 2003). A support for this hypothesis comes from the primarily 
NMR spectroscopy done in collaboration with Dr. Jose Manuel Perez 
Canadillas protein NMR group, used for assigning Mip6 RRM4 
structure. The NMR assignment of the spectrum was poor and not 
complete, as seen on 15N-1H HSQC spectrum of the Mip6 RRM4 
domain shown in figure 5.7. The profile of the resulting peaks might 
be indicating a possible dimerization or a possible monomer/dimer 
exchange. Future experimentation, however, might give us better 
answers.  
(a) (b) 
Trp 442 
Trp 442 
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Figure. 5.7. 2D 1 H,15N HSQC NMR spectra of Mip6 RRM4. Resonance peaks are annotated to 
show the backbone amide assignments. Not all the residues have been successfully assigned. 
Additionally, the ITC kinetics for Mip6 RRM4/Mex67(528-599) 
complex, where Mex67(528-599) was titrated into 50 µM of Mip RRM4 in 
sample cell was calculating a stoichiometry coefficient of n=0.965  ̴ 1 
which indicates a 1:1 binding ratio between both proteins. However, 
when the concentration of Mip6 RRM4 used was increased to 70 µM, 
the stoichiometry coefficient calculated was around n=0.72-0.8 which 
now indicates a different ratio than 1:1. Also, reversing the proteins 
location during the ITC experiment so that the higher concentration 
of Mip6 (700 µM) was titrated into 50 µM of Mex67 lead to a 
calculation of n  ̴1.6 which is consistent with the previous finding. In 
both cases the binding affinity for Mex67 was mildly lower than when 
lower concentration of Mip6 RRM4 was used. This, in addition to the 
NMR assignment profile of Mip6 RRM4 led us to suspect a possibility 
of a higher level of association in Mip6 RRM4 that might be regulating 
its function. 
5.7. Mex67 UBA domain gets an additional partner 
The survival of the cell depends on the proper function of 
Mex67, since it is the major mRNA exporter, conserved from yeast to 
humans (J. Katahira et al., 1999). One critical domain of Mex67 is its C-
terminal UBA not only required for a proper mRNA export, but also 
15N
 (ppm
) 
1H (ppm) 
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for the pre-ribosomal subunit export and also contributes to the 
recruitment of Mex67 to the TREX complex (Gwizdek et al., 2006). 
Although the crystal structure of the human Mex67 UBA was 
previously solved (PDB ID: 1OAI), and recently from Chaetomium 
thermophilum fungal species (PDB ID: 4WP2), we succeeded in solving 
the crystal structure of yeast (Saccharomyces cerevisiae) Mex67 UBA 
with additional N-terminal 18 residues of the linking area connecting 
the NTF2 like domain to the UBA domain.  
The structure showed a general conservation where the UBA 
domain was formed by four alpha helices, while its N-term was made 
of two additional small alpha helices. The highest degree of 
conservation was in the core alpha helices. Comparing Mex67 UBA 
domain to that of the other species, showed the most structural 
conservation with the human homolog. On the other hand, despite 
the conservation of the first three helices, the C. thermophilum UBA 
had significant differences with an N-terminal additional extension 
and a longer more protruding loop connecting α2 and α3 of the UBA 
domain. 
Mex67 is known to interact with many adaptor proteins and 
previous studies have shown that Mex67 UBA is not only the site of 
binding for the FG nucleoporins, but also the site of binding of Hpr1, a 
core THO/TREX complex protein. Curiously, both compete for the 
binding to the same hydrophobic pocket on Mex67 UBA with 
comparable affinities (Hobeika et al., 2009). Furthermore, previous 
study that used the yeast two-hybrid technique to check interaction 
between Mex67 and Mip6 saw no binding when a construct containing 
the UBA domain of Mex67 (residues 549-599) was used, and thus 
concluded that the UBA domain of Mex67 was not the direct site of 
binding of Mip6 and instead an intact Mex67 carboxy-terminal 
domain which includes a part of the UBA domain is required for the 
two hybrid interaction with Mip6 (Segref et al., 1997). 
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Therefore we used different techniques to check whether 
Mex67 also binds to Mip6 through its UBA domain. Initially, using the 
Bio-layer interferometry technique, where a tagged protein is 
experimentally required, indicated that Mip6 was binding on Mex67 
UBA(545-599) while no binding was evident with only the N-terminal 
region (481-544). Subsequent pull down assays confirmed that the N-
terminal region was not sufficient for obtaining binding on its own. 
However, surprisingly, cleaving the fused N-terminal Mex67 UBA tag 
prevented the two proteins holding stably together in gel filtration 
thus indicating a disruption in the binding. Affirmative results from 
the ITC experiments confirmed that indeed N-terminally free Mex67 
UBA lost the ability to interact and bind Mip6, while an N-terminal 
GST tagged Mex67 UBA restored the binding with a binding affinity 
comparable to that with endogenous Mex67(528-599) comprising the 
UBA plus its N-terminal 18 residues (section 4.7.3, 4.7.4). Besides, the 
MASCOT results following the cross-linking experiment, were also 
excluding the N-terminal region of the UBA as part of the interaction. 
Instead, both MASCOT results and NMR spectrometry titration 
experiment of Mip6 RRM4 into Mex67 were pointing to the central 
helix 2 of the UBA, involved in the binding of both the FG repeats of 
the nucleoporins and Hpr1 protein, as the main helix involved in 
binding of Mip6 as visible in figure 5.8.  
  
N-term 
C-term 
UBA starts 
here  
Helix 1 
(a) (b) 
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Figure 5.8. The site of binding of FG nucleoporins on Mex67 UBA domain. (a) An 
illustration showing the expected site of binding of FG nucleoporins on the surface of Mex67(528-
599). In the illustration, a model composition where Mex67 is replacing the human homolog TAP 
or NXF1 UBA domain in the structure solved from it bound to FG nucleoporins (PDB: 1OAI). (b) 
The tertiary structure of Mex67(528-599) with the bound FG peptide. The parts highlighted in red 
are the ones identified by MASCOT as the parts involved in binding. The overlap of results from 
the cross-linking experiment and NMR titration suggests that helix 2 of the UBA  involved in 
nucleoporins binding is majorly involved in Mip6 binding. (c) The surface electrostatic potential 
on Mex67(528-599) surface calculated by ABPS and visualized using Chimera. 
Therefore, we here characterize Mip6 as a new Mex67 UBA 
binding protein in addition to the FG nucleoporins and the Hpr1 
protein. However though, interestingly an N-terminal extension on 
the UBA is mandatory for the protein to be able to interact with Mip6. 
This mandatory N-terminal extension does not seem to be sequence 
specific as the replacement of the endogenous N-terminal region with 
the GST tag replenished the binding with a comparable affinity. 
Moreover, the risk of somehow the Mip6 protein binding non-
specifically to the GST, or an effect of GST dimerization, is dismissed 
as both Mex67 UBA and Mex67 ∆UBA proteins were GST tagged.  
 So depending on the several lines of evidence, we suggest that 
additional residues on the N-terminus of Mex67 UBA are required for 
Mip6 binding, not necessarily sequence specific or because of a direct 
contribution in the binding, but more likely for certain conformational 
purposes putting the Mex67 UBA domain in a conformation required 
for Mip6 identification, or maybe for a role in stabilizing the binding 
once Mip6 is actually bound. Moreover, as visible in the Mex67(528-599) 
(c) 
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structure (figure 5.9), the N-terminal region was not floating in an 
open conformation; instead it was folding toward the first helix of the 
UBA domain, as also seen for the last helix 4 of the UBA. It is known, 
for example, that this last helix of the Mex67 UBA domain (H4) works 
as a switch required for stabilizing the binding of the FG repeats or 
Hpr1 to the UBA, as it packs against the bottom of their binding 
pocket and so seals it although it is not itself directly involved in the 
binding (Grant et al., 2003; Hobeika et al., 2009). Therefore, the 
deletion of H4 would greatly reduce the strength of its interaction to 
its Hpr1 or FG nucleoporins partners (Hobeika et al., 2007). 
Additionally, although it is not directly involved in binding, its 
residues showed chemical shift changes during NMR spectrometry 
titration experiment with FG peptide consistent with an FG induced 
conformational changes in helix 4 (Grant et al., 2003). This might also 
be the case of the N-terminal region of the UBA, but instead of being 
the C-term helix it would be the N-term region stabilizing and locking 
helix 2 in position required for binding, although it might not be itself 
majorly involved in binding (figure 5.9). This would also explain the 
NMR spectroscopy shift changes seen in the UBA N-terminal area 
when Mip6 RRM4 is titrated into Mex67(528-599) (figure 4.54), although 
our cross-linking/MASCOT and ITC results did not show any direct 
involvement of the N-terminal region. Furthermore, an interesting 
future experiment would be to check whether Mip6 binding interferes 
with the FG repeats or Hpr1 binding or vice versa, or whether Mex67 
can carry both partners simultaneously. 
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Figure 5.9. (a) In the illustration, the core helix 2 of the Mex67 UBA domain is highlighted in red 
while both the C-terminal helix 4 and the additional N-terminal region of the UBA are shown in 
green. As demonstrated, these two extremities form like a clamp folding toward the core helix 2 
locking it in position. So while helix four is required for the FG nucleoporins binding (shown in 
blue) it is not itself directly involved in the binding. The N-terminal region might be behaving 
the same for any partner binding on the other sides of helix 2, thus locking it in position and 
stabilising its interaction. (b) The surface of the structure. The illustration was generated using 
Chemira where the human Mex67 UBA from the structure with PDB ID: 1OAI was replaced by 
our Mex67 yeast C-terminal structure in a model composition. 
5.8. Mip6 function in vivo as a possible novel adaptor protein for 
Mex67 
Until this day, only two published studies have looked into the 
in vivo function of Mip6 and only one of them looked at Pes4 function 
along with Mip6, so its exact role in vivo is not yet well understood 
awaiting future details. Carrying out in vivo assays in collaboration 
with Susana Rodriguez Navarro lab however was able to give us a 
better look on the possible Mip6 function. The results (unpublished) 
show that although a deletion of Mip6 (Mip6∆) was not cell-lethal as 
Mex67∆ and did not show any evident cell growth phenotype, a 
double mutant of Mip6 with the thermo-sensitive Mex67-5 strain (a 
thermo-sensitive Mex67 mutant (Segref et al., 1997)) had a negative 
sensitive synthetic growth phenotype where cells were unable to grow 
at 33°C. Interestingly, it was found that the Mip6 W442 mutant, not 
able to interact with Mex67 also exhibits a thermo-sensitive phenotype 
even at 35°C. These results in addition to the fact that Mip6 is an RNA 
binding protein capable of direct RNA binding in vitro as we 
(a) (b) 
N-term Helix 4 
Helix 1 
Helix 4 
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demonstrated would lead us to suggest a mode of function for Mip6. 
Here we suggest a possible function for Mip6 as a novel adaptor 
protein for Mex67 in mRNA export, as it fits all the categories for 
being one.  
As discussed in the introduction (section2), Mex67 as the 
major mRNA export receptor is known to interact with many RNA 
binding adaptor proteins, where some of these adaptor proteins are 
required for the recruitment of Mex67 to transcribing genes before 
export, while others further shuttle with Mex67 to the cytoplasm. It 
might be proposed then, that the RNA binding Mip6 is also playing 
that role, and while it binds Mex67 through its RRM4, the other RRMs 
are still binding RNA as we showed and thus would be holding RNA 
and further shuttling with Mex67 to the nucleus especially as Mip6 
doesn’t have the capacity to shuttle on its own. This hypothesis is also 
supported by the fact that in vivo Mip6 localizes homogeneously both 
in nucleus and in cytoplasm at normal growth conditions (Bolognesi et 
al., 2016), however when Mex67 was inactivated in vivo, most Mip6-
GFP was retained in the nucleus. Additionally, a non-published work 
from in Susana Rodriguez Navarro lab have also provided evidence for 
Mip6 co-purifying with proteins involved in mRNA export and known 
to interact with Mex67 as it exports the nucleus like Sac3 (a part of the 
TREX-2 complex on the nuclear face of the NPC), and Dbp5 (localizes 
at the cytoplasmic face of the NPC) using TAP purification. This 
proposition would fit and explain all what we learned about Mip6 till 
the moment from RNA binding, to its interaction with a major export 
receptor Mex67, and also its localization both in the nucleus and 
cytoplasm. Therefore, we characterize Mip6 as a novel adaptor protein 
for Mex67 exporter. 
5.9. Mip6 additional role during cellular stress 
On the other hand, previous published results also show that 
when stressing the cells to 39°C, Mip6 localization was altered and was 
seen evidently in cytoplasmic stress granules. One study that looked at 
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the cellular toxicity caused by a concentration-dependent liquid phase 
separation upon increased protein expression, suggested that the 
strong over-expression of the dosage-sensitive Mip6 protein indeed 
changes its localization to cytoplasmic foci impairing cell growth, 
reducing the global translation rates, and causing toxicity (Bolognesi 
et al., 2016). The study also found that these cytoplasmic foci 
contained RNA and demonstrated that at least two of the RRM 
domains of Mip6 are required for the cytoplasmic focus formation.  
Another study that dealt with both Mip6 and Pes4 also 
suggested a role for  Mip6 in regulating steady state expression, 
protection, and mRNA localization during stress conditions (Jin et al., 
2017). They also found that during stress induced sporulation, Mip6 
localizes to cytoplasmic foci that contained mRNA transcripts which 
Mip6 protected from degradation. Additionally, the RRM domains of 
Mip6 were also proven required for the function.  
Taking our in vivo results in collaboration with Susana 
Rodriguez Navarro laboratory and the literature studies into account, 
we then propose another function of Mip6 in stress conditions, so 
while Mip6 binds mRNA and may shuttle with Mex67 under normal 
conditions thus playing the role of an adaptor protein in mRNA export 
and gene expression regulation, when the cells suddenly get stressed, 
Mip6 carries mRNA transcripts through its RRM domains to 
cytoplasmic granules for protection until the growth conditions goes 
back to normal so the gene translation of non-stress specific genes 
then continues.    
Recently, a very interesting study also suggested an additional 
role for Mex67 during stress conditions (Zander et al., 2016). It 
demonstrated that unlike Mex67 role under normal growth 
conditions, upon stress Mex67 dissociates from its known adaptors in 
the nucleus such as Npl3 and Nab2 and therefore from regular mRNA 
in favour of binding and rapid export of heat shock, stress-specific 
mRNA, by passing mRNA quality control checkpoints. On the other 
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hand the cytoplasmic mRNA pool accumulates with bound proteins in 
stress granules. However, it was not yet clear whether in this case, 
Mex67 directly binds mRNA on its own or to unknown stress-specific 
adaptor proteins. But primarily results from Susana Rodriguez Navarro 
laboratory suggest that Mip6 is probably also an adaptor protein for 
Mex67 in stress conditions. The results show that in stress conditions 
Mip6 preferentially binds transcripts connected to stress response. 
Additionally, the export of a certain stress induced transcript SSA4 
that depends exclusively on Mex67 for transcripts during stress was 
seen to be less efficiently exported in the absence of Mip6 compared to 
the wild-type strain (unpublished work). 
This is consistent with our hypothesis, as the protein might 
have different functions not only in normal conditions or stress 
conditions, but also in different pools of the protein with different 
function. We then suggest a model where the cytoplasmic pool of 
Mip6 re-localizes with its bound RNA transcripts to stress granules 
under stress, while the nuclear pool of Mip6 acts as an adaptor protein 
for the nuclear pool of Mex67 to rapidly export stress-specific mRNA 
transcripts. This is also consistent with the fact that other studies have 
also shown that a pool of Mex67 re-localizes to stress-granules or P-
bodies under stress conditions (Mitchell, Jain, She, & Parker, 2013). 
Probably, the pool of Mex67 that re-localizes to the stress granules is 
also the cytoplasmic pool of the protein, since it is proven recently 
that the nuclear pool was the one exporting stress-specific mRNAs 
(Zander et al., 2016). This stress granules localization of the 
cytoplasmic pool of the proteins, however, seems to be independent of 
the Mip6/Mex67 interaction, as the Mip6 W442A mutant was still 
localizing to cytoplasmic granules upon stress.  
5.10. Pes4 evolutionary divergence of function 
Our results also indicate that Mip6 and Pes4 may have evolved 
separate functions through time, which is usually the case of paralogs. 
Although both had a role during cellular stress induced sporulation 
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(Jin et al., 2017), and both re-localize to cytoplasmic foci, however each 
protein displayed distinct cytoplasmic protein localization. Moreover, 
while the protection for few mRNA transcripts by either Mip6 or Pes4 
during sporulation was redundant, many mRNA transcripts were 
uniquely protected by either Mip6 or Pes4. These information in 
addition to our results showing that Pes4 did not have the ability to 
interact with Mex67, therefore implicates that whatever function Mip6 
was accomplishing in complex with Mex67, it is not relevant or shared 
with Pes4. Additionally, although both are RNA binding proteins 
having similar roles in stress conditions, but evolved to recognize 
different mRNA transcripts uniquely although some might be still 
recognized by both.  
5.11. Concluding remarks 
Our work that combines structural, functional and biophysical 
analysis hopefully adds to our knowledge and understanding of the 
dynamics of cellular functions especially mRNA export. However, 
scientific knowledge is the fruit of accumulated work, and our work 
here is just a part contribution for a better understanding and future 
possible implications involving the vital interactions and mechanisms 
in which a major exporter like Mex67 is involved in during different 
cellular conditions. 
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1. Mip6 is an RNA binding protein that binds RNA in vitro with 
high nano-molar affinity. 
2. Pes4, the prologue of Mip6, is also an RNA binding protein 
capable of binding general RNA in vitro with high affinity. 
3. Mip6 contains four RNA Recognition Motifs (RRMs), all having 
the capability of binding RNA with the fourth RRM not been 
previously characterized.  
4. Mip6 RRM1/2 when mixed with Poly(A) RNA chaperones the 
growth of crystals formed by a parallel Poly(A) duplex 
structure. 
5. Mip6 RRM3 is a canonical RRM with a flexible loop3 adopting 
different conformations in different structures. Mip6 RRM3 is 
missing the conserved exposed aromatic residues in the RNP2 
sequence and binds with less affinity to RNA possibly due to a 
lower contribution in cooperative RNA binding. 
6. Pes4 RRM3 and RRM4 structures adopt a canonical RRM fold, 
with Pes4 RRM4 showing some structural differences in terms 
of longer ß2 and ß3 with a much shortened and more stable 
loop3. Pes4 RRM3 and RRM4 are connected with a disordered 
15 residues inter-domain linker. Pes4 RRM3 and RRM4 have no 
contacts between each other in their free form. 
7. Mip6 RRM4 binds both RNA and protein, and it is the physical 
site of interaction with Mex67 protein, the major mRNA 
nuclear exporter conserved from yeast to humans. 
8. Pes4 RRM4 does not bind Mex67 despite having more than 
40% sequence conservation with Mip6 RRM4.  
9. The binding of Mip6 to either Mex67 or RNA first conditions 
its ability to bind the other partner: a characteristic not seen 
before for an RRM domain. 
10. A point mutation of Tryptophan W442A on Mip6 RRM4 loop3 
disrupts its interaction with Mex67, but not its interaction with 
RNA. This Tryptophan is not conserved in Pes4. 
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11. Mex67 C-terminal crystal structure includes the UBA domain 
with additional N-terminal 18 residues packing toward the 
UBA domain core forming a clamp like shape. 
12. The Mex67 UBA domain from Saccharomyces cerevisiae is 
more structurally conserved with the human Mex67 homolog 
UBA domain, than that from Chaetomium thermophilum. 
13. Mex67 binds Mip6 RRM4 through its UBA domain. However, a 
non-specific N-terminal region of the UBA is needed not as a 
main contributor in the interaction but most probably to 
stabilize the binding.  
14. In vivo experiments suggest a role for Mip6 protein as a novel 
Mex67 adaptor especially under stress growth conditions.  
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